Development of mass spectrometry protocols for analysis of oxidised lipidome in inflammatory disease models:Using semi-targeted mass spectrometry based approach & optimized chromatographic separation by Thakker, Alpesh
  
Some pages of this thesis may have been removed for copyright restrictions. 
If you have discovered material in Aston Research Explorer which is unlawful e.g. breaches 
copyright, (either yours or that of a third party) or any other law, including but not limited to 
those relating to patent, trademark, confidentiality, data protection, obscenity, defamation, 
libel, then please read our Takedown policy and contact the service immediately 
(openaccess@aston.ac.uk) 
     
 
Development of mass spectrometry protocols 
for analysis of oxidised lipidome in 
inflammatory disease models 
Using semi-targeted mass spectrometry based approach & optimized 
chromatographic separation  
 
Alpesh Thakker 
A thesis submitted for the degree of 
Doctor of Philosophy 
 
 
 
Dec 2016 
 
©Alpesh Thakker, 2016 
Alpesh Thakker asserts his moral right to be identified as the author of this thesis. This copy of the thesis 
has been supplied on condition that anyone who consults it is understood to recognise that its copyright 
rests with its author and that no quotation from the thesis and no information derived from it may be 
published without appropriate permission or acknowledgement. 
 
  I   
Aston University 
DEVELOPMENT OF MASS SPECTROMETRY PROTOCOLS FOR ANALYSIS OF OXIDISED LIPIDOME 
IN INFLAMMATORY DISEASE MODELS 
 
Alpesh Thakker 
Doctor of Philosophy 
2016 
Thesis Summary 
Phospholipid oxidation generates a wide variety of products with potentially novel biological 
activities that may be associated with disease pathogenesis. To understand their role in 
disease requires precise information about their abundance in biological samples. Liquid 
chromatography-mass spectrometry (LCMS) is a sensitive technique that can provide detailed 
information about the oxidative lipidome, but challenges still remain. 
The work in this thesis developed improved methods for detection of OxPLs by improvement 
of chromatographic separation through the comparison and optimisation of several HPLC 
columns such as C8, C18 and C30 reverse phase, polystyrene-divinylbenzene based 
monolithic, and mixed-mode hydrophilic interaction (HILIC) columns & solvent systems, with 
use of semi-targeted mass spectrometry approaches. The results suggests that the monolithic 
column was the most robust method for separating short chain oxPLs from long chain oxidised 
and native PLs. In addition, several approaches for method validation were explored such as 
testing of reproducibility and repeatability of the methods, together with the reanalysis of 
samples on a high resolution QToF mass spectrometer with automated quantitative data 
analysis using the Progenesis QI software to validate the identification. The combination of the 
developed methods allowed the identification of several oxPLs in biological samples. These 
were:  i) ascites fluid of lean and obese rat model of acute pancreatitis; ii) isolated components 
of red blood cells (RBCs) infected with the malarial parasite Plasmodium falciparum; and iii) 
plasma samples of healthy and diabetic patients. In addition, an evaluation of post-acquisition 
data handling to minimise inherent biological variation was performed. Quantitative differences 
in oxPLs were observed in isolated malarial components as well as other studied disease 
models.  
Overall, several  protocols were developed that provide improved performance for the 
identification of OxPL in biological samples that can be used as a reference method by 
research laboratories interested in oxidative lipidomics work. 
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1 Introduction 
1.1 Lipidomics 
The revolution that has become known as the field of ‘omics’ has allowed the detailed 
molecular profiling of complex biological systems to be realized. Although, lipid biochemistry 
was an active field of research in the 1990s,  lipid research gained impetus at the dawn of the 
21st century driven by technological advancment with the emergence of lipidomics ( a new 
discipline in the omics collection, which came about mainly as a result of the advent of novel 
mass spectrometric techniques which have enabled a more rapid and in-depth generation of  
knowledge about lipid biology and the role of lipids as secondary messengers (Hans & Gross 
2001, van Meer 2005, Wenk 2005).  In his personal view on AOCS lipid library website, Dr 
William Christie claimed that the first mention of the terminology “Lipidomics” appeared in an 
article published in 2001, which defined ‘lipidome’ as, the complete spectrum of lipids in a 
tissue, organelle, or membrane. In the last decade ,  publications using the term lipidomics have 
appeared in increasing numbers   (Hans & Gross 2001, Wenk 2005). Lipidomics provides 
analysis and characterisation of lipids on a system-level and may extend to the identification of 
their interaction partners. A lipidome, therefore, is the comprehensive and quantitative 
description of a set of lipid species, and their interaction with other biomolecules (Khalil, Hou 
et al. 2010, Patti, Yanes et al. 2012, Wu, Shon et al. 2014). Lipidomics could be viewed as a 
sub-discipline of metabolomics, which is explained in figure 1.1.  
Lipidomics can be subdivided into distinct areas such as membrane, organelle, metabolism, and 
mediator lipidomics and can address the comprehensive quantitative description of lipid 
metabolism and turn over, the membrane lipid constituents, or the structural characterization 
and quantification of low abundant bioactive lipid species. Oxidative lipidomics is a relatively 
new area that represents a sub-set of lipidomics focussing on the characterisation of oxidised 
lipids and their role in cell signalling and pathogenesis of various diseases. The profiling of an 
oxidised lipidome can be used to describe the responses of biological systems to environmental 
or genetic modifications and is considered one of the important links between phenotype and 
genes (Sparvero, Amoscato et al. 2010).  
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Figure 1.1: Lipidomics is a system level analysis of lipids and their interaction partners. Genes are transcribed and 
translated into proteins that collectively together with environmental factors; influence the metabolite inventory 
of a cell, tissue or body fluid. Technological advances now allow qualitative and quantitative measurements at 
each level on global scales (genomics, proteomics, and metabolomics). Lipidomics is a subgroup within the field 
of metabolomics. Adapted from (Wenk 2005). 
The important  role of lipids in cell, tissue and organ (patho) physiology is evident from:  i) 
their unique membrane organizing properties, which  provide cells with functionally distinct 
subcellular membrane compartments (e.g. endoplasmic reticulum, Golgi apparatus, secretory 
vesicles, plasma membrane, etc.), ii)  their functional role in cell signalling (e.g. phospholipase-
C and phospholipase-A2 in modulating immunological responses), iii)  their endocrine actions 
(e.g. steroid hormones), and iv) their essential role in production and storage of energy (van 
Meer 2005, Blanksby and Mitchell 2010). Cells, whether bacterial, fungal or mammalian, are 
all equipped with metabolic pathways capable of producing a variety of structurally and 
functionally distinct lipid species by various non-polar fatty acid (FA) or fatty alcohol moieties 
with different backbone structures (i.e. glycerol phosphate and long chain sphingosine bases) 
and alternative head groups. In mammalian cell membranes, the total number of molecular lipid 
species may well be in the thousands. Although this diversity of lipids is very well appreciated 
and correlates with specific cellular phenomena and disease states, the molecular mechanisms 
that underpin the diversity are poorly understood due to limited analytical techniques that are 
capable of measuring the structural details of lipid species in direct comprehensive and 
quantitative manner . Most of the studies in the pre-2003 era investigated the mechanistic 
aspects of the lipid metabolism, which in turn was necessary to understand lipid biology. Post 
2003, lipidomics emerged as a result of innovation in techniques such as mass spectrometry 
(MS), nuclear magnetic resonance spectroscopy (NMR), fluorescence spectroscopy, dual 
polarisation interferometry, and computational methods, coupled with the recognition of the 
significance of lipids in neuroscience, inflammation and in many metabolic diseases, e.g., 
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Oxidative 
Lipidomics 
 Lipid isolation     
and analysis 
Oxidised lipid- 
protein 
interaction 
Lipid signalling & 
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obesity, atherosclerosis, stroke, hypertension, and diabetes(Sandra and Sandra 2013) (German, 
Gillies et al. 2007). The foremost objective of lipidomics, and its subsidiary oxidative 
lipidomics, is to identify the dynamic change in lipid (or oxidised lipid) composition and 
conformation during development of an organism or when a cell is shifted from an established 
physiological condition to another condition or pathological state (Spickett and Pitt 2015, Han 
2016) . In addition, it includes understanding lipid modification via non-enzymatic oxidation 
that forms modified compounds, and their interaction with other biologically active molecules 
and its consequence on cellular homeostasis. 
1.2 Lipids: The essential metabolites 
While lipids are classified into several major classes based on their chemical composition and 
functionality (figure 1.2), the focus of the studies in this thesis is a single class of lipids, the 
phospholipids (PL), which can contain various types of glycerol-alkyl chain linkages such as 
ester, ether, and vinyl ether bonds, which account for the additional diversity among its class.
 
Figure 1.2: Lipid groups of the lipidome (adapted from Fahy, 2009) 
Lipids 
classification
Phospholipids (PL) 
and oxidised 
phospholipids 
(OxPL)
Sphingolipids & 
glycosphingolipids
Triacylglycerols 
(TAG),  
Diacylglycerols 
(DAG),Sterols, 
Sulphatides 
Fatty acids (FA), 
Eicosanoids, 
Retinoids, 
Flavonoids 
  4   
 The amphiphilic nature of phospholipids comes from replacing one of the fatty acids in a 
triacylglycerol (TAG) with a polar headgroup. Phosphatidylcholines (PC) are the most 
abundant phospholipid and the key membrane building block. Approximately 50% of the total 
phospholipid present in membranes of most animal tissues is PC, a neutral zwitterionic 
phospholipid, which makes up the majority of the outer leaflet of the plasma membrane 
(Mouritsen 2011, Subramaniam, Fahy et al. 2011).  PC also serves as the biosynthetic precursor 
for sphingomyelin (SM), phosphatidic acid (PA), lysophosphatidylcholine (LPC), and platelet-
activating factor (PAF). A variety of species of phospholipids with different physical and 
chemical characteristics can be formed, by altering the hydrocarbon chains and the level of 
saturation at the sn-1 and sn-2 position (first and second carbon position of the glycerol body), 
as well as the head group moiety at sn-3 chain. Phospholipids are typically classified by their 
head group structures, examples of which are shown in figure 1.3. The number of possible chain 
lengths and level of unsaturation of the fatty acids (represented by R1 and R2 in the table) creates 
a plethora of molecular species within each headgroup class. Phospholipids not only serve as 
components for cellular compartmentalisation but also perform diverse roles in cells from 
signal transduction to cytoskeleton support. Throughout this thesis, the following nomenclature 
is used to denote the structure of a phospholipid molecule; 16:0/18:1 PC where PC indicates 
the headgroup and class of phospholipid (in this case phosphatidylcholine), 16 represents the 
number of carbon atom fatty acyl chain linked to the glycerol body and the number 0 relates to 
the number of double bonds in the chain; the number 18:1 specifies the carbon chain length and 
the levels of unsaturation  of the fatty acyl chain linked at sn-2 position.  
 
 
 
 
 
Figure 1.3: Representative chemical structure of several classes of phospholipids 
1.3 Oxidative stress and phospholipids 
Oxygen is an abundant molecule in biological systems (Harrison, Griendling et al. 2003). 
Despite being a radical, it is less reactive than some other radical species because its two 
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unpaired electrons are in different molecular orbitals that exhibit parallel spins. Thus, oxygen 
undergoes univalent reduction to form superoxide (O2•⁻) by means of enzymes such as the 
nicotinamide adenine dinucleotide (phosphate) (NADH/NAD(P)H) oxidases and xanthine 
oxidases (XO) (Fruhwirth, Loidl et al. 2007) (Buetler, Krauskopf et al. 2004). The oxidants in 
aerobic systems can come from endogenous processes such as respiration, metabolism, and 
phagocytosis or from exogenous sources by inhalation of air pollutants and exposure to oxidants 
(Reis and Spickett 2012) . 
 Non- enzymatically, oxygen can also be converted to O2•⁻ by reacting with redox active 
compounds such as semiubiquinone of the mitochondrial electron transport chain. Superoxide 
dismutase (SODs) converts superoxide radicals to hydrogen peroxide (H2O2) and oxygen. In 
biological tissues, O2
•⁻can also undergo non-enzymatic transformation into H2O2 and singlet 
oxygen (1O2). H2O2 can react with other radicals such as the transition metal Fe
2+ to produce 
highly reactive hydroxyl radicals (OH•); this is known as the Fenton reaction (Bonomini, 
Tengattini et al. 2008). These radicals are capable of destroying biomolecules through 
oxidation. When Fe3+ initially oxidizes O2
•⁻, molecular oxygen and Fe2+ are generated; the Fe2+ 
initiates the Fenton reaction and this regenerates Fe3+ which perpetuates the production of OH•.  
Myeloperoxidase, a haem protein secreted by phagocytes, can amplify the oxidative potential 
of H2O2. At physiological concentrations of Cl
-, hypochlorous acid ( HOCl) is the major oxidant 
generated by the myeloperoxidase-H2O2-Cl
-system, and HOCl can react with O2
•⁻ to produce 
OH•  (Robaszkiewicz, Bartosz et al. 2014). In addition, HOCl can lead to formation of 
chlorohydrins which are oxidised products formed independent of the free radical mechanism, 
and has been implicated in several inflammatory disorders and are products of HOCl addition 
to unsaturated chain of phospholipid (Spickett 2007, Spickett and Fauzi 2011).  
In response to growth factors and cytokines, and during normal metabolic turnover such as 
respiration and phagocytosis, eukaryotic cells produce oxidants. To regulate this, the cells have 
developed both enzymatic and non-enzymatic mechanisms to protect against oxidants’ toxic 
effects. The enzymatic mechanisms include the actions of enzymes such as SOD, catalase, and 
glutathione peroxidase. The nonenzymatic antioxidants include glutathione, ascorbate, and α-
tocopherol. However, in pathophysiologic circumstances, an excess of oxidants can overcome 
the scavenging capacity of cellular antioxidant systems leading to the pathophysiological state 
termed “Oxidative stress” (Bochkov 2007, Bochkov, Oskolkova et al. 2010, Birukova, Starosta 
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et al. 2013) (figure 1.4). The subsequent oxidative stress damages the cell’s lipids, membranes, 
proteins, and DNA.  
 
Figure 1.4: Oxidative stress and its effect on the physiological process  
 Enzymatic oxidation by lipoxygenases and cycloxygenases (LOX & COX), and non-
enzymatic oxidation of phospholipids (PL) containing mono- and polyunsaturated fatty acids 
(PUFA) can be started by reaction with free radicals or non-radical reactive oxygen species 
(ROS) and reactive nitrogen species (RNS) (Philippova, Resink et al. 2014) (figure 1.5). The 
free radical-mediated chain reaction initiated by formation of carbon centred radicals or 
hydroperoxides of PUFAs, i.e. the peroxidation of PUFAs, is one of the best-understood 
mechanisms for oxidative modification of biomolecules. 
Peroxyl radicals react with bisallylic methylene groups in other PUFA molecules, leading to 
the transformation of peroxyl radicals to hydroperoxides and generation of new carbon-centered 
radicals. This initiates additional cycles of peroxidation. PUFA hydroperoxides in turn produce 
reactive alkoxyl and hydroxyl radicals via iron or copper-catalyzed Fenton-like reactions, 
further propagating the chain reaction (Reis and Spickett 2012, Domingues, Reis et al. 2008). 
In addition to free radical mechanism, forming hydroperoxides, and hydroxides, PLs can be 
oxidized by a 2- electron transfer mechanism  (electrophilic addition), for example by halogen 
compounds leading to the formation of chlorohydrins (Arnhold, Osipov et al. 2001, Spickett 
2007, Davies 2011, Reis and Spickett 2012, Korotaeva, Samoilova et al. 2013).  
Non-esterified polyunsaturated fatty acids (NE-PUFA), particularly arachidonate and linoleate 
and PUFA linked to glycerol body as components of phospholipids, are susceptible to oxidation 
enzymatically. The resulting products include hydroperoxyeicosatetraenoates (H(p)ETEs-PL), 
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hydroperoxyoctadecadienoates (H(p)ODEs-PL),  esterified to phospholipid which are formed 
in multiple cell types including macrophages, adipocytes, and endothelial cells (Aldrovandi and 
O'Donnell 2013, Volinsky and Kinnunen 2013).  These products formed either enzymatically 
or non-enzymatically are collectively termed as primary oxidation products. LOX can also 
directly oxidize LDL although the mechanisms by which this occurs are not fully understood. 
LOX products may play a role in the beginning stages of atherosclerosis. 
 
Figure 1.5: Schematic representation of phospholipid oxidation adapted from (Domingues, Reis et al. 2008, 
Bochkov, Oskolkova et al. 2010, Reis and Spickett 2012) 
Peroxidation of PL-esterified PUFAs is initiated by formation of hydroperoxides or peroxyl 
radicals. Further oxidation of primary PL oxidation products into secondary oxidation products 
proceeds non-enzymatically via three major pathways. First, additional oxidation within the 
same PUFA generates oxidised phospholipids (OxPLs) with various combinations of functional 
groups such as hydroperoxides, hydroxides, keto- and epoxy-group. The second pathway 
involves intramolecular cyclization, rearrangement, and further oxidation. If a bicyclic 
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endoperoxide is formed as an intermediate product, three groups of products are generated, 
including isoprostanes, isolevuglandins, and isothromboxanes, while cyclization leading to 
formation of monocyclic peroxide finally produces isofurans (Bochkov, Oskolkova et al. 2010, 
Reis and Spickett 2012). Third group of transformations results from several chemical reactions 
all leading to fragmentation of PUFAs and generation of short residues, having various 
combinations of hydroxide and carbonyl groups, or terminal furan. Oxidative fragmentation of 
hydroperoxides occurs via several mechanisms including β-scission, Hock rearrangement, or 
cyclization of alkoxy radical produced from hydroperoxide (Reis, Domingues et al. 2004, Reis, 
Domingues et al. 2007). 
Several processes play a role in termination of peroxidation chain reaction and detoxification 
of reactive groups in PL-esterified PUFAs. In addition to scavenging of radicals by antioxidants 
such as vitamin E, reactive peroxide groups are reduced by specific form of glutathione 
peroxidase (GPx4) capable of reducing PL-esterified residues, as well as peroxiredoxin VI and 
glutathione-S- transferase (GST) (Kuhn and O'Donnell 2006). Reactive carbonyl groups in PL 
residues can be reduced by aldo-keto-reductases from AKR1A and B families. Furthermore, 
several phospholipase-A forms selectively cleave oxidized residues leading to formation of 
lyso-PLs and free oxidized fatty acids. Similar activity is shown by Lecithin-Cholesterol acyl 
transferases (LCAT). Finally, electrophilic PLs can form covalent complexes with amine 
containing amino acids (Schiff Base and Michael adducts), which may inactivate reactive 
groups on PLs but on the other hand can damage sensitive proteins (Harrison, Griendling et al. 
2003, Hulsmans and Holvoet 2010, Negre-Salvayre, Auge et al. 2010, Aldrovandi and 
O'Donnell 2013, Volinsky and Kinnunen 2013). 
1.4 Biological activities of Oxidised Phospholipids (OxPL) 
Processes associated with oxidative stress can result in elevated levels of oxidatively modified 
or toxic molecules that can cause cellular malfunction, and even cell death. Destruction of 
membrane lipids by lipid peroxidation compromises the cellular membrane integrity that alters 
its physiological role and  has been correlated with many diseases and normal ageing (Ravandi, 
Babaei et al. 2004, Fruhwirth, Loidl et al. 2007, Negre-Salvayre, Auge et al. 2010, Greig, 
Kennedy et al. 2012). 
Thus, peroxidation of PL forms variety of biologically active products that can modify the 
endogenous structures of proteins and other lipids and possibly their function. This leads to the 
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generation of altered lipids as well as oxidized lipid–protein adducts, giving ‘‘modified-self 
molecules’’ or so-called ‘‘neo-self determinants’’ that can be recognized by specific innate and 
adaptive immune responses (Hulsmans and Holvoet 2010, Aldrovandi and O'Donnell 2013). 
Fragmented oxidised products change their conformation within the cell membrane or 
lipoprotein outer layer, and protrude into the aqueous phase, thus enabling recognition by 
cellular receptors (e.g., CD36 immunoglobulins or C- reactive protein). Furthermore, binding 
of OxPLs to CD36 promotes formation of foam cells characteristic of atherosclerosis 
(Hulsmans and Holvoet 2010). Oxidized phospholipid components of low-density lipoporotein 
(Ox-LDL), which are increased in human obesity, can induce endothelial cell activation and 
pro-atherosclerotic changes in vascular endothelial cells (Ravandi, Babaei et al. 2004, Kuhn 
and O'Donnell 2006, Haeggstrom and Funk 2011). In addition, it also increases expression of 
cell adhesion molecules and chemokines involved in monocyte and neutrophil recruitment and 
binding (Greig, Kennedy et al. 2012). Endothelial cell activation is a phenotypic shift 
characterised by expression of inflammatory mediators and cell adhesion molecules. 
 OxPL may lead to endothelial cell activation and formation of foam cells (Kuhn and O'Donnell 
2006). Phosphatidylcholine is the most abundant phospholipid product in mammalian cells, and 
PC oxidation products have been widely studied. PCs that have polyunsaturated fatty acids at 
the sn-2 position, particularly arachidonate, are especially susceptible to oxidation, and this 
result in a variety of potential oxidised products. 1-palmitoyl-2-arachidonoyl‐sn-
glycerophosphatidylcholine (PAPC), which is a major cell membrane constituent is more 
susceptible to oxidative damage and its oxidation forms biologically active products  including 
1-palmitoyl, 2-glutaroyl phosphatidylcholine (PGPC), 1-palmitoyl, 2-(5,6 epoxyisoprostane-
E2),phosphatidylcholine (PEIPC), 1-palmitoyl, 2-oxo-valeroyl phosphatidylcholine (POVPC), 
and lysophosphatidylcholine (LPC). All of these have been shown to activate endothelial cells 
and are implicated in atherosclerotic progression (Birukova, Starosta et al. 2013). These same 
oxidised phospholipids are also deposited in atherosclerotic plaques.. PAPC, POVPC, PGPC, 
and PEIPC are increased 3-12 fold in circulating modified LDL, and 3-6 fold in vascular lesions 
in rabbits fed an atherogenic diet (Subbanagounder, Leitinger et al. 2000, Greig, Kennedy et al. 
2012) 
 POVPC increases monocyte chemo attractant protein 1 (MCP-1) expression and monocyte 
binding to endothelial cell (Niki 2009). A mouse model over-expressing 12/15 LOX, which 
resulted in elevated production of 12(S)HETE (stereospecific hydroxide product of 
arachidonate), also had increased MCP-1 and ICAM expression and increased monocyte 
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binding to the endothelium (Steinberg 2009).  PGPC induces monocyte and neutrophil binding 
and vascular cell adhesion molecule-1 (VCAM-1). PEIPC can cause an increase in MCP-1 in a 
dose dependent manner in human aortic endothelial cells (HAEC) (Bonomini, Tengattini et al. 
2008). LPC also stimulates MCP-1, as well as VCAM-1 and intracellular cell adhesion 
molecule (ICAM-1) (Pegorier, Stengel et al. 2006). PAPC (unmodified phospholipid) alone 
does not induce ICAM-1, or VCAM-1, but does stimulate MCP-1 and monocyte binding 
(Ravandi, Babaei et al. 2004, Niki 2009). 
Compare to oxPL, limited reports has been publoshed on the effects of chlorinated lipids on 
inflammatory cell adhesion (Greig, Kennedy et al. 2012). Chlorohydrin species were identified 
in human atherosclerotic lesions that led to an increase in the expression of P-selectin on the 
endothelial cell surface of human coronary artery endothelial cells (HCAECs) (Panasenko, 
Spalteholz et al. 2003, Messner, Albert et al. 2008, Davies 2011).  Sphingomyelin (SM) 
oxidised by HOCl has been found to activate apoptotic signaling in dopaminergic PC12 neurons 
by the activation of caspase-3 (Nusshold, Kollroser et al. 2010). Phospholipid chlorohydrins 
also depleted ATP levels in human myeloid cells and caused a loss of viability (Dever, Stewart 
et al. 2003, Dever, Wainwright et al. 2006, Dever, Benson et al. 2008). Chlorinated lipids have 
also showed an effect on nitric Oxide (NO) bioavailability in endothelial cells (Davies 2011).  
Treatment with hypochlorite modified LDL of human umbilical cord endothelial cells 
(HUVECs) caused a decrease in synthesis of cGMP compared with native LDL (Nuszkowski, 
Gräbner et al. 2001).   
1.5 Phospholipid and oxidised phospholipid analysis by various methodologies 
By the late 1980s, technological advancements allowed development of newer methods such 
as electron spin resonance, nuclear magnetic resonance spectroscopy (NMR), infrared 
spectroscopy, X-ray scattering, differential scanning calorimetry and mass spectrometry to 
investigate phospholipid structure and the effect of acyl chain unsaturation and substitution 
position on physical properties of the phospholipid as well as higher-order structural properties. 
Oxidative damage of biological compounds has been linked to pathogenesis of various 
inflammatory disorders. Various oxidised phospholipid products have been shown to have wide 
variety of biological and cell signalling effects as described above, and are considered as 
markers of oxidative damage (Spickett 2005, Samhan-Arias, Ji et al. 2012). While utilisation 
of non-mass spectrometry based technologies such as NMR for lipidome analysis is gaining 
momentum owing to advancement in instrumentation, mass spectrometry is likely be the 
technology of choice owing to its simplicity in operation compared to NMR, sensitivity and 
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specificity. In the following section the analysis of lipidome and oxidised lipidome using non-
mass spectrometry based techniques and mass spectrometry based techniques will be described. 
1.5.1 Non mass spectrometry (conventional) methodologies  
In order to gain further insight into the molecular mechanisms that underpin the oxidative 
damage of biological compounds, the application of analytical methodology capable of 
measuring the structural details of oxidised lipid species in a direct, comprehensive, and 
quantitative manner is required. Conventional analytical methods for lipid analysis such as high 
performance liquid chromatography (HPLC), thin-layer chromatography (TLC), and gas 
chromatography (GC) with non-mass spectrometry based detection system such as UV or 
fluorescence. Colorimetric and chemical based assays including targeted analysis using 
radioactively or fluorescently labelled species are only applicable for the characterization of 
global perturbations of lipid composition as these methods can detect only a limited number of 
species or provide information on the lipid class. For example, the thiobarbituric acid activated 
reactive substances (TBARS) assay is used to measure malodialdehyde and other phospholipid 
oxidation products containing two carbonyl functional groups. However, this assay is non-
specific and also measures non lipid compounds containing aldehydes and thus the result does 
not truly reflect the extent of lipid oxidation. Various chemical assays and antibody- based 
assays have been developed to measure products of free radical damage in pathophysiological 
processes. These assays include measurement of malondialdehyde (MDA), conjugated dienes, 
short-chain alkanes, lipid hydroperoxides, and ELISA assays involving EO6 antibody, among 
others (Spickett, Wiswedel et al. 2010). TheEO6 antibody is the monoclonal IgM nautral 
antibody that binds to oxPL as well as OxLDL and protein covalently modified by oxPL. These 
methods, however, suffer from inherent problems related to sensitivity or specificity, 
particularly when applied to in vivo situations.  In general terms, the capabilities of the different 
technologies to analyse an oxidised molecule or a mixture of oxPL differ in the amount and 
type of compounds that can be analysed per run, in the quality of structural information that can 
be obtained, and sensitivity in measuring lowest amounts accurately in presence of signals from 
extraneous sources. The discussion below provides overview of non mass spectrometry based 
techniques used for lipid measurement. 
1.5.1.1 Nuclear Magnetic Resonance Spectroscopy (NMR) 
1H or 13C NMR have long been used to investigate  metabolites including lipid compositon as 
reviewed by (Emwas 2015).  Proton NMR analysis provides a quick and non-destructive 
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technique for lipidomic analysis with the additional benefit of structural elucidation of 
compound although it is only used for pure lipid standard compounds or relatively simple 
mixture (Gross and Han 2011, Khandelwal, Stryker et al. 2014). In a traditional NMR 
experiment, a sample under a magnetic field is pulsed with radio frequency energy and the 
Fourier transform of the signals results in a spectra of chemical shift, which is dependent on 
nuclei environment and presence of functional groups in the vicinity.  1H-NMR spectra are plots 
of intensity vs frequency, and for complex mixtures the resonance fruqency of several nuclei 
can overlap that can make interpretation of NMR spectrum difficult. The possibilities of 
structural elucidation of lipid species and platform resolution have been enhanced with the 
development of 2D NMR due to the reduction in overlapping peaks. This is achieved by adding 
extra experimental variables that introduces a second dimension to the resulting spectra and 
collecting a series of  spectra and combining data on a two frequency array representing bond 
connectivity of the target molecule  and or combining proton NMR and 31P NMR for lipidomics 
analysis (Mahrous, Lee et al. 2008, Clendinen, Stupp et al. 2015) (Li, Yang et al. 2014). Despite 
the advantages of structural elucidation offered for metabolomic analysis by 2D-NMR or 
interfacing NMR with chromatographic separation such as liquid chromatography, these 
technologies has so far not been widely adopted for the analysis of lipidome. This could be 
because of inherent complexity of lipid mixtures and lack of sensitivity of NMR methods 
compared to mass spectrometry (Willmann, Leibfritz et al. 2008, Gross and Han 2011). 
Moreover, liquid chromatography (LC) uses mobile phases typically water, methanol and 
acetonitrile in a gradient manner that can increase the spectral complexity. Alternatively, one 
can use fully deuterated solvents, although, this will increase the sample analysis cost owing to 
the large volume of solvents required for LC separation (Gonnella 2012).  
1.5.2 Mass Spectrometry based approaches 
Advancement in mass spectrometry technology and chromatographic separation has given an 
impetus to the development of mass spectrometry based approaches to decipher lipidome and 
oxidised lipidome in several disease models (Parsons and Spickett 2015). Mass spectrometric 
methods are less time consuming compared to conventional methods and require less sample 
amount because of its higher sensitivity and specificity. A mass spectrometer works by 
monitoring the defined mass range in a narrow atomic mass units (amu) window collectively 
termed as scanning. The defined mass range, scan speed, and sampling for each mass based on 
the defined amu window dictates the resolution and sensitivity that can be obtained. While the 
scanning routines that can be performed as well as sensitivity and resolution that can be 
achieved are characteristic of analyser geometry and type of mass spectrometer, each mass 
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spectrometer can be divided into the three major components: ion generation component, mass 
analyser and detection system (Sauer and Kliem 2010). In order for a molecule to enter the mass 
analyser and be directed to the detector, it must be first converted to the gaseous phase to obtain 
a charge thereby converting it to an ionised form that can be separated by mass analysers; this 
is a pre-requisite of detection by mass spectrometry.  It is achieved in the ionisation chamber 
using different techniques discussed later. The following paragraphs will describe the types of 
ionisation method and different types of mass analysers. 
1.5.2.1 Ionisation techniques 
The primary aim of a mass spectrometer is the measurement of the mass to charge ratio of ions 
generated in the ionisation chamber either by  “Hard ionisation” techniques such as electron 
impact ionisation (EI), which is mostly used with gas chromatography mass spectrometry 
(GCMS), or by “soft ionisation” techniques such as electrospray ionisation (ESI) routinely 
used in liquid chromatography-mass spectrometry (LCMS) based approaches (Willmann, 
Leibfritz et al. 2008, Sandra and Sandra 2013, Spickett and Pitt 2015). Electron impact 
ionisation is performed under high vacuum where the electrons emitted from a heated filament 
are accelerated within an electric field, more often at 70 eV within the source where the sample 
is introduced leading to formation of charged fragments of analytes. Electrospray ionisation 
(ESI) is performed at atmospheric pressure and the sample is introduced as a dispersed stream 
from the ESI probe and charge is  imparted to small droplets formed by applying large potential 
difference of 3 -6 kV. The small droplets are shrunk further through the process of desolvation 
and high temperature thereby forming gas-phase ions that enters the mass analyser. There are 
several others ionisation techniques such as chemical ionisation, matrix assisted laser 
desorption ionisation (MALDI) and others which are of limited relevance to this work and will 
not be discussed here.  
1.5.2.2 Mass analysers 
Mass analysers are considered to be the heart of the mass spectrometer where the ionised 
analytes from the sample are separated based on mass to charge (m/z) ratios.  The mechanism 
via which the separation of ionised analytes occurs in the analyser and the resolution (property 
of distinguishing between ions having similar masses or different masses) is dependent on the 
type and geometry of the analyser. Quadruples are the most common type of analysers and are 
composed of 4 parallel hyperbolic rods. One pair of opposite rods uses radio frequency (r.f) and 
the other uses direct current (d.c) to isolate the selected m/z of the analyte and maintain it on 
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the course to reach the detector. By ramping through different combination of r.f and d.c 
potential, a full spectrum scan over a mass range is possible (Finnigan 1994). Time of flight 
(TOF) analysers consist of a cylindrical flight tube of defined length maintained at high 
vacuum. It separates analytes of different m/z based on time taken by the ion to travel the 
distance across the flight tube, taking into account the principle of ion’s velocity in a vacuum 
in proportion to the mass of ion. Unlike quadruples, a strictly defined period is required in TOF, 
meaning that  ions are pulsed into the analyser with a defined timescale set by the user 
(Guilhaus, Selby et al. 2000). A linear TOF has limited resolution and therefore, to increase 
resolution reflectors are used, which reflect ions at an angle towards the detector and minimise 
any kinetic energy difference between ions. Ion trap analysers (3 –D IT) consist of a cylindrical 
ring electrode and two end cap electrodes that trap ions within a fixed mass range in 3D space 
by applying an initial r.f frequency and a fixed d.c voltage. The basic mass analysis process 
consists of two steps that are performed consecutively in time: injection of ions into the trap by 
means of an ion injection pulse and a low RF at the ring electrode for trapping the ions, followed 
by ramping the RF voltage to eject ions consecutively with different m/z values. As too high a 
number of ions in the trap can adversely affect the mass resolution and accuracy, it led to the 
development of 2-D ion trap (2D-IT), more conventionally called a linear ion trap (LIT). Here, 
the ions oscillate up and down a linear four rod quadruple and each end is capped with a 
reflector to reflect ions back down the quadruple. To increase ion focussing, analyte  ions are 
subjected to continual collision with helium gas to dampen the internal energy (Schwartz, Senko 
et al. 2002).   
1.5.2.3 Tandem mass spectrometry 
To increase sensitivity and resolution further as well as improving the efficiency of mass 
spectrometer instruments, hybrid type of instruments were developed by combining several 
analysers together, such as triple quadruple analysers by serially combining three quadruples 
that can now have the capability to perform MS/MS type-scanning routines collectively defined 
as tandem mass spectrometers. MS/MS is based on the gas phase dissociation of selected ions 
by increasing their internal energy (Glish 2003). The most common method for activation and 
dissociation is collision induced dissociation in which the ion translational energy is partially 
converted into ion internal energy by acceleration and collision of the selected ion or all ions 
with an inert gas such as nitrogen or helium (Johnson and Carlson 2015). Several voltages are 
applied throughout the course of ion detection cycle that covers the ion generation in the ion 
source, to the path the ion travels to reach the detector, and these parameters requires 
optimisation to improve the signal and minimise interference from extraneous sources in all 
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MS/MS scanning routines. Declustering potential and collision energy (CE) are two such 
parameters, which are respectively the voltage applied between ion source and mass analyser 
transmitting ions into vacuum region to dissociate solvent clusters, and the voltage applied to 
give best MS/MS spectra (Sherwood, Eastham et al. 2009).   MS/MS scanning routines (tandem 
mass spectrometry or MS/MS) on a triple quadrupole MS are the most commonly used 
approach in the field of targeted lipidomics. MS/MS enables structural elucidation of lipids and 
their oxidation products, and also increases the overall sensitivity, accuracy and reproducibility 
of the analysis, as the dwell  time ( time spent on recording the signal intensity) for the analyte 
of interest is increased (Schwudke, Oegema et al. 2006). The common selective MS/MS 
approaches used for identification of a specific group or class of molecules having structural 
similarity or a common characteristic are  precursor ion scanning (PIS) and neutral loss 
scanning (NL) as illustrated in figure 1.6. In PIS, the first quadruple is in the scanning mode, 
which scans all the parent ions that are subsequently fragmented in the second quadruple and 
the third quadruple is fixed to monitor the product ion of interest thus, enabling the 
identification of a class or group of compounds, which on fragmentation yields a common 
product ion. In the NL scanning, the first quadruple is in the scanning mode, which scans across 
a pre-defined mass range of interest; parent ions are fragmented in the second quadruple and 
the third quadruple scans across the pre-defined range but with a specific mass offset that 
corresponds to the mass of the neutral loss of fragment of interest.  
Another frequently used approach for quantification is selected (or single) reaction 
monitoring (SRM). SRM approach exploits the fragmentation pattern of the analyte of interest 
and is used in conjunction with chromatographic separation. In this approach, the first 
quadruple is in the non-scanning mode and is fixed for the parent ion of interest, which is 
fragmented in the second quadruple and the third quadruple is fixed for the specific product 
ion, corresponding to the analyte of interest. If more than one analyte is monitored 
simultaneously, it is called multiple reaction monitoring (MRM). 
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Figure 1.6: Schematic representation of quadruple MS/MS scans to elucidate structural details of lipids. Adapted 
from (Blanksby and Mitchell 2010) The top panel shows the general survey scan  that allows all ions within the 
defined mass range to be transmitted through the analysers. The second panel shows the product ion scan where a 
single ion is allowed through the Q1 analyser, fragmented in Q2 and all the fragments are scanned in Q3. Panel 3 
shows precursor ion scan mode where the Q1 is in scanning mode, Q2 fragments all precursors and Q3 is fixed to 
a single mass i.e it allows only ions that give same fragment ions to pass. Panel 4 is the neutral scan where Q1 and 
Q 3 are both in the scanning mode but with a specific mass offset corresponding to loss of neutral compound on 
fragmentation. Panel 5 is the multiple (single) reaction-monitoring mode where the Q1 and Q 3 are fixed to detect 
specific precursor giving a specific fragment ion on collision with neutral gas. 
 
In  lipidomic approaches, the infusion of crude lipid extracts into the MS and the ionisation via 
ESI can result in mass spectra with overlapping signals from isobaric species and a high 
chemical noise from the matrix. Therefore, this selective MS/MS scanning routines supports 
the identification process, which enables distinguishing between isobaric species. The specific 
fragmentation pattern by collision-induced dissociation potentially allows identification of each 
lipid class and species with significantly reduced noise. An early study demonstrated the use of 
selective scanning routines on tandem mass spectrometers as a powerful tool for the analysis of 
phospholipids in complex lipid extracts (Brügger, Erben et al. 1997). The selective scanning 
approach has significantly improved the identification and quantification of modified and un-
modified lipid species in both targeted and untargeted lipidomics discussed in section 1.5.3 
(Zehethofer and Pinto 2008, Blanksby and Mitchell 2010). The approach used more commonly 
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to support the identification of the molecular species and distinguish between isobaric species 
is the product ion scanning. In this approach, the parent ion of interest is selected in the first 
quadruple, fragmented in the second quadruple, and the product ions or the fragmented pattern 
is measured in the third quadruple, which further confirms the identification of the molecular 
entity (Schwudke, Oegema et al. 2006, Zehethofer and Pinto 2008, Sherwood, Eastham et al. 
2009, Blanksby and Mitchell 2010). 
In the early days of lipidomics, the analysis of complex, high-molecular-weight lipids was 
carried out by fast atom bombardment (FAB) MS or electron ionisation (EI) MS. FAB and EI 
have made a major influence on lipid MS, but were limited by sensitivity issues owing to the 
presence of matrix ions that led to ion suppression, as well as frequent in-source fragmentation 
that made quantitation very difficult and erroneous. The application of ESI-MS to the analysis 
of lipids solved the problems of in source fragmentation. In contrast to FAB, ESI is a soft 
ionization technique (Glish and Vachet 2003). It creates protonated, deprotonated, or adduct 
ions (e.g. Na+, Li+, NH4+) with minimal fragmentation in source. Additionally, an ESI-MS 
provides better sensitivity over FAB. Therefore, ESI has given rise to two main approaches for 
lipid analysis, namely online high-performance liquid chromatography-mass spectrometry 
(LCMS) and direct infusion ESI-MS commonly referred to as shotgun lipidomics (Isaac, 
Jeannotte et al. 2007, Khalil, Hou et al. 2010). 
1.5.2.4 Direct infusion mass spectrometry approach (shotgun lipidomics approach) 
Shotgun lipidomics analysis is a very rapid method making it possible to screen 100-1000s of 
samples per day. In contrast to the LC-MS approach discussed in the subsequent section, in the 
shotgun approach the extracted lipid mixture is injected without further purification into the 
mass spectrometer in the shotgun approach. The terminology “ shotgun lipidomics” was first 
used by Han and Gross in their  review article on lipidomics (Han and Gross 2005) (Ekroos 
2002, van Meer 2005, Wenk 2005). Later, various reports were published that introduced 
important innovations in the field of lipidomics. The strategy of in-source separation of different 
classes of molecules was explained by Hans and Gross. In this process, the environment in the 
ion source was modulated to favour the ionisation of a particular class/group of lipid species, 
thus, maximising the ionisation efficiency, which enabled the analysis of less abundant 
molecule species present in complex matrix by reducing the ion suppression effects of abundant 
molecules. The ion suppression phenomenon relates to the particular manifestation of the 
matrix effect, which is associated with the extent of influence on analyte ionisation and affects 
the detection capability. The problem of the ion suppression effect on the less abundant 
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molecule species is expected to be more constant. It is lipid class dependent and this effect can 
be corrected using  class specific internal standards to attain the objective of quantification 
(Koivusalo, Haimi et al. 2001, Khalil, Hou et al. 2010) .The parameters that can be adjusted for 
ion source separation to achieve  optimal ionisation are polarity of the electrospray, adduct 
formation, pH and declustering potential  (Han and Gross 2003, Han and Gross 2005, Han, 
Yang et al. 2006). While this strategy is useful for selective ionisation of different classes of 
lipids, it may not be possible to analyse very less abundant molecule species like ceramides and 
free fatty acids and conjugates. Hence, LC-MS based approach was the only other alternative 
for analyse such low abundant molecules. Alternatively, a sample preparation and enrichment 
steps  like solid phase extraction (SPE) or off line HPLC can be added to the protocol, when 
using the shotgun approach (Yang, Cheng et al. 2009).  
Due to inherent problems in the shotgun approach caused by lack of separation most recent 
studies involving mass spectrometric analysis utilise chromatographic separation. Similar to the 
detection method, the chromatographic method chosen influences the sensitivity and class of 
compounds detected. The two most common hyphenated (separation) platform used in lipid 
analysis are GCMS and LCMS. 
1.5.2.5 Gas Chromatography Mass Spectrometry (GC-MS) 
GC is an analytical technique used to separate vaporised compounds without thermal 
degradation of analytes of interest. GCMS utilises the hard ionisation technique: EI that 
fragments the molecular ion in the ion source chamber and thereby the molecular ion is hardly 
observed in the GCMS spectra (Carrasco-Pancorbo, Navas-Iglesias et al. 2009). Compounds 
are separated using an inert carrier gas such as helium as the mobile phase that flows through a 
stationary phase bonded to a GC column. A typical GC column is a reverse stationary phase 
allowing polar compounds to elute before non polar compounds. The elution is dependent upon 
the temperature gradient of the GC and rate of increment in temperature. The ability to 
selectively fragment ions and the ability to search mass spectral libraries make identification 
straightforward and much quicker (Roberts, McCombie et al. 2008, Griffiths, Ogundare et al. 
2011).  The use of GC-TOFMS compared to low resolution GC-MS increases mass accuracy 
and therefore confidence in metabolite identification and has been used to good effect in a 
number of metabolomic analyses, although, GCMS studies in lipidomics field has been limited 
to fatty acid, sterol and isoprostanes analysis (Navas-Iglesias, Carrasco-Pancorbo et al. 2009).  
A number of recent advancements have significantly improved GC-MS analysis for 
metabolomics including 2 dimensional GC separation and linkage to high resolution TOFMS 
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platforms but never attempted for lipidomics work. However, whilst GC separation is suitable 
for only thermostable and volatile compounds or compounds rendered thermostable and volatile 
through transformation by derivatisation reactions (Spickett, Wiswedel et al. 2010, Reis and 
Spickett 2012, Li, Yang et al. 2014, Spickett and Pitt 2015). These properties limit the analysis 
to a smaller selection of the molecules than some of the other techniques available. GC-MS has 
proved to be a reliable and sensitive method for analysis of isoprostanes that are considered as 
markers of oxidative stress. 
1.5.2.6 Liquid chromatography mass spectrometry (LCMS) 
Most of the methods developed using shotgun approach either utilise high-resolution mass 
spectrometers like Orbitrap or Q-TOF to overcome its limitation of overlapping signals for 
isobaric species thereby allowing exact lipid identification or employ MS/MS scanning routines 
discussed above with or without coupling chromatographic separation to ESI-MS on a low-
resolution mass spectrometer.  A combination of reversed phase (RP) HPLC and MS allows 
detailed analysis of individual molecule species with a high precision in a lipidomic approach 
by providing distinction (through separation) between polar and non polar species and reducing 
ion suppression (Mouritsen 2011, Murphy and Axelsen 2011, Sandra and Sandra 2013). 
Moreover, the identification of individual molecular species can be achieved by introducing the 
third dimension of retention factor together with m/z value and intensity, which reinforces the 
identification process even using the low-resolution mass spectrometer. To achieve adequate 
separation and retention of different lipid and oxidised lipid species, several column chemistries 
need to be considered as no single column chemistry is capable of covering the entire 
lipidome/oxidised lipidome. To date reverse phase (RP) column chemistry dominate oxidised 
lipidomics analysis with hydrophilic interaction liquid chromatography (HILIC) being reserved 
for lipidomics analysis and separation of lipidome based on lipid class. 
The stationary phase of RP columns is nonpolar typically bonded C-18 alkyl chains linked to 
silica or hybrid hydrocarbon-silica particle. In RP based separation, the polarity of the mobile 
phase decreases over the LC gradient, thereby supporting separation of analytes based on 
hydrophobicity. Polar analytes elutes first followed by nonpolar analytes, which are retained 
more strongly with the non polar stationary phase. The mechanism via which HILIC column 
separates is opposite to the reverse phase columns although it is completely different to normal 
phase chromatography. Under HILIC conditions, the unbound stationary phase particle is polar 
and is adsorbed by the molecules of water and the polarity of the mobile phase increases over 
the course of the LC gradient allowing more polar compounds eluting with increased polar 
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mobile phase and non polar compounds eluting early in the run (Koch, Forcisi et al. 2014). 
Also, the compositions of mobile phases for HILIC column are more compatible with ESI-MS. 
The theory behind HILIC separation is thought to be based on two observed mechanism that 
complement each other. It has been observed that the stationary phase particle is layered with 
immobile water coating that may lead to liquid - liquid extraction between the water layer and 
the mobile phase. The other mechanism by which the separation is possible is through hydrogen 
bonding between analytes and immobilised water layer. .  
1.5.3 Benefits of Global approach vs a Targeted approach 
If the overall lipid composition of the sample is known and the objective of the research is to 
look at the specific class of lipid species or a pre-defined list of lipids/oxidised lipid species and 
to ascertain the structural details, a targeted approach using MRM is the approach to be 
considered. Contrary to the targeted approach, global approach is more suitable if less 
information is available about the overall composition of the sample as this will enable further 
developing the hypothesis after understanding the global perturbation on the lipid composition 
in the diseased state (Han and Gross 2003). Other advantage of this approach is the detection 
of previously unknown or poorly characterized lipids or the modified lipid species. However, 
absolute quantification is a challenge due to the complexity of the analysis and lack of adequate 
standards (Han and Gross 2003). 
 As mentioned earlier, a targeted approach focuses on specific lipids or lipids classes depending 
on the prior knowledge about the sample or diseased condition on which the objective or the 
hypothesis is based. The MS/MS scanning routines such as precursor ion and neutral loss 
scanning, can be used for semi-targeted analysis of a  specific class of lipids without any prior 
knowledge of the exact lipid composition of the biological sample that needs to be analysed 
(Ejsing, Duchoslav et al. 2006, Ejsing, Sampaio et al. 2009).  This selective scanning routines 
enables identification of a specific group or class of analytes having a specific characteristic, 
which increases the sensitivity of the analysis In addition, this approach enables quantification 
of hundreds of lipids species with high accuracy and precision. For example, the neutral loss 
scan for 34 Da will enable identification of all hydroperoxides in a complex biological sample 
(Adachi, Yoshioka et al. 2005, Hui, Chiba et al. 2010, Reis, Domingues et al. 2013). A targeted 
approach can be based on either HPLC/MS or shotgun methods, which are discussed above. 
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1.5.4 Mass Spectrometric analysis of   phospholipids and their oxidised products 
Collision induced dissociation of phospholipids creates many informative fragments. Perhaps 
the most useful ones are those deriving from the head group (Table 1.1), since they allow one 
to do lipid class specific scans (Domingues, Reis et al. 2008). Phosphatidylethanolamines are 
characterized by loss of 141 Da corresponding to the head group (O'Donnell 2011). 
Fragmentation at the head group in phosphatidylserines equates to a loss of 185 Da 
(phosphoserine), but serine can also be lost (– 87 Da). Phosphatidylinositols are characterized 
by a loss of 241 Da (Spickett and Fauzi 2011). 
Table 1.1: Specific scan modes for phospholipid classes adapted from (Spickett, Reis et al. 2011) 
Phospholipid Class 
Headgroup Ions formed Specific scans 
Polarity 
PC 
Phosphocholine (M+H)+ PIS 184 
Positive 
PE 
Phosphoethanol
amine 
(M+H)+ NL 141 
Positive 
PS 
Phosphoserine (M-H)- NL 87 
Negative 
PI 
Phosphoinositol (M-H)- PIS 241 
Negative 
The most useful ones are those deriving from the head group (table 1.1); since they allow one 
to do phospholipid class specific scans. In addition, the fragmentations involving the fatty acid 
ester bond are useful as they provide information on the acyl chains either directly or indirectly 
based on the lyso-phospholipid fragments (Tyurina, Tyurin et al. 2009, Ozbalci, Sachsenheimer 
et al. 2013). It is also noteworthy that the intensities of the fragment ions can vary depending 
which adduct-forming ions (e.g. H+, Na+, and Li+) are present (Han and Gross 1994). Positional 
isomers are difficult to identify using mass spectrometric methods because they usually produce 
the same fragment ions. However, the relative abundances of the acyl chain loss ions often 
differ significantly and can be used for identification (Khalil, Hou et al. 2010). It has been 
observed that the ester bond of the sn2 fatty acid is more labile. Identification of the double 
bond positions in the fatty acids of lipids relies on multistage MS (MSn).  
PC has a constitutive positive charge at the quaternary nitrogen atom so most of studies are 
confined to positive ionisation mode analysis. The fragmentation pathway observed in tandem 
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mass spectra (MS/MS) of PC ions and their oxidised products depends on the selected precursor 
ion. The MS/MS mass spectra of the (M+H) + ions are simple and of easy interpretation, while 
the MS/MS spectra of the (MNa)+ ions show higher number of product ions. The product ion 
spectrum of (M+H)+  gives an abundant base peak ion at m/z 184.07, which is the peak 
characteristic of this class of molecules referring to the polar head group (O'Donnell 2011). 
Other peaks in the product spectra shows loss of fatty acyl chains placed at sn-1 as (M-R1COOH 
and M-R1=C=O) and sn-2 position as (M-R2COOH and M-R2C=O). The MS/MS spectrum of 
(MNa)+ shows loss of trimethylamine (59 Da), loss of polar head group (-183 Da), loss of 
sodiated polar head group (-205 Da), loss of fatty acyl group at sn-1 and sn-2 position as neutral 
loss of fatty acid and sodiated adduct and  the product ion at m/z 147 Da (cyclophosphane 
group) and acyl product ions (R1CO
+ and R2CO
+) (O'Donnell 2011, Reis and Spickett 2012). 
 However, PC analysis in negative mode provides more information about the fatty acid 
moieties esterfied to the glycerol backbone and is performed using a solvent system containing 
acetate or formate salts, which gives (M+ Acetate)- or (M+formate)- ions that on fragmentation 
gives (M-CH3)
- ions (Zhang and Salomon 2005, Zhang and Reid 2006). The MS/MS spectra  
in negative mode provides more information on the fatty acyl chains linked at sn-1 and sn-2 
position, although further information regarding the double bond position requires MSn 
fragmentation at the expense of sensitivity. 
Long chain oxidation products include products resulting from insertion of oxygen atoms or 
hypohalous acids (HOCl) molecules, giving products with higher molecular weight such as 
hydroxyl, epoxy, keto, hydroperoxy, polyhydroperoxy and chlorohydrin derivatives (Tyurina, 
Tyurin et al. 2009, Uppu, Murthy et al. 2010, Spickett and Fauzi 2011, Uchikata, Matsubara et 
al. 2012). Hydroperoxides of PC are observed based on increment of 32 Da to the mass of the 
unmodified PC (Spickett, Rennie et al. 2001, Spickett 2005).  Main product ions observed 
correspond to loss of neutral molecule of the polar head (183 Da), conﬁrming that the oxidation 
product is of PC class. Loss of the fatty acids at the sn-1 and sn-2 positions, forming lyso-
phosphocholines (LPC) ions, allowed identification of  the fatty acyl chain that undergoes 
oxidative modiﬁcations (Reis, Domingues et al. 2004, Reis, Domingues et al. 2007). Other 
fragment ions, not observed in tandem mass spectra of unmodiﬁed PC, such as loss of water 
(−H2O,−18 Da), loss of hydrogen peroxide (−H2O2, −34 Da) or combined loss of two or three 
water molecules (−2 or 3 H2O, −36 or 48 Da), have been used to infer the presence of hydroxyl, 
peroxyl, and di-hydroxyl or poly-hydroxyl groups on oxidized phosphatidylcholines .  Neutral 
loss scanning of 34 Da is a typical scan for PC hydroperoxides formed during photoxidation of 
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unsaturated  phosphatidylcholine species of fibroblasts (Murphy and Axelsen 2011). Other ions 
which are observed in the MS/MS spectra is because of charge remote fragmentation of the C-
C α -bond near the functional group i.e fragmentation near oxidation position of the fatty acyl 
chain away from the head group (Domingues, Reis et al. 2008). Recent studies on human 
atherosclerotic tissue  have identified a wider range of oxidized phosphocholines (Ravandi, 
Babaei et al. 2004). These researchers were able to detect hydroperoxides (C34:2-OOH, m/z 
790; C36:2-OOH, m/z 818) and hydroxides (C34:2- 2xOH, m/z 790; C36:2 -OH, m/z 802; 
C36:4 -2xOH, m/z 814) of PC species that he correlated with different stages of atherosclerotic 
plaque. 
More than a decade ago, Watson et al. first identified three oxidation products of PAPC using 
ESI-MS at m/z 594, 610 and 828 corresponding to POVPC, PGPC and PEIPC respectively 
(Greig, Kennedy et al. 2012). Short chain oxidised products of PC were observed in MS/MS 
spectra in positive and negative mode. However, most of the published work used the ion at 
m/z 184 for (M+H) + as means of identifying PC class. Other product ions are formed because 
of cleavage near the terminal group of the short fatty acyl chain. This includes cleavage of the 
γ bond near the carboxylic acid and α bond near the aldehyde group. The presence of aldehydic 
and carboxylic acids with hydroxy and keto groups increases the fragmentation observed in ESI 
tandem mass spectra (Reis, Domingues et al. 2004, Reis and Spickett 2012). This allowed 
identification of product ions resulting from cleavage of the α-bond near the hydroxy and of the 
γ -bond near the keto group, and recognition of the substituted carbon atom in the modiﬁed acyl 
chain (Zehethofer and Pinto 2008). In oxPC with a terminal carboxylic group, the MS/MS 
spectrum show a loss of acyl residue with 14 Da increment in negative mode, which suggests 
the transfer of a methyl group from the trimethylamine to the COO- group (Domingues, Reis et 
al. 2008).  
Fewer studies have been reported concerning the characterisation of chlorinated PCs formed 
under oxidative conditions. Analysis of chlorinated fatty acids in free form and bounded with 
phospholipids was carried out using GC-MS by Winterbourn et.al in 1992 (Winterbourn, van 
den Berg et al. 1992). Schiller et.al  attempted to profile the lipids in LDL and HDL using 
MALDI-TOF MS and compared the results with 31P-NMR (Schiller, Zschornig et al. 
2001).While lysophosphocholine were detected with both methods, chlorohydrins of 
phospholipids were not detected with MALDI-TOF MS.  Long chain oxPCs are formed in 
presence of HOCl, which are identified based on the observation of increment in mass of 52 Da 
for monochlorohydrin. PC with more than 1 double bond, when oxidised with HOCl, shows 
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mono, bis, tris and tetrakis chlorohydrins with increment of 52 Da, 104 Da, 156 Da and 208 Da 
(Arnhold, Osipov et al. 2001, Spickett and Fauzi 2011). The chloride atoms 35Cl- and 37Cl- 
occurs in nature at ratio of 3:1, which led to development of specific  neutral loss scanning 
routines for analysis of chlorinated products in biological samples. Myeloperoxidase-derived 
HOCl reacts with the vinyl ether bond of plasmalogens yielding α-chlorofatty aldehydes. The 
α-chlorofatty aldehyde 2-chlorohexadecanal (2-ClHDA) was quantified after conversion to its 
pentafluorobenzyl oxime derivative using gas chromatography-mass spectrometry and 
negative-ion chemical ionization detection (Wacker, Albert et al. 2013). In addition, selective 
scanning routines like neutral loss scans have been established for identification of oxidised 
and chlorinated PCs as detailed in table 1.2. 
Table 1.2: Specific ions and losses for oxidised PC adapted from (Spickett, Reis et al. 2011) 
Headgroup 
 
Positive mode 
         
         Negative mode 
Hyderoperoxide 
Neutral loss of 34 Da 
Neutral loss of 34 Da 
Chlorohydrin 
 
Neutral loss of 36 and 38 Da* 
 
Neutral loss of 36 and 38 Da* 
POVPC 
 
Neutral loss 98 Da 
          
            Neutral loss 98 Da 
PGPC 
 
Neutral loss 114 Da 
 
Neutral loss 114 Da 
PONPC 
 
Neutral loss 154 Da 
 
Neutral loss 154 Da 
PAzPC 
 
Neutral loss 170 Da 
 
Neutral loss 170 Da 
* This is the specific and selective scan for 37Cl isotope which constitute 24% of the total Cl- 
ion. 
Multiple reaction monitoring (MRM) which is the most sensitive and quantitative MS/MS 
scanning routine was used to detect 39 different oxylipins (epoxy eicosatrienoic, oxo-and 
hydroxy-eicosatetraenoic (HETE-PC) and octadecenoic acids HODE-PC) generated by the 
action of cyclooxygenase, lipoxygenase and cytochrome P450 enzymes (Morgan, Hammond et 
al. 2010). Using Qtrap 4000 instrument, a series of HETE-PC were identified by performing 
MRM scanning in negative mode. More recently a fingerprinting protocol using SRM approach 
and chromatographic separation using a core shell kinetex column was developed to profile 
oxidised phosphatidycholines in UV treated fibroblast (Gruber, Bicker et al. 2012).  
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1.6 Data handling and analysis approaches for mass spectrometry technique 
The (oxidised) lipidome of a biological system may include hundreds of different oxidised 
species that can vary in abundance by up to 6 orders of magnitude. Therefore, any valid 
approach to study the oxidised lipidome must be able to provide unbiased analysis that can 
handle this enormous diversity and multi dimensionality of the data. While the capabilities of 
mass spectrometry technologies to measure the lipidome is constantly evolving, data analysis 
approaches still requires optimisation and improvisation to enable handling of wide chemical 
diversity and range of concentration of all compounds  present in biological samples. A 
necessary requirement of the approach is to interpret very large numbers of chromatographic 
peaks and mass spectra produced, and to make meaningful comparisons of data obtained from 
different instruments as well as different biological matrices.  
A wide range of mass spectrometric techniques are used in lipidomics, each of them having 
particular advantages regarding accuracy, precision, comprehensiveness and sample 
throughput. While the capabilities of mass spectrometry technologies are constantly 
progressing, a global lipidomic analysis is still constrained by the considerable challenges of 
covering the wide chemical diversity and range of concentration of all lipids present in an 
biological sample. In fact, a combination of different technologies may always be necessary for 
a thorough metabolomic analysis. Based on the analytical platform and the knowledge about 
its limitations, it is imperative to decide on the data handling process beforehand. Parameters 
that dictate the accuracy and precision of the mass spectrometry measurement can be broadly 
categorised into instrument dependent  and instrument independent. Mass accuracy is the 
measurement of the closeness of the measured mass to the true mass of the analyte whereas, 
precision is the measurement that defines closeness of agreement between the independent 
results obtained of achieving mass accuracy across multiple runs.  An accurate and precise 
measurement increases the certainity of identification and reduces ambiguity of the detection 
and quantification process (S L R Ellison & A Williams 2012).  
Instrument dependent parameters includes  but are not limited to tuning and peak shape, ion 
abundance, resolving power and calibration.  As accurate measurements are often performed in 
peak profile mode (continuum scanning), the centre of the peak assignment that is finding the 
centroid on the m/z scale should be accurately assigned, which is influenced by the peak shape, 
peak symmetry, ion counts unresolved interference and mechanical vibration. Tuning of the 
instrument that is optimisation of the ionisation conditions, ion transmission and fragmentation, 
which collectively increases the ion count and improve  peak shape is required for accurate 
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assignment of peaks.  Ion abundance is important in the determination of accurate mass both in 
terms of being too high or too low.  
Resolving power of the mass analyzer that is the ability to separate two masses and is different 
from mass resolution that the former is the performance parameter which is set and the later 
describes separation of two mass spectral peaks and is the function of both peak width and the 
mass being measured. In his report debating about mass resolution and accuracy, Baloch 
(Baloch, 2004) stated that the usual trade off to gain mass resolution is the sensitivity and it 
often does not seem convincing until the masses being measured becomes significant as the 
number of possible corresponding element formulae increases with the mass that makes the 
identification difficult,  if not impossible. Therefore, the required resolving power must be 
defined by the measurement problem and the level of accuracy required to umambiguiously 
identify the peak (Webb, Bristow et al. 2004).  For example, the LTQ Orbitrap instrument has 
a very high mass resolution and allowed one to resolve PS and PE species that differ by 0.0726 
Da (Schwudke et al., 2007). Koulman et al. (2009) were able to resolve lyso PC 18:3 from the 
sodiated adduct of lyso PC 16:0 that differed by 0.0024 Da using high resolution FTMS 
instrument.  
Mass calibration is one of the most significant parameters that requires consideration in the 
achievement of accuracy. If the instrument is poorly calibrated then the accuracy of the 
measurement will be compromised even for high precision measurements.  The reference 
compound for calibration should be selected carefully that will cover the entire mass range as 
well as is of similar  nature to the analyte of interest.  
Non-instrument dependent parameters or workflows that influence accuracy and precision of 
the measurement are dependent on the complexity of sample,the type of hyphenated technique 
used for measurement as well as the pre-processing and treatment of raw data before the 
statistical analysis can be performed to infer relationship  and comparison (Bro and Smilde 
2003). For example, in a hyphenated technique involving chromatographic separation, the 
signal corresponding to the analyte is transient as oppose to constant during the direct infusion 
mode and the residence time of the signal must be considered and instrument parameters such 
as scan speed of the measurement should take into account the width of the transient signal in 
order to improve the accuracy of measurement and quantification.  
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The information about the analyte of interest beforehand dictates the types of pre-processing 
steps involving correction of the signal. For example, in lipidomic and oxidative lipidomic 
studies, isotopic correction for signal overlap from analytes differing in 2 Da mass (having an 
extra double bond) is important for accurate quantification as baseline separation of all 
molecular species is rarely achieved using chromatographic system alone. Moreover, the mass 
spectrometric response is different for lipid homologues with varing chain length or 
unsaturation, which further complicates their quantitative analysis (Hans and Gross, 2006). 
Lipid molecules typically consist of C, H, O, P, N, and also S is present in Sulfatides. Lipids 
also form adducts with sodium (Na), lithium (Li) and chloride (Cl) ions. 13C is the most relevant 
isotope for lipids, since they contain many carbons and the abundance of 13C is relatively large 
(1.109 %) to other elements and correction for this element is sufficient to reduce experimental 
error to acceptable limits (Hans and Gross, 2006).  
One should bear in mind that the isotopic distributions are dependent on isotope abundancies, 
which differs e.g. in inorganic samples, although for lipidomics studies this rarely is the case. 
Notably, lipidomics studies often employ specific precursor ion scans. This will introduce bias  
in the observed isotopic distribution, because it represents only the part of the molecule that 
reaches the detector . One LC run can produce hundreds or thousands of individual spectra. The 
goal of the data processing is to reduce complexity through peak assignment, integration and 
deisotoping, so that a single value (total peak area) can be assigned for each compound. The 
data is often preprocessed by smoothing for example, by using median or Savitzky-Golay 
filtering. Baseline correction can be done by modelling approaches.  
Before integration, the peak positions and limits have to be known. This can be done by 
different filtering approaches, for example wavelets or derivatives.  Peak assignment is based 
on mass information and can be guided by other information, like fragmentation data   or LC 
retention times (Shrivastava and Gupta 2011, Subramaniam, Fahy et al. 2011). Good mass 
accuracy and high resolution obviously helps in the assigment. Deisotoping consists of 1) 
combining the areas of all the isotope peaks originating from the same compound, and 2) 
estimating the contributions of different compounds in unresolved peaks. When analyzing 
biological samples, the mass spectrometer often cannot resolve all the lipid peaks. In the mass 
spectra produced by instruments with unit resolution, the monoisotopic peak of many lipids 
overlaps with the second isotope peak of another lipid having one additional double bond.  This 
kind of overlap can be readily corrected for by taking into account the isotopic distributions.  
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Data handling can be considered as a series of steps involving pre-processing of raw data to 
extract features; pre-treatment such as scaling and normalisation to address specific properties 
of the data; and statistical modelling to decipher the subtle biological variation from inherent 
variability (Yetukuri, Ekroos et al. 2008, Boccard, Veuthey et al. 2010). Data pre-processing 
constitutes the first step of data handling and its prime objective is to extract all the relevant 
information from the raw data using noise filtering, data filtering, peak picking and 
chromatographic alignment algorithms (Shrivastava and Gupta 2011, Subramaniam, Fahy et al. 
2011).  
While the pre-processing steps such as peak picking and chromatographic alignment are based 
on software algorithms and mathematical modelling of the chromatographic peak that are not 
sample specific whereas, data pre-treatment steps involving normalisation and scaling may 
affect the information content of the data and the appropriate approach should be used with due 
consideration given to the type of sample and origin (Bro and Smilde 2003, Shurubor, Paolucci 
et al. 2005, van den Berg, Hoefsloot et al. 2006).  
Specific properties of the dataset such as technical variation can limit the interpretability of the 
lipidomics data, and a normalisation approach is used to remove systemic variation while 
preserving biological information. Normalisation approaches are often overlooked but in fact, 
it can have a significant impact on the outcome of the statistical analysis. Due to the large 
dynamic range of the lipidome each metabolite may be present at concentrations differing in 
orders of magnitude from each other. This means that abundant metabolites with high variance 
will skew the analysis of low abundance metabolites (Yetukuri, Ekroos et al. 2008). To resolve 
this, mass spectrometry data are generally transformed, centred and scaled. While this is very 
common in the field of metabolomics, surprisingly, these approaches are yet to be used in the 
field of lipidomics and oxidative lipidomics.  The use of centering centres all variance on zero 
as opposed to the mean intensity. Thus, high and low abundance metabolites are treated equally 
with the intensity variation being the focus of the statistical analysis (Karpievitch, Taverner et 
al. 2009, Boccard, Veuthey et al. 2010). The most common form of scaling is a log 
transformation which not only reduces the impact of very high abundance compounds, but also 
minimises data skewing by making data normally distributed (van den Berg, Hoefsloot et al. 
2006). However, this comes at the price of reduced signal to noise ratio as the noise levels are 
increased (van den Berg, Hoefsloot et al. 2006). In metabolomic data sets, scaling is also used 
to reduce the effect of varying fold changes between different metabolites. This is achieved by 
dividing the variable by a scaling factor and this results in an increased impact of variables with 
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small variation, which typically would go unnoticed as a result of a few metabolites with a large 
degree of variation between sample groups.  
There are several statistical methods for normalisation: one of the most common is internal 
standard normalisation ,where a known amount of internal standard having chemical similarity 
to the analyte of interest is added and its peak area is used as scaling factors for more efficient 
normalisation (Shurubor, Paolucci et al. 2005, Cao, Koulman et al. 2008). Other normalisation 
approaches are described below: the first is mass spectrometer total intensity normalisation 
(MSN) and global normalisation (GN). The first MSN normalises all mass spectral peak 
intensities to the sum peak intensity for the entire chromatogram, effectively giving all 
chromatograms a uniform sum peak intensity (Chawade, Alexandersson et al. 2014).  GN on 
the other hand normalises to the sum peak intensity of peaks that are present in all samples in 
the batch with the assumption that most of the ions observed does not change between samples 
and filtering out outliers effect. Following this normalisation technique, the sum intensity of 
these common peaks is the same for each chromatogram as opposed to the total peak intensities 
being equal (Mizuno, Ueda et al. 2016).  This eliminates the introduction of any bias due to 
large peaks associated with uncommon peaks such as those of native lipid species. 
1.7 Basis of project 
During the last decade liquid chromatography coupled to tandem MS (LC-MS/ MS) has become 
a powerful tool for lipid species analysis. However, existing methods for the analysis of 
oxidised lipids, show disadvantages like time consuming LC-separation, high sample volumes 
(low sensitivity), or insufficient validation data. The challenge with the analysis of vast number 
of different lipid peroxidation products that can be formed at both primary and secondary stages 
is to establish correlation between concentrations of these oxidised products in biological 
samples to the pathological state of the disease. Moreover, most of the methods developed for 
analysis of chlorohydrins and hydroperoxides have used commercially available lipids as model 
systems. Fewer methodologies were translated to biological samples for identification of 
hydroperoxides and chlorohydrins. To achieve adequate separation and broad coverage of 
oxidised lipidome, several column chemistries need to be considered as no single column is 
capable of including the entire lipidome. As such, the column chemistry that allows for the 
detection of greatest number of lipid analytes or a combination of methods that provides broader 
coverage of oxidised lipidome is required. 
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In addition, existing methodologies while applied to oxPL generated in-vitro seemingly does 
not cover the lipidome in entirety  and has limited application in measurement and 
quantification of  oxidised and chlorinated products in biological samples. There are significant 
challenges to overcome to achieve a sensitive and reliable oxidised phospholipid methodology. 
These includes the detection of low abundance short chain oxidised  species and relatively 
unstable hydroperoxide species, which have been shown to have different biological properties. 
To date, these concerns have been muted in favour of speed of analysis, with the aim of being 
able to run more samples in any given time. This however has the drawback in that only the 
most abundant species present are analysed, potentially leaving low abundant  to go undetected, 
and thus reducing the coverage of potentially important part of the oxidised lipidome.  Hence, 
there is a need of an improved methodology for detection and quantification of oxidised PC in 
biological samples, which formed the basis of my project. 
1.7.1 Aim of the project 
 
LCMS methods for lipidomic analysis is limited by factors such as long run times, limited back 
pressures (2000 – 4000 psi) and column particle size greater than 2 µm that all impacts the 
resolution and peak capacity of the chromatographic separation, meaning that the analyte 
species are more likely to co-elute leading to ion suppression. This PhD project aimed to 
develop an improved and robust LC-MS methodology for detection and quantification of wide 
range of oxidised phospholipids including hydroperoxide and chlorohydrins species. It aims to 
develop a method by exploiting the specificity and selectivity of the MS/MS scanning routines 
for hydroperoxides and chlorohydrins, together with the sensitivity of the scans provided by 
ABSciex QTrap 5500 instrument (QQLIT MS). The QQLIT instrument exhibits no new scan 
functions; however scan combinations of triple quadruple mode and trap mode can be 
performed in the same LC-MS run leading to increased sensitivity and specificity. For example, 
in this project, precursor ion scan for headgroups (PIS 184 Da) was combined with neutral loss 
scan for hydroperoxides (NL34) and data dependent enhanced product ion scan (EPI), which 
utilises the ion trap to provide sensitivity thereby enhancing the structural information. This 
project also aimed to develop a data handling protocol to minimise any variation caused by 
sample handling and or normalisation bias. The project further aimed to implement the 
improved LCMS methodology with data handling protocol to profile oxidised phospholipid in 
several disease models such as ascites of lean and obese rats induced with acute pancreatitis; 
isolated components of red blood cells infected with malarial parasite; plasma samples of 
healthy and diabetic patients. The final aim was to apply the developed method to investigate 
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the effect of antifoaming agents used in bioreactors on lipid composition during membrane 
protein production using yeast expression systems. 
The work to meet these aims is detailed in 5 chapters of the thesis: 
Chapter 3 describes method development and validation that involved optimisation and 
evaluation of chromatographic separation using several reverse phase and mix mode columns 
in combination with various solvent systems. It involved formation of oxidised phospholipid 
mixtures using invitro models and identification and annotation based on studying 
fragmentation spectra, accurate masses and knowledge based on prior literature. The chapter 
also reports assessment of repeatability and reproducibility by calculating coefficient of 
variation for inter day quality control and intra-day quality control samples.  The chapter further 
describes the assessment of two-dimensional orthogonal separation using serially coupled 
reverse phase and HILIC column and analysis of oxidised PC and PE analysis.  
Chapter 4 describes implementing the methodology to profile oxidised phospholipids in ascites 
of lean and obese rat model of acute pancreatitis as well as comparison of different 
normalisation approaches. 
Chapter 5 describes implementation of the methodology to profile oxidised phospholipids in 
isolated components of RBC infected with malarial parasites, followed by Chapter 6, which 
describes the implementation of methodology to study the levels of oxidised 
phosphatidylcholine species in diabetic patients relative to healthy plasma samples. 
The work described in chapter 7 involved application of the sensitive lipidomics platform 
developed using HILIC column to investigate the effects of different antifoaming agents used 
in bioreactors on lipid composition during membrane protein production using yeast expression 
system. 
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2 Materials and Methods 
2.1 Chemicals and reagents for liquid chromatography – mass spectrometry (LC-
MS and Nuclear Magnetic Spectroscopy (NMR) 
 
2.1.1 Chemicals 
L-α phosphocholine mixture (PC mixture from egg yolk), L-α phosphatidylethanolamine 
mixture (PE mixture from egg yolk) and 1,2-diacyl-sn-glycero-3-phospho-L-serine mixture (PS 
mixture from bovine brain) was bought from Sigma-Aldrich, Dorset, UK. 2-2’-Azobis (2-
methylproprionamidine).2HCl (AAPH), a water soluble radical initiator and Sodium 
Hypochlorite solution (10 – 15 % chlorine) were obtained from Sigma-Aldrich, Dorset, UK. 1-
stearoyl-2-oleoyl-sn-glycero-3-phosphocholine (SOPC), 1-stearoyl-2-linoleyl-sn-glycero-3-
phosphocholine (SLPC) and 1-stearoyl-2-arachidonyl-sn-glycero-3-phosphocholine (SAPC) 
were procured from Avanti Polar Lipids, Inc, USA. 1-palmitoyl-2-arachidonyl-sn-glycero-3-
phosphoethanolamine (PAPE), 1-O-1'-(Z)-octadecenyl-2-(5Z, 8Z, 11Z, 14Z-eicosatetraenoyl)-
sn-glycero-3-phosphoethanolamine (O-18:0, 20:4 PE) and 1-palmitoyl-2-arachidonyl-sn-
glycero-3-phosphoserine (PAPS) were procured from Avanti Polar Lipids, Inc, USA. 1-
didecanoyl-2-tridecanoyl-sn-glycero-3-phosphoethanolamine(PE (12:0,13:0)), 1-didecanoyl-
2-tridecanoyl-sn-glycero-3-phosphoserine (PS (12:0,13:0)) and 1,2-ditridecanoyl-sn-glycero-
3-phosphocholine (PC(13:0,13:0)) used as internal standards and were procured from Avanti 
Polar Lipids, USA. 1-hexadecanoyl-2-azelaoyl-sn-glycero-3-phosphocholine (PAzPC), 1-
hexadecanoyl-2-(5’-oxo-valeroyl)-sn-glycero-3-phosphocholine (POVPC) and 1-
hexadecanoyl-2-(9’oxononanoyl)-sn-glycero-3-phosphocholine (PONPC) were procured from 
Avanti Polar Lipids, USA.   
2.1.2 Reagents 
 
Deuterated solvents for nuclear magnetic resonance spectroscopy (NMR), namely pyridine-d5, 
deuterated chloride, deuterated-methanol, and chloroform, were procured from Goss Scientific, 
UK. All solvents (methanol, chloroform, water, tetrahydrofuran and hexane) were of HPLC 
grade and obtained from Thermo Fisher Scientific, UK.  
2.1.3 HPLC columns 
Pro-swift RP-4H (1x250mm) monolithic column was purchased from Thermo Scientific, UK 
for LC-MS analysis. The Luna C8 column (150mm X 1 mm), Luna C-18 column (150 X 1 mm) 
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and C-30 column (150 X 2.1 mm) were purchased from Phenomenex, UK. Mix – mode HILIC 
column (300 X 2.1 mm) was procured from HiChrom, UK. 
2.2 Chemicals and reagents for FOX-2 assay and total phospholipid content assay 
(ammonium ferrothiocynate assay and malachite green assay) 
 
Xylenol orange, Hydrogen peroxide (H2O2), Ammonium ferrous sulphate hexahydrate 
((NH4)2FeSO4.6H2O), Ferric chloride (FeCl3.6H2O), Ammonium molybdenum and 
Ammonium thiocyanate (NH4SCN) were bought from Fisher Scientific, UK. Malachite green 
free base (MLG, purity > 98%) and tween 20 were procured from Sigma – Aldrich, Dorset, 
UK. 
2.3 Methodology 
2.3.1 Direct infusion mass spectrometry (DIMS) and Liquid chromatography mass 
spectrometry (LC-MS) method development 
2.3.1.1 Preparation of Vesicles 
PC, PE or PS mixture and unmodified  individual species of PC,PE or PS class were pre-
aliqoted as 100 µg dried weight and reconstituted in 10 µl milli-Q water to make a 10mg/ml 
suspension. The suspension was vortexed for 1 minute followed by sonication for 30 min. The 
mixture was further vortexed for 1 minute to form multilamellar lipid vesicles(Akbarzadeh, 
Rezaei-Sadabady et al. 2013). 
2.3.1.2 Oxidative Treatments 
2.3.1.2.1  Generation of peroxidation products from PC/PE or PS mixture and individual species of 
PC, PE or PS class. 
 
 1mg/ml lipid vesicles were prepared as described above followed by addition of 100 µl of 10 
mM AAPH solution. The reaction mixture was incubated for 24 hr at 37oC. The reaction was 
stopped by placing the vial on ice and adding 100 µl of ice cold Methanol containing 0.005% 
BHT. 100 ng of PC (13:0, 13:0) or PE (12:0,13:0) or PS (12:0,13:0)  was added to the mixture 
as internal standard and lipid extraction was carried out using modified Folch method as 
reported in (Reis, Rudnitskaya et al. 2013). Briefly, the extraction of lipids was performed by 
addition of 200 µl ice-cold methanol followed by 15 minutes sonication while maintaining cold 
temperature by addition of ice to the sonication bath. This is followed by addition of 400 µl of 
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ice cold chloroform and 15 sonication in the water bath at cold temperatures. Subsequently, 150 
µl of ultra-pure water was added and the mixture was vortexed for 2 minutes. Sample was left 
on ice for 10 minutes with occasional mixing. Sample was centrifuged at 2000g for 5 minutes 
and the upper (aqueous) phase was removed and re-extracted with addition of 400 µl of 
chloroform. The upper phase was discarded and the organic phase was combined to the previous 
organic layer.  The organic layer collected was dried under gentle stream of nitrogen and stored 
in -20 oC freezer until further analysis. 
2.3.1.2.2 UV oxidation of PC mixture 
 
Lipid vesicles were prepared as detailed in section 2.3.1.1 from 4 -100 µg PC mixture vials and 
the suspension was transferred to 4  glass petri plates for Control, 30 minute, 60 minute and 90 
minute UV treatment respectively. Since superoxide radical are formed by UV radiation which 
are not effective at causing hydrogen abstraction to form carbon centred radicals,  100 µl of 
10µM ferrous sulphate solution was added to aid in formation of carbon centred radicals (Reis 
& Spickett 2012) . 500µL of milli Q water was added to the plates and are placed under the 
IUV 250 flood-curing lamp (Intertronics, UK) for specified time period and the reaction was 
stopped by placing the plates on ice after the UV oxidation and adding 300µl of Methanol with 
0.005%BHT.  Methanol, chloroform mixture (1:1, 200 µl) was added and the mixture was store 
dried in -20o C freezer until analysis by direct infusion as detailed in section 2.2.4. The UV 
IUV 250 curing lamp was switched on 10 minutes prior to the exposure of lipids and the UV 
dose was measured using the intensity meter which gives UV intensity values in mW/cm2. The 
UV dose was calculated from the formula: UV Dose (mJ/cm2) = UV intensity x time (in 
seconds), which was 4000mJ/cm2. 
2.3.1.2.3 Generation of chlorohydrins products from PC/PE or PS mixture and individual species of 
PC, PE or PS class 
 
Determine the concentration of sodium hypochlorite solution: The concentration of NaOCl in 
the stock solution was determined by Perkin-Elmer Lambda 25 UV/Vis Spectrophotometer at 
292 nm (ε292 = 350 M-1cm-1). Briefly, serial dilutions of NaOCl were prepared in 0.1mM 
NaOH and the absorbance was measured at 292nm. The concentration was calculated using 
Beer-Lambert’s equation: Concentration= Absorbance/Extinction coefficient x dilution factor. 
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The PC/PE/PS mixture vesicles (10mg/ml) or individual molecular species of PC,PE or PS class 
were treated with 150 mM of sodium hypochlorite (NaOCl) at pH 6.0 for 30 min to achieve 
maximum conversion of native lipid to chlorohydrin. Excess hypochlorite was removed by 
passing the mixture through a reverse phase C18 Sep-pak cartridge (Waters, UK) and washing 
with an excess of water. The column was pre-conditioned with methanol (1 ml) and equilibrated 
with water (2 ml) prior to loading the sample and lipids were extracted with 100% methanol 
(0.5 ml) and 1:1 methanol/chloroform (1.5 ml). The organic solvent was dried under nitrogen 
and PC mixture chlorohydrins (PC Mix-ClOH) were stored in -200 C freezer until further 
analysis on a mass spectrometer. 
2.3.1.3 Lipid extraction after treatment 
 
After the oxidative treatment, the oxidised PC/PE or PS mixture (OxPC or OxPE or OxPS) was 
supplemented with 100 ng of (13:0/13:0) PC or (12:0/13:0) PE or (12:0/13:0) PS respectively 
as internal standard by adding 100 µl of 1 µg/ml (13:0/13:0) PC or (12:0/13:0) PE or (12:0/13:0) 
PS in methanol with BHT, followed by adding 100 µl of methanol containing  0.005% BHT to 
make total volume of methanol as 200 µl. The mixture was sonicated for 15 minutes followed 
by adding 400 µl of chloroform and 150 µl LC-MS grade water. The mixture was vortexed and 
sonicated for 15 minutes followed by centrifugation at 14500g for 2 minutes. The top aqueous 
layer was collected and re-extracted with 400 µl of chloroform as above. The upper phase was 
discarded and both organic phases were combined, dried under nitrogen stream and stored at -
700C. 
2.3.1.4 Optimisation of mass spectrometry parameters for precursor ion scans (PIS), neutral loss 
scans (NL) by direct infusion mass spectrometry 
The instrument parameters were optimised to achieve better sensitivity and the detailed 
description about the method is  written in section 3.3.1.2 of chapter 3. 
2.3.1.5 LC-MS analysis of peroxidation and chlorohydrins products of PC, PE or PS  mixture using 
targeted approaches on ABsciex Qtrap 5500 mass spectrometer. 
PC,PE or PS mixture oxidation products were separated by reverse phase chromatography on 
an HLPC system (Dionex ultimate 3000 system) controlled by Chromoleon software, fitted 
with the Proswift RP-4H column (1mm x 250mm) kept at room temperature in the column 
compartment. The eluent used was (A) water with 0.1% formic acid and 5mM ammonium 
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formate and (B) methanol with 0.1% formic acid and 5mM ammonium formate. The run time 
for the entire LC-MS was 50 minutes and the chromatographic elution was programmed using 
dionex chromatographic management system where the mobile phase at 0 – 4 time was fixed 
at isocratic hold of 70% B followed by 3 step gradient increase to 80% B at 8 minutes, 90% B 
at 15 and 100% B at 20 minutes. The gradient remained constant until 38 minutes and decreased 
back to 70%B until 50 minutes. The flow of the mobile phase was set to 50 µl/minute. The mass 
spectrometry detection using targeted scanning routines was performed on a Absciex 5500 
QTrap instrument and the validation of data analysis was performed on a high resolution 
Absciex Q-TOF instrument using accurate masses.  
Eluting Oxidised PC mixture (OxPC) was detected on a Q-Trap Absciex 5500 mass 
spectrometer controlled with Analyst software. The targeted approaches for detection of OxPC 
used were Neutral loss scanning (NL) of 34 Da for mass range of 700 Da – 1000 Da and 
precursor ion scanning (PIS) of 184 Da for mass range 400 Da -1000 Da. For PE and PS 
mixture, targeted approaches for detection of OxPE and OxPS species were neutral loss scan 
of 141 Da and neutral loss scan of 185 Da respectively. The declustering potential was set to 
50 V for all scans; collision energy for NL scan for 34 Da set to 35 eV and PIS for 184 Da scan 
set to 45 eV. Collision energy for NL scan for 141 Da to identify OxPE species and NL 34 scan 
for PE hydroperoxides were set to 32 eV and 23 eV respectively. Collision energy for NL scan 
for 185 Da to identify OxPS species and NL 34 scan for PS hydroperoxides were set to 35 eV 
and 23 eV respectively.  Information dependent data acquisition (IDA) was used to collect 
MS/MS data based on following criteria: 1 most intense ion with +1 charge and minimum 
intensity of 1000 cps was chosen for analysis, using dynamic exclusion for 20 seconds after 2 
occurrences and a fixed collision energy setting of 47 eV.  Other source parameters were 
adjusted to give optimal response from the direct infusion of a dilute solution of standards. 
For analysis of chlorohydrin species belonging to PC,PE and PS class; neutral scanning of 36 
Da for 35Cl isotope and 38 Da for 37Cl isotope was performed to confirm the detection of 
chlorohydrins. Collision energy used for NL 36 and 38 Da respectively was optimised at 35 eV 
with mass range scanned from m/z 700 – 1000 and setting the resolution at Q1 and Q3 at low 
and unit respectively. 
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2.3.1.6  Data validation by LC-MS analysis of peroxidation and chlorohydrins products of PC, PE 
or PS  mixture using high resolution TOF-MS scan on ABsciex Q-TOF 5600 mass 
spectrometer 
 
For analysis of OxPC, OxPE and OxPS samples on high resolution Q-TOF mass spectrometry, 
similar chromatographic elution program was used and the Q-TOF MS survey scan was 
collected in positive mode from 400 Da – 1200 Da using high resolution and accumulation time 
of 250 ms. IDA was used to collect MS/MS data for 4 most intense ions with intensity greater 
than 200 cps, fixed collision energy of 45 eV and dynamic exclusion activated after 2 
occurrences for 20 seconds. The experiment was repeated 3 times with each experiment 
performed in triplicates. 
2.3.1.7 Manual Data analysis 
Data analysis was performed manually using Peakview 2.0 software by calculating peak area 
through generating Extracted ion chromatograms (XIC) for individual masses of different 
oxidised species and native species at fixed peak width setting of 0.5 Da. The identification of 
the species was performed by comparing the MS/MS spectra at each m/z to the published 
literature as well as the MS/MS spectra of the standard preparations. The peak area was 
normalised using the peak area of the internal standard and the mean value of three technical 
replicates was calculated and used for relative quantification. 
2.3.1.8 Data validation by automated data analysis on Progenesis QI 
 
The LC-MS run acquired with the 5600 Triple TOF were loaded as .wiff files onto the software 
Progenesis QI for Lipidomics (Non Linear Dynamics, Newcastle upon Tyne, UK), used for the 
label-free quantification of phospholipids belonging to the PC,PE and PS class and the 
oxidation products formed via non-enzymatic oxidation of these classes. For each LC-MS run, 
elution profile and isotope pattern of the analysed unmodified and oxidised phospholipid 
classes are integrated in a 2D map where m/z is plotted against retention time. Each detected 
ion that produces a peak across the mass spectrum represents a feature that can be determined 
by the feature-finding algorithm. 2D maps generated by different LC-MS runs are then aligned 
for comparison so that features corresponding to the same species are assigned to each other. 
Finally, the abundance of a given feature is measured summing the peak intensities in the 
feature region and compared across multiple aligned 2D maps corresponding to different runs 
or samples. The alignment was performed by loading LC-MS runs corresponding to control and 
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in-vitro oxidised mixture of different classes in triplicates. The alignment reference was chosen 
by letting the software automatically assess every run in the each of the single run experiment 
for suitability. After manual validation of the alignments, additional vectors were added where 
necessary. The feature normalization was set to normalize to all compounds or set of 
housekeeping internal standards. 
The automatic sensitivity parameter of the peak picking algorithm was set to default. The 
maximum allowable ion charge was set at 1. The experimental design setup was set as Between-
subject Design. The identification of native and oxidised species for PC,PE and PS classes were 
performed manually by studying the MS/MS fragmentation spectra and  observing 
experimental masses against theoretical masses.Furthermore, identification is confirmed by 
searching against the in-house built sdf database consisting of all the PC,PE and PS species 
from the lipidmap database and oxidised species structures drawn manually using Knowitall 
software (BioRad), with mass tolerance set at 5 ppm and performing theoretical fragmentation.  
Relative quantification and statistics is performed by the in-built feature in the progenesis QI 
software. The conceptual workflow in the Progenesis QI automated data analysis in further 
explained in chapter 3, section 3.3.1.3.  
2.3.1.9 Optimisation of chromatographic separation using several reverse phase columns and 
eluent systems 
 
The steps taken to optimise chromatographic separation by modulating the mobile phases and testing 
several columns is detailed in  methodology section 3.3.1.2 of chapter 3. 
2.3.1.10 Method validation 
 
To validate the method to confirm its suitability for application to profile the oxidised lipidome 
of biological samples, several approaches were considered. 
1. Repeatability and reproducibility of the method:  Quality control samples were prepared by 
in-vitro oxidation of PC, PE and PS mixture in triplicatess 2.3.1.3 and the samples were 
analysed on Qtrap ABsciex 5500 mass spectrometer using targeted approaches and monolith 
column (section 2.3.1.9) for separation at different times of the day to investigate the 
repeatability, and on different days to access the reproducibility. Peak area for all oxidised 
species and native species were calculated, normalised with the internal standard and the 
relative standard deviation was calculated for intraday and inter day samples. 
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2. Assessment of sample loss during sample preparation steps involving lipid extraction:  
Two equimolar mixture of different phospholipid classes (PC, PE and PS) and commercially 
available oxidised phospholipid species (PAzPC, PGPC, POVPC) were prepared in triplicates 
and one of the set was processed through the extraction protocol2.3.1.3  followed by preparation 
of samples for mass spectrometric analysis on Qtrap 5500 MS using targeted approaches with 
monolith column for separation and normalised peak area for different species were calculated 
and compared to assess the loss of individual species or cluster of species belonging to a single 
class during sample preparation. Subsequently, the total phospholipid content was investigated 
in both sets by performing phosphorous release assay involving malachite green detailed below. 
Briefly, the samples from each set were dried and digested by adding perchloric acid (200 µl) 
and heated at 160oC for 30 minutes to release the inorganic phosphate. Subsequently, 2 ml of 
working solution that contains 0.4 % malachite green in water, 4.2 % ammonium molybdate in 
5 M HCl and 1.5 % tween 20 was added to the sample. The absorbance reading at 660 nm was 
reported and the total inorganic phosphate content was extrapolated from the calibration graph 
prepared using potassium dihydrogen phosphate. 
3. Assessment of limit of quantification and the linear dynamic range:  
Different concentration of commercially available oxidised PC species (PAzPC, PONPC, 
POVPC and PGPC) were prepared covering the range over six orders of magnitude and 
analysed on Absciex Qtrap 5500 mass spectrometer using targeted approaches involving 
precursor ion scan for 184 Da, coupled with monolith column for separation. Subsequently, the 
samples were re-analysed on a high resolution Absciex 5600 Q-TOF mass spectrometer 
coupled to monolith column for separation, involving general TOF-MS survey scan and 
information dependent acquisition (IDA) based product ion scan to compare the instrument 
response and linear dynamic range. The normalised peak area for different concentration of 
PGPC, PONPC, POVPC and PAzPC were calculated and plotted against the respective 
concentration and linearity of the response was calculated using weighted linear regression 
model with residual analysis to confirm the suitability of the model. 
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2.3.2 Non-mass spectrometric assay methods 
2.3.2.1   Ferrous ion oxidation xylenol orange (FOX-2) assay 
 Ferrous ion oxidation xylenol orange-2 (FOX-2) method of hydroperoxide estimation is based 
upon oxidation of Fe2+ to Fe3+ by sample oxidising agents which then binds with reagent xylenol 
orange (XO) to give a colour complex having absorption maximum at 560 nm as described by 
Wolf et al.  The Fox-2 reagent was prepared as follows: 250 µM of ammonium ferrous sulphate 
(6.9 mg) was dissolved in 25 µM of sulphuric acid  (10 ml) designated as solution B and 4.4 
mM of BHT (98 mg), 100 mM xylenol orange ( 7.6 mg) was dissolved in 90 ml of methanol 
designated as solution A and 1 part of solution B was mixed 9 parts of solution A to make the 
working FOX-2 reagent with final concentration of ferrous sulphate as 250 mM , 25 mM of 
sulphuric acid and 100 mM xylenol orange. Standards were prepared using different 
concentrations of hydrogen peroxide (0.01 mM to 0.4 mM) from the stock 30 % hydroperoxide 
solution, where the concentration was pre-determined by titration with potassium 
permanganate. All the other reagents were at least of reagent grade. Double distilled water was 
used throughout the experiment. Glassware were cleaned with warm concentrated nitric acid 
and thoroughly rinsed with double distilled water before an experiment. A Perkin-Elmer 
Lambda 25 UV/Vis Spectrophotometer and 1 ml quartz cuvette were used throughout the 
experiment. 
Aliquots of 100 µg of invitro oxidised PC, PE and PS mixture and control in 50 µl 1:1 methanol 
chloroform mixture were added with 950 µl of working solution of FOX 2 reagent and left to 
react for 30 minutes at room temperature in the dark and the absorbance of the samples were 
read at 560 nm against the H2O2 standards. 
2.3.2.2 Phosphorous release assay using malachite green 
 
The digestion of phospholipids followed by estimation of the released inorganic phosphorous 
based on interaction with phosphomolybdenum and malachite green as described by (Zhou and 
Arthur 1992) was used for determination of phospholipid content in invitro oxidised samples. 
A stock solution of malachite green (0.4 %) was prepared by vigorously mixing the required 
amount in distil water using magnetic stirrer for 30 minutes. Separately, 4.2 % of ammonium 
molybdate in 5 M HCl was prepared and one volume of this solution was mixed with 3 volumes 
of malachite green suspension. This mixture was vigorously stirred and filtered through 
whatman filter paper. The working solution of malachite green was prepared fresh by adding 
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0.045 % tween -20 to the above mentioned mixture of malachite green and ammonium 
molybdate with vigorous stirring for 30 minutes on a magnetic stirrer. 
Dried extract of invitro oxidised samples of PC, PE and PS mixture and control samples were 
reacted with concentrated perchloric acid and placed on a multi block heater pre-heated to 160 
oC for 30 minutes to release inorganic phosphate. The tubes were cooled down and 2ml of 
working solution was added to ach tube and the tubes were allowed to stand for 20 minutes. 
Absorbance was measured at 660 nm on a Perkin- elmer lambda 25 UV/vis spectrophotometer 
against the standards prepared using potassium dihydrogen phosphate. 
2.3.2.3 Ammonium ferrothiocynate assay for total phospholipid content  
 
This colorimetric assay is based on the formation of complex between phospholipids and 
ammonium ferrothiocynate  and was performed for determination of total phospholipids in 
clinical samples (Stewart 1980). Working solution was prepared by adding 2.7 g of ferric 
chloride and 3 g of ammonium thiocynate in 100 ml water. Dried lipid extracts were 
reconstituted in 2 ml lchloroform and 1 ml of working reagent is added. The samples were 
vortexed for 1 minute and centrifuged at 14500 g for 5 minutes and the bottom coloured layer 
were collected in clean glass tubes using Pasteur pipettes and the absorbance was measured at 
488 nm. The concentration was determined by comparing the absorbance reading against 
standard phospholipid solution. 
2.3.3 Nuclear magnetic resonance spectroscopy (NMR) analysis of lipid chlorohydrins 
The NMR analysis was performed on 270MHz Bruker NMR instrument for only individual 
species of PC class. Deuterated solvent was used for chlorohydrin analysis to acquire highly 
resolution spectra while preventing any interference from proton coupling. The solvent system 
used was 1:1:2:10 mixture of pyridine-d5: deuterated chloride in D2O: methanol-d4: 
chloroform-d adapted from (Edzes, Teerlink et al. 1992). Spectra were acquired in the Fourier 
transform mode with 5000 data points, 90 0 pulses. The parameters optimised for 1H-NMR 
analysis of chlorohydrins were the relaxing time, which was set to three seconds and the number 
of scans acquired were 5000 to achieve optimum sensitivity. The acquired NMR spectra was 
corrected for phase and baseline distortions by applying a simple polynomial curve fit and 
referenced to Trimethylsilane (TMS) peak (δ 0.0).  The data analysis of chlorohydrins was 
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executed on Mestrenova version 1.0 software where the control and modified lipid spectra were 
overlaid for comparison after pre-processing the spectra. 
2.3.4 Oxidised lipidome profiling of clinical samples  
 
2.3.4.1 Lean and obese rat model of acute pancreatitis 
 
The ascites of lean and obese rat ( 7 each) induced with acute pancreatitis were received from 
University of Valencia, Spain and stored in – 80 oC. Total lipids were extracted using modified 
Folch method as described in section 1.3.1.3 from 500 µl of ascites of lean and obese rats and 
the dried lipid extracts were reconstituted in 1:1 methanol: chloroform mixture before preparing 
5-fold dilution with starting solvent (70% Methanol with 5mM ammonium formate and 0.1 % 
formic acid) and analysis was performed on Qtrap 5500 followed by Q-TOF MS using monolith 
column for separation. Manual data analysis was performed on data generated on low resolution 
Absciex Qtrap 5500 MS using targeted approaches for PC, PE and PS class oxidation products 
and data validation was performed on high resolution QTOF ABsciex 5600 MS with automated 
data analysis using Progenesis QI for lipidomics software. 
2.3.4.2 Isolated components of malarial parasite 
The isolated components of malarial parasite (hemozoin, residual bodies, mature Schizonts & 
uninfected RBC) were received from University of Turin, Italy and stored in – 80 oC. Total 
lipids were extracted using modified Folch method as described in section 1.3.1.3 from 40 µl 
of each sample and the dried lipid extracts were reconstituted in 1:1 methanol: chloroform 
mixture before preparing 5-fold dilution with starting solvent (70% Methanol with 5mM 
ammonium formate and 0.1 % formic acid) and analysis manual data was performed for data 
generated on Qtrap 5500 followed by cross validation analysis of data generated on Q-TOF MS 
using monolith column for separation. Manual data analysis was performed using peakview 
software and calculating peak area of each identified species by generating XIC with peak width 
set at 0.5 Da as detailed in section 2.3.1.7. Cross data validation was performed with automated 
data analysis using Progenesis QI for lipidomics software as detailed in section 2.3.1.8. 
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2.3.4.3 Diabetic plasma samples 
 
This work was done in collaboration with Dr James Brown group at Aston University who 
provided us the plasma samples of healthy and diabetic patients.The plasma samples of diabetic 
patients (N=7) and healthy volunteers (N=7) were collected after  Aston University ethics 
committee approval by Dr Brown research group.  Plasma sample (40 µl) was used for lipid 
extraction using the method described in section 2.3.1.1 using 100 ng of (13:0/13:0) PC as 
internal standard. The dried lipid extract was reconstituted in 1:1 methanol:chloroform mixture 
before preparing 10-fold dilution with starting solvent (70% Methanol with 5mM ammonium 
formate and 0.1 % formic acid) and analysis was performed on Qtrap 5500 for PC, PE and PS 
class oxidation products followed by  cross validation of data acquisition and analysis using Q-
TOF MS and monolith column for chromatographic separation. Manual data analysis was 
performed on data generated on low resolution Absciex Qtrap 5500 MS using targeted 
approaches and data validation was performed on high resolution QTOF ABsciex 5600 MS 
with automated data analysis using Progenesis QI for lipidomics software as detailed in section 
2.3.1.7 and 2.3.1.8. 
2.3.4.4 Lipidomic analysis of total lipid extract of yeast expressing recombinant protein treated with 
different concentration of antifoaming agents. 
 
This work was done in collaboration with Prof Roslyn Bill group at Aston University who 
provided us the total lipid extract of yeast producing different proteins treated with different 
concentration of antifoaming agents. 
Two different antifoaming agents: P-2000 and J673-A at 0.5 % and 1 % concentration were 
investigated for the effect on lipid composition of the P.Pastoris strain producing GFP protein 
and A2aR membrane protein. The dried lipid extract was reconstituted in 1:1 
methanol:chloroform mixture before preparing 10-fold dilution with starting solvent (70% 
Methanol with 5mM ammonium formate and 0.1 % formic acid) and analysis was performed 
on QTOF 5600 for speciesPC, PE and PS class using HILIC column and solvent system D for 
chromatographic separation as detailed in 2.3.1.6 and 2.3.1. 9 section. Manual data analysis 
was performed on data generated on high resolution QTOF ABsciex 5600 MS using targeted 
approaches and data validation was performed with automated data analysis using Progenesis 
QI for lipidomics software as detailed in section 2.3.1.7 and 2.3.1.8. 
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3 Development of LC-MS methods using targeted approaches and 
optimisation of chromatographic separation to provide better coverage 
of oxidised lipidome  
3.1 Background 
Global oxidised lipidome analysis of biological samples offers great potential for detection of 
biomarkers of disease. A single species belonging to the glycerophospholipid group bearing an 
unsaturated fatty acyl chain can give rise to over 50 different modified species. The species 
formed through oxidation can further be categorised based on the nature of oxidant, extent of 
oxidation and concentration of oxidant and other aiding compounds (Reis and Spickett 2012). 
For instance, oxidation through the action of myeloperoxidase in presence of chloride ions will 
predominantly give rise to chlorohydrin species (Jerlich, Pitt et al. 2000, Arnhold, Osipov et 
al. 2001),  whereas oxidation through Fenton type reaction will form peroxidation species  that 
can be grouped or classified into “long chain oxidation products” (where the mass of the 
modified compound is greater than the parent mass depending on the number of oxygen atoms 
attached to the species) and “short chain oxidation products” (formed after oxidative cleavage 
of long chain oxidation products) (Arnhold, Osipov et al. 2001, Dever, Benson et al. 2008, 
Gruber, Bicker et al. 2012). Examples of these oxidised and chlorohydrin species are shown in 
figure 3.1, 3.2 and 3.3 respectively. The nomenclature was established with the terminology in 
the parentheses corresponded to the aldehyde or carboxylate bearing truncated acyl chain at sn-
2 position followed by the first letter of the fatty acyl chain linked at sn-1 position and last 2 
letters belonged to the phospholipid class. For instance, the (oxonanonyl) SPC corresponds to 
the stearoyl fatty acyl chain bearing phosphatidylcholine class species with nine carbon 
terminal aldehyde chain at sn-2 position.  
Similarly, for long chain species the nomenclature system was established as follows: the first 
two letters corresponded to the fatty acyl chain linked at sn-1 and sn-2 positions followed by 
the class specific information. Based on level of oxidation and type of oxidised species the 
name of the species was associated with OOH, OH, O or ClOH that corresponded to 
hydroperoxide, hydroxide, keto or chlorohydrin species respectively, with di, tri or tetra as 
prefix to define the level of oxidation.  
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Figure 3.1: Representative structures of short chain oxidation products formed by non-enzymatic oxidation of 
phosphatidylcholine species 
 
Figure 3.2: Representative structures of long chain oxidation products formed by non-enzymatic oxidation of 
phosphatidylcholine species 
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 Figure 3.3: Representative structures of chlorohydrin products formed by 2 electron oxidation of 
phosphatidylcholine species 
In lieu of the extreme diversity of phospholipid species due to the fact that more than 1000 of 
species that can be formed by combination of different headgroups and fatty acyl chains,  the 
number of oxidised species that are generated in response to reactive oxygen species can be 
overwhelming. In addition, they can exist as many different derivatives and isomers in vivo. 
This can lead to formation of hundreds of different modified species from the lipidome of 
mammalian membrane, adding to the complexity and difficulty in characterisation and 
quantification of these species in biological samples (Nakanishi, Iida et al. 2009). These 
oxidised phospholipid species (OxPL) can have non- identical biological activities (Bochkov, 
Oskolkova et al. 2010, Aldrovandi and O'Donnell 2013, Spickett and Pitt 2015).  To understand 
the biological importance of oxidised phospholipids (OxPL) along with their role as a disease 
biomarker, information on the precise concentration of all oxidised species in biological 
samples must be obtained (Gruber, Bicker et al. 2012). Moreover, it is important to measure 
simultaneously all long chain oxidation products including hydroperoxides and hydroxides, and 
short chain oxidation products including saturated and unsaturated aldehydes and di-carboxylic 
acids derivatives. This is required to investigate the dynamic assessment of oxidised 
phospholipids in a disease state, and to examine their relevance to function and disease in-vivo 
(Uchikata, Matsubara et al. 2012).  
The analytical technologies to measure the abundance and identification of oxPL species have 
evolved over the years. In the pre- 2000 era, methods involving mass spectrometry 
measurements were limited and general methodology to analyse oxPL species were used such 
as UV spectrophotometric assays & fluorescence based assays like FOX2 assay, isoluminol 
assay and DNPH assay that provided only global measure of oxidative stress without giving 
any information on the molecular level (Zhang, Cazers et al. 1995, Konishi, Iwasa et al. 2006). 
Although, these methods provide useful initial insights about potential oxidative state, they 
suffer from inherent problems related to sensitivity and specificity of detecting individual 
molecular species, when applied to situations in-vivo (Tyurina, Tyurin et al. 2009). 
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 On the other hand, mass spectrometry coupled with liquid chromatography as a technique to 
measure oxidised phospholipids has gain popularity because it measures mass –to charge ratio 
(m/z) of compounds and can distinguish or separate different molecular species based on their 
masses and functional chemistry, therefore, can selectively identify several different species in 
complex mixture simultaneously. The last decade has seen surge in more sophisticated methods 
involving use of liquid chromatography coupled with mass spectrometry (LC-MS), supporting 
the significance of OxPL in health and disease (Spickett 2001, Sparvero, Amoscato et al. 2010, 
Spickett, Wiswedel et al. 2010, Spickett, Reis et al. 2011, Stutts, Menger et al. 2013). Table 3.1 
illustrates the limitation of methods based on the level of structural information that can be 
obtained. While the mass spectrometry based scanning approaches such as PIS and NL used 
alone can provide limited information, their strength and specificity in identifying a range of 
species is increased when used in combination. Similarly, shotgun approaches like direct 
infusion mass spectrometry (DIMS) provides qualitative information when used alone and 
requires combination of several different scanning methods to improve the information content 
of the method. 
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Table 3.1: Summary of analytical methods and the level of information that can be obtained using different 
approaches 
Representative example about 
information obtained 
Method 
description 
Limitations Publications 
using this 
methods 
 
An oxidised 
phospholipid 
molecule 
UV, Fluorescence 
based methods 
like FOX-2 
Assay, DNPH 
assay, TBARS 
assay 
No 
information at 
molecular 
level 
(Breusing, Grune 
et al. 
2010),(Zhang, 
Cazers et al. 
1995, Wu, 
Svenungsson et 
al. 1999, 
Grintzalis, 
Zisimopoulos et 
al. 2013) 
 
An oxidised phospholipid molecule belong to 
phosphatidylcholine class  
Direct infusion 
mass 
spectrometry 
(DIMS), 
Precursor ion 
scan (PIS) or high 
resolution (HR) – 
LCMS (All used 
alone) 
Only Class 
specific 
information 
obtained, 
application to 
complex 
samples 
challenging 
(Spickett, Pitt et 
al. 1998, 
Spickett, Rennie 
et al. 2001, 
Ekroos 2002, 
Wang, Xie et al. 
2004, Christer S. 
Ejsing 2006) 
 
An oxidised phospholipid molecule belong to 
phosphatidylcholine class  with further 
information on fatty acyl chains 
LC-MS/MS 
approaches based 
on  Precursorion 
scanning (PIS) in 
combination with 
neutral loss 
scanning (NL) 
and product ion 
scanning (EPI) 
and HR-
LCMS/MS 
method 
Information 
on exact 
location of the 
oxidation  not 
possible 
(Yin, Cox et al. 
2009, Gruber, 
Bicker et al. 
2012, Lee, Lim et 
al. 2013, Reis, 
Domingues et al. 
2013) 
 
Moreover, the type of scanning approaches that one can perform on a mass spectrometer 
depends on the type of mass analysers. For instance, selective scanning approaches like 
precursor ion scanning (PIS) and neutral loss scanning (NL) can be performed on triple 
quadruple mass spectrometers whereas MSn based approaches to elucidate structural 
information to the highest level can be performed on instruments with ion trap analysers.  Due 
to extreme chemical diversity of the oxidised lipidome together with the range of concentrations 
of these species in biological samples, complementary analytical approaches are required to 
monitor it completely (Domingues, Reis et al. 2008, Spickett and Pitt 2015). It is analytically 
impractical to measure oxidised species of all classes in a single run because of variation in the 
charge of the polar head group and extreme diversity of oxidised phospholipid species OxPL). 
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Moreover, sensitivity is the major concern, because currently no method is available to 
selectively enrich or amplify these species to improve their detection (Mousavi, Bojko et al. 
2015, Ulmer 2015). Therefore, the strength of the mass spectrometric analysis can be exploited 
by enhancing the selectivity of the methods.  
Selectivity of the analysis can be improved by using semi-targeted approaches like PIS and NL, 
which decrease the contribution of the background ions to the measured signals, producing a 
net gain in sensitivity and signal to noise ratio, and further structural information can be 
obtained using MSn approaches to gain confidence in the identification (Blanksby and Mitchell 
2010, Spickett, Reis et al. 2011). This was made possible by development of hybrid instruments 
by manufacturing companies like Absciex Inc., which developed the Qtrap 5500, an instrument 
that consists of three quadruples and a linear ion trap mass analyser (QQQLIT). This enabled 
the enhanced performance of selective scanning approaches like PIS and NL, and MSn 
approaches together, thereby improving the detection range. 
 Although  semi-targeted  scanning approaches like PIS 184 Da, NL 141 Da and NL 185 Da for 
selective identification of phosphatidylcholine class, phosphatidylethanolamine class (PE) and 
phosphatidylserine class (PS) respectively were reported earlier, these scanning approaches 
have not been used extensively for analysis of OxPL species (Murphy and Axelsen 2011, 
Murphy and Gaskell 2011, O'Donnell 2011, Reis and Spickett 2012). Moreover, NL 34 Da, NL 
36 Da and NL 38 Da scanning methods for identification of hydroperoxide and chlorohydrin 
species respectively, reported by several research groups  were not widely exploited for 
development of mass spectrometry methods (Spickett, Reis et al. 2011, Reis, Domingues et al. 
2013).   
Moreover, advancement in the mass spectrometry field has led to development of sophisticated 
instruments that can theoretically handle the diversity of OxPL. Examples of such instruments 
are 3rd generation Orbitrap mass spectrometers and imaging mass spectrometers. However, such 
sophisticated instruments are very expensive therefore, are limited to small number of institutes 
whereas, most common bench top instruments like Qtrap, triple quadruple or QTOF based 
instruments can be found in several mass spectrometry laboratories. Therefore, the primary aim 
of this project was to develop methods that can be utilised by wider research communities using 
semi targeted scanning approaches. Our study focused on the detection of oxidised 
phosphatidylcholines (OxPCs), oxidised phosphatidylethanolamines (OxPE) and oxidised 
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phosphatidylserines (OxPS), which represent three important classes demonstrating a variety 
of biological activities but insufficiently characterised in several inflammatory diseases. 
Targeted  approaches like precursor ion scanning (PIS) and neutral loss scanning (NL) were 
developed based on the knowledge of  common fragmentation patterns of a small group of 
molecular species bearing a common structural motif, have been reported earlier but have not 
been extensively used to measure OxPC species in biological samples      
While mass spectrometer instruments can separate and identify species that have different 
molecular masses, there are limitations in separation of isomeric and isobaric species (Sandra, 
Pereira Ados et al. 2010). Moreover, isobaric and isomeric species are not uncommon in 
oxidative Lipidomics and therefore, to handle the diversity of OxPL species that can be formed, 
it is often required to couple chromatographic separation with mass spectrometry detection (van 
Meer 2005, Peterson and Cummings 2006, Wörmer, Lipp et al. 2013).  
Various reports describe the combination of either reverse phased and or normal- phase LC 
coupled with mass spectrometry in multi-dimensional set ups to detect and measure long chain 
oxidation products(Hui, Chiba et al. 2010, Morgan, Hammond et al. 2010, Thomas, Morgan et 
al. 2010, Strassburg, Huijbrechts et al. 2012). Most of the methods developed so far relied on 
mass spectrometric and chromatographic development (Fu, Xu et al. 2014, Groessl, Graf et al. 
2015) or focused on high throughput analysis (fast HPLC) at the expense of detection of low 
abundant oxidation products (Gruber, Bicker et al. 2012). Most of the current methods 
published so far, have been either confined to a small number of molecular species based on 
Multiple Reaction monitoring (MRM) based approach or have used high resolution mass 
spectrometry coupled with liquid chromatography to detect specified oxidised phospholipid 
species, solely based on accurate masses and/or tandem mass spectrometry (MS-MS) to obtain 
structural information(Adachi, Asano et al. 2006, Uchikata, Matsubara et al. 2012, Uchikata, 
Matsubara et al. 2012). The MRM and high resolution based methods are highly sensitive and 
focused methods and are ideal for observing and quantifying certain pre-determined species. 
Nevertheless, further improved methods that are capable of quantifying multiple oxidised 
species in biological samples belonging to different phospholipid class are still required.  
To date, there is no report of systematic evaluation of chromatographic separation for OxPL 
species. The resolution parameter that dictates the chromatographic separation is dependent on 
three other parameters: efficiency, selectivity, and capacity;  the maximum improvement in 
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resolution is related to altering the selectivity parameter, which is the factor that is dependent 
upon the chemistry of the analyte, mobile and stationary phases (Zhou, Song et al. 2005, Weng 
2014). All of these factors may be altered to optimise the chromatographic separation. In this 
project, one of the primary objectives was to perform systematic evaluation of chromatographic 
separation by testing several stationary and mobile phase systems to achieve best separation of 
OxPL species. We also investigated the two dimensional separation by serially coupling two 
columns that provides orthogonal selectivity. The set up was adapted from (Haggarty, 
Oppermann et al. 2015) by coupling the HILIC column and reverse phase column. 
The number and chemical composition of OxPL species that need to be identified and measured 
shapes the experimental design and choice of instrumentation. When the objective is to identify 
and measure as many OxPL species as possible and compare between samples without bias, an 
appropriate validation approach needs to be identified in advance to confirm the findings and 
minimise the number of false positive identifications and measurement. Moreover, when the 
method analyses low abundant OxPL species belonging to different classes and high abundant 
phospholipid species together, it becomes inevitable to have an efficient validation approach 
that is equally specific and sensitive for analytes of interest to confirm the identifications and 
findings. An ideal approach should be a non-mass spectrometric approach. In this project, we 
tried different approaches like 1H-NMR for chlorohydrin species, UV spectroscopy for 
hydroperoxide species. However, it was realised that only a separate mass spectrometric 
approach can complement a mass spectrometry methodology. Therefore, validation of our 
findings was done by transferring the method to a high resolution Q-TOF mass spectrometer 
with added layer of identification based on high resolving power. 
Moreover, peak identification and integration across multiple samples manually can introduce 
bias that can further add to systemic error, which affects the accuracy and reproducibility of the 
experiment (Vogeser and Seger 2010).  Furthermore, missing values and overlapping peaks can 
complicate the manual data handling process and can substantially skew the statistical analysis. 
Therefore, automated data analysis using Progenesis QI software was performed to validate 
manual data analysis. Annotation of species was performed by searching against the in-house 
built data base of all possible OxPL species in sdf format to enable theoretical fragmentation 
search with mass tolerance less than 5 ppm. 
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The multiple steps involved in sample preparation, varied composition of analyte solution due 
to the use of gradients or presence of co-eluents during chromatographic separation, minor 
alteration in ionisation conditions and instrumentation may contribute to differential ionisation 
conditions from run to run and affect the ion intensity measurement process (Kofeler, Fauland 
et al. 2012) (Sandra, Pereira Ados et al. 2010, Weng 2014). Moreover, the variation in sampling 
of biological samples can be substantial and add to the total uninduced variation, thereby 
affecting the extraction of biological information from the data analysis (Sysi-Aho, Katajamaa 
et al. 2007) (Veselkov, Vingara et al. 2011, Yang and Han 2011). In this study, different 
normalisation approaches like addition of internal standard, global normalisation, total ion 
intensity and total phospholipid content were tested to pre-estimate the propagated error and 
minimise systemic variation. Moreover, to confirm the accuracy and reproducibility of the 
method, inter- day, intra-day and extraction variability were tested. The linear dynamic range 
was assessed by examining the responses of several commercially available OxPLs at different 
concentrations. 
3.2 Study aim and objectives 
 
In summary, the aim of this chapter is 3 fold: 
 The development of an improved LC-MS method using targeted approaches like 
precursor ion scanning and neutral loss scanning and optimisation of chromatographic 
separation of OxPL to provide better coverage of the oxidised lipidome. 
 Development and testing of several data processing approaches to reduce unnecessary 
variation caused by systemic errors propagated during sample preparation and 
handling. 
 Cross validation of LC-MS data analysis through testing several analytical platforms 
like NMR, high resolution LCMS and automated data analysis using Progenesis QI 
software. 
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To meet these aims, following steps were undertaken: 
 Assessment of different methods to generate OxPL species. 
 Tuning of MS parameters such as collision energy and declustering potential to improve 
the signal to noise ratio and achieving optimum sensitivity. 
 Evaluation of several reverse phase columns and solvent systems outlined in the 
appendix to achieve best separation. 
 Cross validation of the method using different analytical approaches like NMR and high 
resolution Q-TOF mass spectrometry analysis. 
 Assessment of reproducibility and repeatability of the method by testing several 
normalisation approaches and determining inter –day and intra- day repeatability. 
3.3 Methodology 
 
3.3.1.1 Optimisation of mass spectrometry parameters for precursor ion scans (PIS), neutral loss 
scans (NL) by direct infusion mass spectrometry 
 Commercially available standard phospholipids (SOPC, SLPC, SAPC, PAPE and PAPS) 
and/or PC/PE or PS mixtures and their corresponding oxidation products and chlorohydrins 
were analysed by electrospray mass spectrometry (ESI-MS) in positive mode. All analysis was 
performed on ABSciex 5500 QTrap Mass spectrometer (QQQLIT) with parameter tuning and 
optimisation performed using Analyst 1.5.1 software. The parameters optimised for analysis of 
phospholipids and their oxidation products are stated below. The ion spray voltage optimised 
for positive mode analysis was 5500 V. Other source parameters that were optimised for 
analysis of oxidised phospholipids were the source temperature that was fixed at150oC and the 
nebulisation gas flow rate (GS1) at 13 L. Moreover, other parameters like declustering potential 
(Hajjar and Gotto) was optimised to 50 V and collision gas was kept high and was fixed at 10 
for general scanning and was ramped from 10 - 47 for MS/MS experiments (neutral loss, 
precursor ion and product ion scanning) to identify optimal collision energy. Syringe 
parameters were fixed by selecting the syringe code corresponding to 500µl syringe and flow 
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rate at 10 µl/ minute for direct infusion. The resolution was set to unit for general enhanced 
mass spectral scanning (EMS) and enhanced product ion scanning (EPI). For MS/MS spectra 
in precursor ion scanning, the resolution was set to unit for both Q1 and Q3 analyser, and Q1 
at low and Q3 at unit resolution for neutral loss scanning (NL). The filling of the ion trap was 
set to dynamic and the m/z range scanning for positive mode was 490- 1000. The scan rate was 
set to 10,000 scans per second for general mass scanning and 200Da/ seconds for MS/MS 
scanning routines. The solvent system used for analysis of oxidised phospholipids in positive 
mode was ternary mixture consisting of methanol, water and formic acid at the ratio of 
90:9.9:0.1. The modified lipid aliquots were diluted to 100 fold prior to MS analysis by direct 
infusion.  
In analysis of lipid chlorohydrins by direct infusion in positive mode, the native phospholipids 
were identified as (M+H)+ peak of m/z 788.5 for SOPC, 786.5 for SLPC and 810.5 for SAPC 
respectively.  The increment of 52 Da (monochlorohydrin) to the mass of native phospholipid 
corresponding to addition of ClOH group, that is proportional to the number of double bonds 
in the unsaturated fatty acid chain esterified at sn-2 position, was detected for chlorohydrins. 
Moreover, neutral scanning of 36 Da for 35Cl isotope and 38 Da for 37Cl isotope was performed 
to confirm the detection of chlorohydrins. The precursor ion scanning at m/z 184.07 Da was 
performed to characterise all ions having phosphocholine as their head group. 
For UV treated and AAPH oxidised samples, along with EMS scan and PIS scan of 184 to 
characterise phosphatidylcholines, neutral loss scan of 34 Da was performed to detect 
hydroperoxides. In EMS scan, the hydroperoxides peaks were detected with increment of 32 
Da corresponding to monohydroperoxides and hydroxides were monitored with increment of 
16 Da corresponding to mono-hydroxides. For PE class mixture and individual PE species 
neutral loss scan of 141 Da was optimised to selectively identify all oxidation and native PE 
species. For PS class mixture and individual PS species, neutral loss scan of 185 Da in positive 
mode and neutral loss scan of 87 Da in negative mode was optimised and compared to achieve 
better signal to noise ratio. The solvent used for negative mode was the mixture containing 
methanol and 10mM ammonium acetate in the ratio of 90:10. The ion spray voltage optimised 
for negative mode analysis was 4500 V. Other source parameters that were optimised for 
analysis of oxidised phospholipids were the source temperature that was fixed at150oC and the 
nebulisation gas flow rate (GS1) at 13 L. Moreover, other parameters like declustering potential 
(Hajjar and Gotto) was optimised to 50 V and collision gas was kept high and was fixed at 10 
for general scanning and was ramped from 10 - 47 for MS/MS experiments (neutral loss, 
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precursor ion and product ion scanning). For MS/MS spectra in neutral loss scanning mode, the 
resolution was set to low for Q1 and unit for Q3. The filling of the ion trap was set to dynamic 
and the m/z range scanning for negative mode was m/z 200 – 1000Also, secondary 
(fragmented) oxidised products like lysophosphocholines (LPC) at m/z 496.5 and 524.5, 
corresponding to palmitoyl-LPC and stearoyl-LPC respectively where the fatty acid esterified 
at sn-2 position is lost is detected along with other lipid species specific oxidation products like  
1-palmitoyl-2-glutaryl-sn-glycero-3-phosphocholine (PGPC) at m/z 610.5 and 1-palmitoyl-2-
(5’-oxo-valeroyl)-sn-glycero-3-phosphocholine (POVPC) 594.5 for PAPC. In addition, other 
products for linoleyl PC oxidation products at m/z 650 and 666, corresponding to PONPC and 
PAzPC were also detected in positive mode analysis of oxidised phospholipids. 
3.3.1.2 Optimisation of chromatographic separation using several reverse phase columns and 
eluent systems 
 
Figure 3.4: The figure shows graphical representation of the chromatographic gradient programs that were 
evaluated to achieve better separation.  Solvent system A consists of LC-MS grade water with 5 mM ammonium 
formate and 0.1 % formic acid as eluent A and Methanol with 5 mM ammonium formate and 0.1 % formic acid 
as eluent B; Solvent system B consists of ternary mixture of methanol, hexane and 0.1 M ammonium acetate 
(71:5:7) as eluent A and methanol, hexane mixture (95:5) as eluent B; Solvent system C consists of ternary mixture 
of tetrahydrofuran (THF), methanol and 10 mM ammonium acetate (30:20:50) as eluent A and THF, methanol 
and 10mM ammonium acetate (70:20:10) as eluent B; Solvent system D consists of 20 % isopropyl alcohol (IPA) 
in Acetonitrile (ACN) as eluent A and 20 % IPA in 20 mM ammonium formate as eluent B. 
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Conventional reverse phase columns like C-8 Luna column (150 x 1mm), C- 18 Luna column 
(150 x 1mm), C-30 Luna column (150 x 2.1mm) and Proswift –RP 4H polystyrene – divinyl 
benzene coated monolith column (1 x 250mm); and mix mode Hichrom amino based HILIC 
column (150 X 3.1mm) were evaluated using combination of different eluent systems, while 
maintaining the linear flow rate and using mass spectrometry for detection.  
The solvent systems that were used to achieve best separation were: Solvent system A 
consisting of LC-MS grade water with 5 mM ammonium formate and 0.1 % formic acid as 
eluent A and Methanol with 5 mM ammonium formate and 0.1 % formic acid as eluent B; 
Solvent system B consisting of ternary mixture of methanol, hexane and 0.1 M ammonium 
acetate (71:5:7) as eluent A and methanol, hexane mixture (95:5) as eluent B; Solvent system 
C consisting of ternary mixture of tetrahydrofuran (THF), methanol and 10 mM ammonium 
acetate (30:20:50) as eluent A and THF, methanol and 10mM ammonium acetate (70:20:10) as 
eluent B; Solvent system D consisting of 20 % isopropyl alcohol (IPA) in Acetonitrile (ACN) 
as eluent A and 20 % IPA in 20 mM ammonium formate as eluent B. The figure 3.4 shows the 
gradient program for each solvent system used for chromatographic evaluation. 
 Gradient run for solvent system A consisted of a 50 minute run with 0 – 4 minute isocratic hold 
at 70 % B, followed by 3 step gradient increase to 80 % B at 8 minutes, 90 % B at 15 and 100 
% B at 20 minutes. The gradient remained constant until 38 minutes and decreased back to 70 
% B until 50 minutes.  Gradient run for solvent system B  was a 45 minute run with 0 – 4 minute 
at 100 % A followed by 3 step gradient increase to 10 % B at 8 minutes, 40 % B at 20 minutes 
and 100 % B at 26 minutes with isocratic hold at 100 B until 36 minutes and equilibration to 
100 % A from 38 – 45 minutes. Gradient run for solvent system C consisted of a 50 minute run 
starting at 20 % B at 4 minutes and increasing to 100 % B at 20 minutes, followed by isocratic 
hold at 100 % B until 36 minutes and back to starting condition at 38 minutes. Gradient program 
for solvent D consisted of a 45 minute run under HILIC conditions only used for the silica based 
HILIC column from Hichrom, UK with multi step gradient as follows: 0 – 1 minute held at 5 
% B, 1 – 5 minutes to 8 % B, 5 – 10 minutes to 15 % B, 10 – 13 minutes held at 15 % B, 13 – 
23 minutes to 35 % B, 23 – 28 minutes held at 35 % B and back to starting conditions at 29 
minutes until 45 minutes.  
 Mass spectrometric parameters were similar for all solvent systems as outlined in section 
1.3.1.5 expect for solvent system D under HILIC conditions. The mass spectrometric detection 
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for solvent system D under HILIC conditions at 300 µl/ minute was as follows: The source 
temperature was set at 350 oC; the spray voltage was 5500V; the declustering potential was set 
to 50 V for all scans; nitrogen was used as the curtain gas and nebulising gas with flow rates 
set to 35 AU and 26 AU respectively. Survey scan MS data were acquired by electrospray 
ionization in positive mode from 400-1200 Da in high resolution mode for 500 ms. Information 
dependent data acquisition (IDA) was used to collect MS/MS data based on following criteria: 
the 4 most intense ions with +1 charge and a minimum intensity of 250 cps were chosen for 
analysis, using dynamic exclusion for 20 seconds after 2 occurrences and a fixed collision 
energy setting of 47 eV. Each chromatographic program and solvent system is further outlined 
in Appendix 1. 
Chromatographic separation was also evaluated for monolith column by running the gradient 
outlined for solvent system A at different flow rates: 50 µl/ minute, 100 µl/ minute and 200 µl/ 
minute and the sensitivity and elution profile was evaluated. Furthermore, different gradient 
program were evaluated for monolith column with solvent system A. The 3 step gradient 
program as outlined in section 2.3.1.5 was evaluated against a 16 minute steep gradient (70 % 
B at 4 minutes to 100 % B at 20 minutes) and 26 minute shallow gradient (70 % B at 4 minutes 
to 100 % B at 30 minutes) and the separation profile of OxPC species was evaluated. The 
chromatographic program for 16 minute steep gradient and 26 minute shallow gradient is 
graphically represented in appendix 1.  
For optimisation of two dimensional LCMS work serial coupling of monolith column and 
HILIC column was set up and solvent A and solvent system D were used as mobile phases. The 
technique was adapted from the published work used for polar metabolites (Louw, Pereira et 
al. 2008, Haggarty, Oppermann et al. 2015). For the first separation monolith column (Proswift 
RP-4H, 1x 250mm) was used using solvent system A as mobile phases and the 2nd separation 
was performed using HILIC column (ACE Silica, 150 x 3.1mm) column in combination of 
solvent system D as mobile phases. 
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Figure 3.5: Schematic representation of the setup for 2D- orthogonal reversephase-HILIC chromatography 
interfaced with QTOF MS. 
The two columns were coupled in series using a T-piece with third port connected to the 2nd 
binary pump. The scheme of the chromatographic program is explained in appendix 1 and in 
figure 3.5. The two different gradient program using solvent system A for monolith column and 
solvent system D for HILIC column are as below: 
For reverse phase separation gradient run for solvent system A, the program consisted of a 50 
minute run with 0 – 4 minute isocratic hold at 70 % B, followed by 3 step gradient increase to 
80 % B at 8 minutes, 90 % B at 15 and 100 % B at 20 minutes. The gradient remained constant 
until 38 minutes and decreased back to 70 % B until 50 minutes. For HILIC separation  gradient 
consisted of multi-step increment as follows: 0 – 1 minute held at 5 % B, 1 – 5 minutes to 8 % 
B, 5 – 10 minutes to 15 % B, 10 – 13 minutes held at 15 % B, 13 – 23 minutes to 35 % B, 23 – 
28 minutes held at 35 % B and back to starting conditions at 29 minutes until 45 minutes. 
For the modified gradient program for HILIC column used for 2D-LCMS work the gradient 
was as follows: 0 – 1 minute held at 5 % B, 1 – 5 minutes to 8 % B, 5 – 10 minutes to 15 % B, 
10 – 15 minutes to 17.5 % B, 15 – 20 minutes to 20 % B, 20 – 30 minutes to 30 % B, 30 – 35 
minutes to 35 % B, 35 – 40 minutes held at 35 % B and back to starting conditions at 41 minutes 
until 50 minutes.  
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3.3.1.3 Conceptual framework for the automated data anlaysis workflow using Progenesis QI 
software 
 
Untargeted mass spectrometry analysis generates a huge amount of data. While processing the 
data is crucial for subsequent comparative analysis, the outcome of the data processing strongly 
depends on parameter settings and if mot chosen carefully, can easily lead to biased results 
(Libiseller, Dvorzak et al., 2015). The workflow in Progenesis QI is designed to provide 
accurate measurement of the analytes to allow comparative analysis.  
After the raw data files are uploaded, the feature detection algorithm, which is based on the 
combination of determining the boundaries, that is centre and intensities of the two dimensional 
signal of the LCMS raw data is applied to extract features defined by the matrices of m/z and 
retention time of ions. This is done by combining the density based detection approach (an 
alternative to common binning approach) introduced by Stolt et al. and wavelet based approach. 
Based on the information provided by the user about possible adducts that can be formed with 
the anlayte, the software implements the deconvolution step , which will group the ion as a 
single compound representing the cluster of an analyte with different adduct forms. 
In parallel, all the raw data files are represented by an ion intensity map, the map of sample’s 
MS signals separated by m/z and time, which provides an immediate visual quality check, 
highlighting any problems experienced in sample acquisition. These ion maps are further used 
for chromatographic alignment that produces an aggregate run representative of the 
compounds/analytes in all samples and uses these aggregates for peak picking and these can be 
used to manually correct for chromatographic drift by placing landmarks in the 
chromatographic run called alignment vectors. 
The next step of data preprocessing is peak picking also known as feature extraction that 
requires correction for isotopes. To ensure consistent peak picking and matching across all data 
files, an aggregate data set is created from the aligned runs. This contains all peak information 
from all sample files, allowing the detection of a single map of compound ions. This map is 
then applied to each sample, giving 100% matching of peaks with no missing values, so you 
can generate reliable results using valid multivariate statistical analysis. 
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After detection, the ion abundance measurements are normalised  so that the comparisons can 
be made between the runs and find compounds of biological interest. Once the detected 
compounds are listed, the identification can be carried out based not only on neutral mass and 
retention time (if data was available) but also collisional cross-sectional area (CCS) and MS/MS 
fragmentation data. Compounds which have more than one possible identification can be 
reviewed so the results can be narrowed down and the correct identification can be selected by 
observing the measured isotope distribution compared to the theoretical. This isotope 
distribution match contributes to the overall compound identification score.  
3.4 Result 
3.4.1 Assessment of different methods to generate OxPL species 
Commercially available egg yolk lecithin (crude phosphatidylcholine mixture) was subjected 
to oxidation using different methods: exposure to UV light, treatment with the azo initiator: 2, 
2’-Azobis (2amidinopropane) dihydrochloride (AAPH), or reaction with hypochlorous acid 
(HOCl). 
The figures 3.6 and 3.7 show the different profiles of OxPL formed when PC mixture is exposed 
to UV radiation or 10 mM AAPH treatment. Figure 3.6 show the zoomed spectra of the PIS 
scan for 184 Da of control samples as well as UV treated and AAPH oxidised samples in the 
m/z 480 – 750 range. The complete spectra is shown in the appendix II. Several peaks in the 
mass range of m/z 500 – 700 were observed in the treated samples that were absent in control 
samples. 
The top panels of figure 3.6 show the spectra of control samples whereas the bottom panels 
show spectra of the treated sample, showing a 10-fold decrease in intensity of unmodified lipids. 
The peaks observed in the m/z 500-700 range are collectively termed “short chain oxidation 
products”, which are secondary oxidation products and have masses smaller than the 
unmodified phospholipid species. The peaks at m/z 594.5, (oxo-valeroyl)PPC;  610.5, 
(Glutaryl)PPC;  622.5, (oxo-valeroyl)SPC; 638.5, (Glutaryl)SPC; 650.5, (oxo-nanonyl)PPC ; 
666.5, (azelaoyl)PPC;  678.5, (oxo-nanonyl)SPC  and 694.5, (azelaoyl)SPC were observed and 
their respective identification were confirmed by studying the fragmentation spectra and 
comparing them to the published literature. The table 3.2 shows the common fragment masses 
observed for short chain oxidised species in the product ion spectra in addition to the fragment 
mass of 184 Da that corresponded to the phosphocholine fragment. 
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Table 3.2: List of masses of fragment ions of short chain oxidised species observed in product ion scanning. 
Compound name m/z 
M-
R2CO 
M-
R2COOH 
M-
R1CO 
M-
R1COOH 
M-
phosphocholin
e 
M-R1COOH-
phosphocholin
e 
(oxo-valeroyl)PPC 594.38 496.34 478.33 356.15 338.14 411.31 155.07 
(Glutaryl)PPC 610.37 496.34 478.33 372.14 354.13 427.31 171.07 
(oxo-valeroyl)SPC 622.41 524.51 506.24 356.18 338.17 439.34 155.10 
(Glutaryl)SPC 638.52 524.51 506.24 372.29 354.28 455.45 171.21 
(oxo-nanonyl)PPC 650.44 496.34 478.33 412.21 394.20 467.37 211.13 
(azelaoyl)PPC 666.43 496.34 478.33 428.20 410.19 483.37 227.13 
(oxo-nanonyl)SPC 678.52 524.51 506.24 412.29 394.28 495.45 211.21 
(azelaoyl)SPC 694.52 524.51 506.24 428.29 410.28 511.45 227.21 
Figure 3.7 shows the zoomed spectra of the PIS scan for 184 Da of control samples as well as 
UV treated and AAPH oxidised samples in the m/z 700 – 1000 range. Several peaks in the mass 
range of m/z 700 – 1000 were observed in the treated samples that were absent in control 
samples. The peaks observed in the m/z 700- 1000 range are collectively termed as “long chain 
oxidation products”, which are primary oxidation products and have masses larger than the 
unmodified phospholipid species. The peaks at m/z 774.5 and 802.5 respectively correspond to 
hydroxide species of PLPC (phosphatidylcholine class species bearing palmitoyl and lineoyl 
fatty acyl chain) and SLPC respectively with increment of 16 Da in mass with addition of 1 
atom of oxygen. The assignment of m/z values to corresponding oxidised species was done by 
performing product ion scanning for each observed oxidised species and also comparing the 
observed fragment spectrum to published literature. For example, a peak at m/z 818.5 was 
observed in both UV treated as well as AAPH oxidised samples that can be assigned to either 
the di-hydroxide peak of SLPC with increment of 32 Da at m/z 818.5 or an hydroperoxide 
derivative of SLPC. The peak in UV treated samples was assigned to a di-hydroxide peak (2-
OH, +32 Da: SLPC di (OH)) of SLPC instead of a hydroperoxide peak (OOH, +32 Da: SLPC-
OOH) by observing the neutral loss scan for 34 Da, which is selective scanning method for 
hydroperoxide species. Moreover, the fragment ion with loss of 34 Da was absent in product 
ion spectra.  Similarly, the peak at m/z 818.5 was assigned to the hydroperoxide species in 
AAPH treated sample that was confirmed by performing MS/MS scan and neutral loss for 34 
Da scan as shown in figure 3.8. Moreover, higher levels of oxidation products bearing more 
than 4 oxygen atoms were only apparent in AAPH treated sample at m/z 904.5, 958.5 that 
corresponds to dihydroperoxide-hydroxyl-keto species of highly susceptible poly-unsaturated 
bearing native species: 18:0/20:4 PC (m/z 810.5), which is abundantly present in mammalian 
cellular membrane and trihydroperoxide-diketo species of ω 3 fatty acid bearing species: 
18:0/22:6 PC (m/z 834.5).  The table 3.3 shows the common fragment masses observed for long 
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chain oxidised species in the product ion spectra in addition to the fragment mass of 184 Da 
that corresponded to the phosphocholine fragment. 
Table 3.3: List of masses of fragment ions of long chain oxidised species observed in product ion scanning. 
Compound name m/z M-R2CO 
M-
R2COOH 
M-R1CO 
M-
R1COOH 
M-
phosphocholine 
M-R1COOH-
phosphocholine 
PLPC-OH 774.52 496.34 478.33 536.29 518.28 591.45 335.21 
POPC-OH 776.54 496.34 478.33 538.31 520.30 593.47 337.23 
PLPC-OOH 790.50 496.34 478.33 552.27 534.26 607.43 351.19 
SLPC-OH 800.50 524.51 506.24 534.27 516.26 617.43 333.19 
SOPC-OH 802.50 524.51 506.24 536.27 518.26 619.43 335.19 
SLPC-OOH 818.52 524.51 506.24 552.29 534.28 635.45 351.21 
SLPC-OOH(OH) 834.56 524.51 506.24 568.33 550.32 651.49 367.25 
SAPC(O)OHdi(OOH) 904.50 524.51 506.24 638.27 620.26 721.43 437.19 
SDHPCdi(O)3(OOH) 958.52 524.51 506.24 692.29 674.28 775.45 491.21 
 
Figure 3.6:  Direct infusion mass spectrometry (DIMS) analysis of   UV-A oxidation (left panel) and AAPH treated 
(right panel) of PC mixture using Precursor ion scan for 184 Da (A) shows PIS scan of control-1 sample for UV-
A treatment (B) is the PIS scan of UV-A treated sample (C) show PIS scan of control sample for10 mM AAPH 
treatment and (D) shows the PIS scan of 10 mM AAPH treated sample respectively. Secondary fragmented product 
ions are observed in 500-600 m/z range
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Figure 3.7: Direct infusion mass spectrometry (DIMS) analysis of   UV-A oxidation (left panel) and AAPH 
treatment (right panel) of PC mixture using Precursor ion scan for 184 Da (A) shows PIS scan of control-1 sample 
for UV-A treatment (B) is the PIS scan of UV-A treated sample (C) shows PIS scan of control sample for 10 mM 
AAPH treatment and (D) shows the PIS scan of 10 mM AAPH treated sample respectively. No hydroperoxides 
peaks are apparent in UV treated samples, which may have been decomposed to hydroxides that are more stable. 
For example, peak at m/z 774.5 and 802.5 which are hydroxides of PLPC and SLPC respectively. Higher masses 
of oxidation products at m/z 872.5, 904.5 and 958.5 are only apparent in 10 mM AAPH treated sample. 
 
Figure 3.8: Direct infusion mass spectrometry (DIMS) analysis of   UV-A oxidation ( B) and AAPH treatment 
(D) of PC mixture using Neutral loss scan for 34 Da selective for hydroperoxide species (+ OOH, 32 Da). The 
AAPH treated spectra shows the peaks at m/z 790.5 and 818.5 that corresponds to hydroperoxide species of PLPC 
(m/z 758.5) and SLPC (m/z 786.5) and the spectra for UV treated sample does not shows any hydroperoxide 
species. 
Hydroperoxide 
species 
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PC mixture oxidation with 50 mM, 100mM and 150 mM of HOCl predominantly generated 
chlorohydrin species.  Figure 3.9 shows the MS spectra for PIS 184 Da of control and three 
treatment samples. The control group showed (M+H) + ion peaks for unmodified 
phosphatidylcholine class species.  The peaks at m/z 732.5 (16:0,16:1 PC), 758.5 (16:0, 18:2 
PC) , 760.5 (16:0, 18:1 PC), 786.5 (18:0, 18:2 PC), 788.5 (18:0, 18:1 PC) , 806.5 (16:0, 22:6 
PC), 810.5 (18:0, 20:4 PC) and 834.5 (18:0, 22:6 PC) were observed in the control sample that 
got modified to chlorohydrin species on treatment with hypochlorous acid as observed with 
disappearance of these peaks in the treated samples. The treatment group panel spectra showed 
emergence of new peaks with mass shift in multiples of 52 Da to the mass of native 
phospholipids.  For instance, a peak at m/z 812.5 corresponds to monochlorohydrin of 16:0, 
18:1 PC (m/z 760.5). SOPC (18:0, 18:1 PC) have a single double bond hence, only a 
monochlorohydrin is formed at an increment of 52 Da at m/z 840.5. The bischlorohydrin 
species of SLPC (18:0, 18:2 PC) was observed at m/z 890.5 with increment of 104 Da 
corresponding to addition of two ClOH moieties to the SLPC molecule. SLPC has 2 double 
bonds, and therefore there are 2 possibilities: a mono-chlorohydrin with a double bond 
remaining and/or di-chlorohydrin at increment of 104 Da. However, only peak at m/z 890.5 
corresponding to addition of 2 ClOH moieties is apparent while a mono-chlorohydrin is not 
observed at m/z 838.5. For SAPC (18:0, 20:4 PC, m/z 810.5) having four double bonds, there 
is a possibility of forming mono, bis, tris and tetra chlorohydrin with increment of 52 Da, 104 
Da, 156 Da and 208 Da respectively. However, a peak at m/z 966.5 corresponding to tris-
chlorohydrin is observed. Since the mass range of the Qtrap instrument for scanning is 50- 
1000, tetra-chlorohydrin of SAPC was not observed because of the mass (1018.5 Da) which is 
beyond the scanning range of the Qtrap instrument. The abundance of 35Cl to 37Cl isotope of 
chlorine atom in nature is at the ratio of 3:1. Therefore, a (M+2) peak at intensity approximately 
at one-third of the (M+H) + peak is observed for all molecules containing chloride atom that 
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supports the identification of chlorohydrins.
 
Figure 3.9: PIS for 184 Da spectra by direct infusion of PC mixture and the three test samples oxidised with 
different concentration of HOCl (50mM, 100mM, and 150mM). A) Control group showing peaks corresponding 
to 8 different PC molecular species viz. PPPC,POPC,PLPC,SOPC,SLPC,PDPC,SAPC and SDPC respectively. 
B, C, D) showing mass shift in multiples of 52 Da corresponding to monochlorohydrin formation (52 Da) and 
104 Da (bis-chlorohydrin) corresponding to bischlorohydrin formation from PC species having unsaturated fatty 
acid at sn-2 position with 2 double bonds. 
 
Neutral loss of 36 Da and 38 Da are the selective MS/MS scanning approaches that support 
identification of chlorohydrins containing 35Cl and 37Cl respectively. In neutral loss scanning, 
the Q1 analyser and Q3 analyser are set to the scanning mode but with a specific mass offset, 
which on collision with inert gas in Q2 analyser, only allows those ions to pass through the Q3 
analyser that loses neutral masses proportional to the mass offset. Hence, chlorohydrin 
molecules with 35Cl isotope loses H35Cl on collision with inert gases proportional to 36 Da and 
chlorohydrin molecules with 37Cl  isotope loses H37Cl on collision with inert gases proportional 
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to 38 Da. The neutral loss scanning for 36 Da and 38 Da was used to support the identification 
of chlorohydrins as shown in figure 3.10. The peaks in NL 36 scan at m/z 812.6, 862.6, 890.6 
and 966.6 corresponded to chlorohydrins with 35Cl and likewise, peaks at m/z 814.6, 864.6, 
892.6 and 968.6 corresponds to chlorohydrins with 37Cl. The neutral loss scanning for control 
sample did not showed any of this peaks thus, supporting the identification. 
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Figure 3.10: MS/MS data for PC mix chlorohydrins showing characterization by neutral loss (NL) of 36 and 38 Da, corresponding to loss of H35Cl and H37Cl respectively. 
Panels A & D show PC mix ClOH peaks at m/z 812.6,862.6, 890.6, and 966.6 for HO35Cl and m/z  814.6, 864.6, 892.6, and 968.6 for the and HO37Cl products. Similarly, 
panel (B&E) and (C & F) are showing similar spectra for 100mM oxidised test sample and 150mM oxidised test sample respectively 
.
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3.4.2 Mass spectrometry parameters optimisation for Semi -targeted approaches 
 
The first step in method development is optimising the instrument source and compound 
parameters to maximise ionisation efficiency, ion transmission and focussing. The parameters 
critical for semi- targeted approaches like precursor ion scanning (PIS) and neutral loss 
scanning (NL) are the collision energy (CE), declustering potential, step size, mass range and 
quadruple 1 resolution (Q1-R) to improve the duty cycle and % transmission, which are 
associated with sensitivity gain. 
3.4.2.1 Neutral loss of 34 Da to detect hydroperoxide species 
Hydroperoxide are the primary oxidation products formed by addition of OOH moiety (+32 
Da) to the unsaturated phospholipid species. On collision induced activation (CAD), the 
species tend to lose a functional group bearing 34 Da mass. This information can be used to 
selective identify all hydroperoxide species present in a mixture. The figure 3.11 shows the 
representative spectrum for NL 34 scan acquired  at different CE and the graph with the plot 
of peak height and CE for PLPC-OOH and SLPC-OOH respectively.  The peaks at m/z 790.5 
and 818.5 are the monohydroperoxide species of PLPC and SLPC respectively.
 
Figure 3.11: Direct infusion mass spectrometry (DIMS) analysis of 10 mM AAPH treated phosphatidylcholine 
mixture using NL 34 scan for optimisation of compound parameters. Hydroperoxides peaks at increment of 32 
Da are observed at m/z 790.5 (758.5 + 32 Da) and 818.5 (786.5 + 32 Da) in 10 mM AAPH treated samples. The 
3 panel in the left shows the raw mass spectra . The figure (right hand) shows the plot of peak height and CE for 
PLPC-OOH and SLPC-OOH respectively with solid and dotted lines representing experimental repeats. 
As the CE is ramped from 30 eV to 32eV marked improvement in sensitivity  is observed as 
represented by the peak height of PLPC-OOH and SLPC-OOH in figure 3.11. The dotted and 
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the solid line represents the experimental repeats.However, as the CE is gradually increased to 
40 eV, drop in sensitivity is observed. This suggested that the optimum CE for this scan for 
hydroperoxide of PC species to be between 30 -35 eV. 
Similarly, gain in sensitivity was optimised by changing the Q1 resolution and step size for 
oxidised PC mixture, keeping the CE constant at 35 eV. The figure 3.12 A & B (and figure 2.2, 
appendix II) shows the graphical plot of peak height and resolution parameter (A) and step size 
(B) respectively with  oxidised PC mixture acquired using NL 34 scan by direct infusion on a 
Qtrap 5500 mass spectrometer. The peak height of two analytes: PLPC-OOH and SLPC-OOH 
is plotted at different MS parameter with solid and dotted lines representing experimental 
repeats. The data suggests that the step size set to 0.1 Da and low Q1 resolution provided 
maximal ion counts. 
 
 
 
Figure 3.12: Direct infusion mass spectrometry (DIMS) analysis of 10 mM AAPH treated phosphatidylcholine 
mixture using NL 34 scan for optimisation of compound parameters. Hydroperoxides peaks at increment of 32 
Da are observed at m/z 790.5 (758.5 + 32 Da) and 818.5 (786.5 + 32 Da) in 10 mM AAPH treated samples. The 
panel shows that the scan with step size of 0.1 and low Q1 resolution maximised ion intensity. 
Similarly, NL scan for 34 Da to selectively identify hydroperoxide species of 
phosphatidylethanolamine (PE) mixture and phosphatidylserine (PS) species was performed 
The spectra are shown in appendix II. The figure 3.13 and 3.14 shows the optimisation of CE 
parameter for NL 34 scan for hydroperoxide species of PE mixture and PS mixture 
respectively. The peak at m/z 748.5 and 776.5 are the monohydroperoxide species of PLPE-
OOH (16:0/18:2 PE) and SLPE-OOH (18:0/18:2 PE) respectively and the CE between 23 eV 
and 25 eV provides best gain in sensitivity.  Likewise, the peak at m/z 822.5 in figure 3.14 
relates to the monohydroperoxide species of SOPS (18:0/18:1 PS) and the signal to noise ratio 
for this species was improved at CE 25 eV. 
A B 
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Figure 3.13: Direct infusion mass spectrometry (DIMS) analysis of 10 mM AAPH treated 
phosphatidylethanolamine (PE) mixture using NL 34 scan for optimisation of compound parameters. 
Hydroperoxides peaks at increment of 32 Da are observed at m/z 748.5 (716.5 + 32Da) and 776.5 (744.5 + 32Da) 
in 10 mM AAPH treated samples. The solid and dotted lines represents experimental repeats. 
 
 
Figure 3.14: Direct infusion mass spectrometry (DIMS) analysis of 10 mM AAPH treated phosphatidylserine 
(PS) mixture using NL 34 scan for optimisation of compound parameters. Hydroperoxides peaks at increment of 
32 Da are observed at m/z 822.5 (790.5 + 32 Da) in 10 mM AAPH treated samples. The 3 panel shows that the 
scan with CE set between 20 -25 eV provided better sensitivity. The solid and dotted lines represents experimental 
repeats. 
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3.4.2.2 Head group based scanning approaches 
 
3.4.2.2.1 A) Precursor ion Scan for 184 Da 
The signature fragmentation specific to lipid classes have been known since a decade and can 
be used to selectively identify all species belonging to a specific phospholipid class. Precursor 
ion scanning of 184 Da is selective for identification of all species belonging to a PC class. To 
improve the ion count, the CE and declustering potential (DP) were optimised as shown in 
figure 3.15. The ramping of CE from 10 – 50 eV and DP from 20 – 100 eV was performed and 
the peak height of representative species were observed. The species were the 16:0 lyso PC 
(m/z 496.5), POVPC (m/z 594.5), PONPC (m/z 650.5), PLPC-OH (m/z 774.5), SLPC-OOH 
(m/z 818.5), PLPC (m/z 758.5) and POPC (m/z 760.5). The data suggested that the ion counts 
were maximal around 40 -45 eV for the CE and no effect of the declustering potential ramping 
was observed. The representative spectra can be found in the section 2.2 of appendix II.  
 
 
 
 
 
 
 
 
Figure 3.15: Direct infusion mass spectrometry (DIMS) analysis of 10 mM AAPH treated phosphatidylcholine 
mixture using PIS 184 Da scan for optimisation of collision induced dissociation parameters: Collision Energy 
(CE) and Declustering Potential (DP) . Peak heights for representative species of PC class were measured at 
different CE and DP. The peak height profile at different values of DP did not showed any significant difference 
whereas the ion counts that constituted the peak height of representative species showed improvement at CE range 
of 40 – 45 eV.  
 
3.4.3 Assessment of different analytical approaches to determine a suitable cross 
validation method 
Individual phosphatidylcholine species like SOPC (18:0/18:1), SLPC (18:0/18:2) and SAPC 
(18:0/20:4) were oxidised with molar equivalent molar concentrations of hypochlorous acid 
(HOCl) and analysed using several approaches like Nuclear Magnetic Resonance (NMR) 
spectroscopy, negative mode mass spectrometry and high resolution mass spectrometry on Q-
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TOF instrument to determine a suitable cross validation approach that can be used for all 
subsequent experiments to confirm the identification and comparative profiling. 
3.4.3.1 Direct infusion mass spectrometry in positive mode to confirm the generation of 
chlorohydrin species 
 
With the objective of developing a better methodology for analysis of chlorohydrins, simple 
in-vitro model systems like standard phospholipids that are commercially available and are 
found naturally in mammalian cell membranes were oxidised with molar equivalent 
concentration of hypochlorous acid to generate chlorohydrins. The analysis was performed in 
positive ion mode by direct infusion of the diluted solution of the unmodified and chlorohydrin 
lipids.  
Analysis of  3 model system of standard lipids namely SOPC, SLPC and SAPC gave abundant 
peak in MS spectra corresponding to (M+H)+ ions at m/z 788.5, 786.5 and 810.5 as shown in 
figure 3.16. The chlorohydrin peaks in the test spectra were observed at increment of 52 Da 
corresponding to addition of a single HOCl moiety. SOPC have a single double bond hence, 
only a monochlorohydrin is formed at an increment of 52 Da at m/z 840.5. The chlorohydrin 
of SLPC was observed at m/z 890.5 that corresponded to the addition of two HOCl groups with 
increment of 104 Da to the native mass. For SAPC having four double bonds, there is a 
possibility of forming mono, bis, tris and tetra chlorohydrin with increment of 52 Da, 104 Da, 
156 Da and 208 Da respectively. However, as observed in the spectra of SAPC-ClOH in the 
figure 1-16, only a peak at m/z 966.5 corresponding to tris-chlorohydrin is apparent.  
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Figure 3.16: ESI-MS spectra of SOPC, SLPC, and SAPC showing abundant peak corresponding to their (M+H)+ 
ions at 788.5, 786.5 and 810.5 respectively, B) showing their chlorohydrins at increment in multiples of 52Da 
(per addition of chlorohydrin moeity). SOPC-ClOH (+52Da) at m/z 840.5, SLPC-diClOH (+104Da) at m/z 890.5 
and SAPC-trisClOH (+156Da) at m/z 966.5. This experiment was carried by direct infusion of the 1000 fold 
diluted lipid extract at 5μl/minute on AbSciex 5500 QTrap instrument. 
 
Neutral loss of 36 Da and neutral loss 38 Da were performed to confirm the formation of 
chlorohydrins as observed in figure 3.17.  As observed in figure3.17, the neutral loss for 36 Da 
for SOPC-ClOH, SLPC-ClOH and SAPC-ClOH samples showed corresponding chlorohydrin 
peaks at m/z 840.5, 890.5 and 966.5 respectively. Other peaks observed at m/z 822.5 in SOPC-
ClOH spectra, m/z 872.5 in SLPC-ClOH spectra and at m/z 948.5 in SAPC-ClOH are the 
dehydrated peak of the chlorohydrin molecules with loss of water molecule (- 18 Da). Other 
spectra in figure 3.17 (B, D and F) for the neutral loss of 38 Da, showed the M+2 peak 
corresponding to the loss of  H37Cl molecule at m/z 842.5, 892.5 and 968.5 respectively in 
SOPC-ClOH, SLPC-CLOH and SAPC-ClOH spectra. 
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Figure 3.17: MS/MS data for phospholipid chlorohydrins showing characterization by neutral loss (NL) of 36 and 
38 Da, corresponding to loss of H35Cl and H37Cl respectively. Panels A & B show SOPC mono-chlorohydrin at 
m/z 840 and 842 respectively for the HO35Cl and HO37Cl products. Panels C & D show SLPC chlorohydrins 
with the bis-chlorohydrins at m/z 890 and 892. Panels E & F show multiple SAPC chlorohydrins, although the 
tetra-chlorohydrin cannot be observed as the top instrument m/z is 1000. All chlorohydrin show the presence of 
dehydration products under the fragmentation conditions used, as described previously. No significant formation 
of lysolipids was observed with SOPC and SLPC, but a small amount (~10%) of lysolipid at m/z 524 did occur. 
MS analysis was carried out using direct infusion onto an ABSciex 5500QTrap, essentially as described 
previously. 
 
These identifications were confirmed by performing product ion scanning of individual 
species. The MS/MS fragmentation spectra of chlorohydrin peaks at m/z 840.5 (SOPC-ClOH) 
and m/z 890.5 (SLPC-2(ClOH) showed the lysolipid peaks (m/z 506 and 524) retaining the 
stearate at sn-1 position, which corresponded to the dehydrated 18:0 lysoPC and the 18:0 
lysoPC respectively (figure 3.18). Also, it showed the lysolipid peak retaining the  chlorohydrin 
modified chain at m/z 556 and 574 for the SOPC-ClOH MS/MS spectra (m/z 840.5) and at m/z 
606.5 and 624.5 for the SLPC-ClOH  spectra (m/z 890.5). Also, both parent ions showed 
characteristic loss of water (18 Da) and HCl (36 Da) respectively at 822.5 and 804.5 for the 
SLPC-ClOH parent ion and at 854.5 and 872.5 respectively. These fragmentation spectra that 
strengthened the identification of the chlorohydrin formation, showing the lysolipid peaks 
retaining the chlorohydrin modified chain, has not been reported yet and was a novel finding. 
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Figure 3.18: MSMS fragmentation profile of SOPC mono-    chlorohydrin at   m/z 840.5 (A) and SLPC bis-
chlorohydrin at m/z 890.5 (B).  SOPC chlorohydrin shows fragment ions at m/z 524 and 506, corresponding to 
the lysolipid retaining stearate, and peaks at m/z 574 and 556 for lysolipid retaining the chlorohydrin modified 
chain. SLPC chlorohydrin shows the same fragment ions for the lysolipid retaining stearate, and peaks at m/z 624 
and 606 for lysolipid retaining the bis-chlorohydrin modified chain. Both parent ions also show characteristic loss 
of water (18 Da) and HCl (36 Da). MS analysis was carried out using direct infusion onto an ABSciex 5500QTrap, 
essentially as described previously. 
 
 
3.4.3.2 1H-Nuclear Magnetic Spectroscopy (NMR) of chlorohydrins 
NMR analysis of SOPC, SLPC, and SAPC chlorohydrins was performed to confirm and 
validate the mass spectrometric results of formation of chlorohydrins. The proton attached to 
allylic carbon (adjacent to the olefeinic carbon) and bisallylic carbon (carbon atom conjugating 
two-olefeinic carbon atom) have electron deficient environments due to the double bond in the 
vicinity and are deshielded, and are observed downfield in the NMR spectra along with the 
vinylic protons. Formation of chlorohydrins was confirmed by loss of signals due to these 
protons in the downfield region, which were apparent in the unmodified lipids (figure 3.19). 
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For instance, in SAPC-control (red spectrum in figure 3.19, c), the peak at 5.3ppm related to 
the vinyl proton, peak at 2.8 ppm corresponded to the  bisallylic proton and peak at 2.04 ppm 
observed was due to the allylic protons which were absent in the SAPC-ClOH spectra (green 
spectra,3.19, c). Moreover, additional peak appeared around 1.8ppm and 3.8ppm that 
corresponded to the formation of new bonds near these protons. 
This experiments was performed on a 250 Mhz Bruker NMR instrument and owing to low 
magnetic strength of the instrument, either the number of scans had to be quadrupled or the 
loading amount had to be doubled to achieve better signal to noise ratio and integration of these 
peaks. Moreover, these were relatively simple samples and the instrument could not have been 
able to handle complex biological samples where the amount of chlorohydrins can differ in 
orders of magnitude and can be very low, and therefore, other approaches were investigated. 
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Figure 3.19: 1H-NMR spectra showing the formation of chlorohydrins from SOPC (a), SLPC (b) and SAPC (c). 
In each panel, native lipid is the bottom, red spectrum and chlorohydrin is the top, blue spectrum. In the native 
spectra, the multiplet labelled (1) at 5.3 ppm corresponds to the vinyl protons (CH=CH), the multiplet (2) at 2.8 
ppm is bis-allylic protons (=CCH2C=) which is absent in SOPC, and the multiplet (3) at 2.04 ppm corresponds 
to allylic protons (CH2C=). These signals all disappear on formation of chlorohydrins indicating the loss of the 
double bonds, and other signals corresponding to CHs and CH2s adjacent to the substituted carbons appear (4 & 
5). Phospholipids were prepared in 1:1:2:10 pyridine-d5: DCl in D2O: methanol-d4: chloroform-d; spectra were 
acquired at 270 MHz and referenced to tetramethylsilane (TMS) at 0 ppm. (Printed with permission from Elsevier-
permission letter can be viewed in the Appendix II section of the thesis) 
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3.4.3.3 Negative mode analysis of chlorohydrin species 
The SOPC-ClOH, SLPC-ClOH and SAPC-ClOH and their native lipid species were also 
analysed in negative mode using an ammonium acetate solvent system (methanol: 10mM 
ammonium acetate (90:10)) that formed (M+acetate) - adduct with increment of 58 Da to the 
neutral mass.  Also, (M-methyl) - ion corresponding to loss of 15 Da mass was observed in the 
general survey spectra (figure 3.20). The peak at m/z 846.5 and 772.5 corresponding to the 
acetate adduct and (M-15) - ion, observed for the SOPC-control spectra. Likewise, the spectra 
for SLPC showed peak at m/z 844.5 and 770.5 that are related to acetate adduct and the peak 
with loss of methylene respectively.  The SAPC-control spectra also showed the similar peaks 
at m/z 868.5 and 795.5 respectively. Similarly, the spectra of the chlorohydrins in negative 
mode showed similar peaks as acetate adduct and with loss of methylene (-15 Da). 
 
Figure 3.20:  ESI-MS analysis of SOPC, SLPC, and SAPC chlorohydrins in negative mode using ammonium 
acetate buffer solvent system. All peaks are observed as (M+acetate) - ion (+58Da). A-C) shows SOPC, SLPC 
and SAPC control at m/z 846.5, 844.5, and 868.5 respectively. Also, (M-15) - peak is observed at m/z 772.5, 
770.5, and 795.5 respectively. D-F) spectra of SOPC-ClOH and SLPC-ClOH at m/z 898.5 and 948.5 respectively. 
However, the top limit of the Qtrap spectrometer is 1000 m/z, it is not possible to observe ion for tris-chlorohydrin 
of SAPC with acetate adduct at m/z 1024.5 
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The  fragmentation profile of the acetate adducts in negative mode showed peaks 
corresponding to the fatty acid anions corresponding to the saturated chain at sn-1position 
(stearate anion) and  unsaturated fatty acid at sn-2 anion for control samples (figure 3.21). For 
example, the EPI scan of m/z 846.5 showed abundant ion at m/z 283.3 and 281.3 corresponding 
to stearic acid at sn-1 position and oleic acid at sn-2 position. The EPI scan of m/z 844.5 (SLPC-
control) showed fatty acid ion peaks at m/z 283.4 (stearate ion) and 279.4 (linoleate ion) and 
for the SAPC-control (m/z 868.5), the fatty acid anion peaks were observed at m/z 283.4 and 
303.4 corresponding to stearate and arachidonate anion respectively. Moreover, the peak at 
m/z 259.4 was observed in the fragmentation spectra of SAPC-control showing characteristic 
loss of CO2 (44 Da) from the arachidonate anion.  
The SOPC-ClOH fragmentation spectra of m/z 898.5 showed abundant ion at m/z 283.3 
corresponding to the stearic acid anion, and at m/z  297.42 that showed the fatty acid anion 
retaining the chlorohydrin modified chain with loss of HCl (36 Da). Similarly,  SLPC-ClOH 
fragmentation spectra of parent ion 948.5, showed  fatty acid anion peak at m/z 283.4 (stearate 
ion) and chlorohydrin modified chain at m/z 311.4  with loss of two molecules of HCl (72 Da) 
proportional to the number of chlorohydrin moieties added to the unsaturated fatty acid chain 
at sn-2 position with loss of double bond. Likewise, SAPC-ClOH fragmentation spectra of 
parent ion m/z 1024.5showed fatty acid anion peak at 283.4 (stearate ion) and at m/z 351.5 
corresponding to the chlorohydrin modified chain with loss of three molecules of HCl (108 
Da) that is proportional to the number of chlorohydrin moieties added on reaction with HOCl 
(figure 3.21). 
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Figure 3.21: MS/MS fragmentation spectra of acetate adducts of SOPC, SLPC and SAPC and their respective 
chlorohydrins in negative mode direct infusion MS. A-C) shows EPI scanning spectra for control samples in m/z 
range 200-450 providing information about the fatty acid esterified at sn-1 and sn-2 position. D-F) EPI scanning 
of SOPC, SLPC, and SAPC chlorohydrins supported the formation of chlorohydrins. The experiment was 
performed on ABSciex 5500 Qtrap instrument. 
3.4.3.4 Liquid-chromatography mass spectrometry (LC-MS) analysis of chlorohydrin species on 
Qtrap 5500 mass spectrometer using targeted approaches 
The data so far was qualitative in nature and did not addressed the quantification and 
comparison of these species in different species. Therefore, we commenced on adding another 
layer of parameter profiling: retention time to assist in identification and quantification. 
LC-MS analysis of SOPC, SLPC and SAPC control and chlorohydrin species was performed 
by coupling the Dionex 3000 UHPLC system to the Qtrap 500 MS with management of the 
instruments performed using Chromoleon and Analyst softwares. The  dionex monolith 
column (Proswift RP -4H, 1x 250 mm) with  phenyl surface chemistry linked to divinyl 
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benzene polystyrene polymer base was tested for  reverse phase chromatographic separation 
along with binary solvent system involving methanol and water with buffering  provided by 
5mM Ammonium formate and 0.1 % formic acid.An odd chain based phosphatidylcholine 
species (13:0 PC) was used as an internal standard to correct for technical variation.The figure 
3.22 shows the average relative abundance level and retention time of native, chlorohydrin and 
oxidised species (N=3)   in the form of heat map in control and HOCl treated SOPC, SLPC and 
SAPC samples. 
 
Figure 3.22: LC-MS analysis of HOCl treated SOPC,SLPC and SAPC samples using monolith column for 
chromatographic separation and NL 36, NL 38 and IDA based product ion scanning for identification of species 
on Absciex Qtrap 5500 mass spectrometer (N=3). The individual peak areas were calculated by generating 
extracted ion chromatogram (XIC) for individual species, normalised using peak area of internal standard (13:0 
/PC) added before extraction step and represented as heat map where light colour corresponds to low abundance 
level and dark colour corresponds to relative high abundance. 
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The abundance level is proportional to colour intensity and the data displaying the average 
normalised peak area of three replicates suggests relatively higher levels of chlorohydrin 
species in treated samples compared to control samples. Moreover, as the complexity of the 
model system defined by the level of unsaturation increases from SOPC to SAPC, the number 
of species identified increases along with some oxidised species identified in samples with poly 
unsaturated species (SAPC), which could be due to adventitious oxidation because of exposure 
to air during handling. Moreover, the lysophospholipid species, which are species that lost 
either fatty acyl chain and may retain the oxidised/chlorinated moieties, were also observed. 
For example, the peak observed at m/z 574.32 is the lyso species that has lost the fatty acyl 
chain (18:0 carbon chain), which was esterified at sn-1 position, and have retained the 
chlorohydrin group. Moreover, some peroxidised species in the form of secondary fragmented 
products and long chain oxidation products were observed in treated SAPC samples along with 
chlorohydrin species. This may be due to the adventitious oxidation due to exposure to air 
and/or peroxidation in response to hypochlorous acid. However, the predominantly species that 
are formed by treatment with hypochlorous acid is the chlorohydrin species.  The peak area for 
individual species was calculated in all the replicates by generating the extracted ion 
chromatogram (XIC), corrected for technical variation using the peak area of internal standard 
that was added to each sample in equal amount prior to extraction and statistical analysis was 
performed using averaged peak area for all species on graph prism by comparing the corrected 
peak area values across samples. 
3.4.3.5 High resolution LC-MS analysis of chlorohydrin species on Absciex 5600 Q-TOF mass 
spectrometer and data analysis using Progenesis QI 
The same method was transferred onto the high resolution QTOF mass spectrometer and the 
parameters for general TOF MS survey scan were optimised like the accumulation time was 
set to 500 ms for QTOF scan and 250 ms for MS/MS scans. All other parameters were similar 
to that optimised for Qtrap 5500 MS. For data analysis, mass tolerance was set to 5 ppm to 
confirm high accuracy in identification. Data analysis was performed using Progenesis QI 
software by performing chromatographic alignment, peak picking using co-detection algorithm 
to minimise the effect of missing values, deconvolution of all adducts and identification based 
on search and matching of MS and MS/MS profile against in house built database that consisted 
of structures of all possible chlorohydrin and oxidised species and native species present in 
eukaryotes.The table 3.4, summarise the findings of automated data analysis of SOPC, SLPC 
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and SAPC samples treated with molar equivalents of hypochlorous acid, generated on high 
resolution QTOF instrument. 
Table 3.4: Automated data analysis using Progenesis QI of high resolution data of chlorohydrin samples of SOPC 
(a), SLPC (b) and SAPC (c) respectively generated on Absciex 5600 QTOF instrument. The table shows the 
retention time, statistical analysis p-value post ANOVA, accepted identification, mass error and the sample where 
high levels was found.  
a) SOPC 
 
Experimental 
m/z 
Retention 
time (RT) 
ANOVA 
(p) 
Accepted 
compound ID 
Formula Mass 
Error 
(ppm) 
Highest 
Mean 
524.3700 7.86 3.0E-05 PC(18:0/0:0) C26H54NO7P -2.05 treated 
574.3255 4.69 3.5E-07 PC(0:0/18:1-ClOH) C26H53NO8PCl -2.60 treated 
788.6120 25.47 1.4E-07 SOPC C44H86NO8P -5.56 control 
840.5834 22.87 4.8E-08 SOPC-ClOH C44H87ClNO9P -5.44 treated 
b) SLPC 
520.3379 6.16 7.6E-07 PC(18:2(9Z,12Z)/0:0 C26H50NO7P -3.58 control 
524.3697 8.63 1.2E-01 PC(18:0/0:0) C26H54NO7P -2.65 treated 
624.2800 4.45 3.9E-07 PC(0:0/18:2-diClOH) C26H52NO9PCl2 -4.70 treated 
786.5956 25.14 4.0E-06 SLPC C44H84NO8P -6.52 control 
838.5668 22.21 6.0E-05 SLPC-ClOH C44H85ClNO9P -6.58 treated 
890.5398 21.10 3.1E-04 SLPC-diClOH C44H86Cl2NO10P -4.60 treated 
c) SAPC 
524.3703 8.71 5.7E-05 PC(18:0/0:0) C26H54NO7P -1.47 treated 
596.3532 6.97 5.9E-03 Unknown    
622.4060 10.58 3.9E-01 SOVPC C31H60NO9P -2.99 treated 
638.4011 10.52 6.1E-06 SGPC C31H60NO10P -2.54 treated 
650.4343 11.13 1.9E-01 (7’-oxo heptanoic 
acid) SPC 
C33H64NO9P -7.43 treated 
680.4119 9.91 2.9E-01 Unknown    
692.4125 10.88 1.5E-01 (5’-oxo,6-
octenedioicacid) SPC 
C34H62NO11P -1.25 treated 
694.4265 11.74 7.5E-02 (5’-hydroxy,6-
octenedioicacid) SPC 
C34H64NO11P -3.59 treated 
696.4490 7.83 1.8E-02 Unknown    
810.5975 25.26 4.5E-08 SAPC C46H84NO8P -3.98 control 
856.5668 20.32 3.3E-06 SEIPC C46H82NO11P -3.59  
858.5825 18.77 1.9E-05 D2isoprostane-SPC C46H84NO11P -3.45 control 
874.5755 19.49 2.3E-06 SAPC-diOOH C46H84NO12P -5.60 control 
906.5666 18.39 4.3E-05 SAPC-triOOH C46H84NO14P -4.00 treated 
938.5513 16.80 2.2E-01 SAPC-tetraOOH C46H84NO16P -9.30 treated 
948.5279 18.21 2.0E-06 Unknown    
962.5168 19.06 8.5E-07 Unknown    
966.4947 21.28 5.2E-08 SAPC-triClOH C46H87NO11PCl3 -2.50 treated 
1018.4649 19.75 2.9E-11 SAPC-tetraClOH C46H88NO12PCl4 -2.30 treated 
1 Nomenclature PC phosphatidylcholine; Letter S, O, L and A corresponds to Stearoyl, Oleoyl, Linoleoyl and 
Arachidonyl fatty acyl chain; numerical type nomenclature is used for lysophospholipids that lost 1 fatty acyl 
chain. For example:  in PC (18:0/0:0), first two digit corresponds to the number of carbon fatty acyl chain; the 
next digit corresponds to the number of double bonds and similarly the other digits post hypen corresponds to the 
similar chain at sn-2 position; SEIPC corresponds to eoxyisoprostane compound with stearoyl chain and other 
higher hydroperoxides and chlorohydrin species are designated with OOH and ClOH with di, tri and tetra 
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corresponding to number of these functional groups associated with the structure. Please see abbreviation section 
for more details. 
Similar results were obtained when relatively complex mixture of PC species was treated with 
HOCl. The data can be viewed in the appendix II section. 
3.4.4 LC-MS analysis of peroxidation products of SOPC, SLPC and SAPC treated with 
10 mM AAPH 
 
3.4.4.1 Semi-targeted approach analysis on Qtrap 5500 
Non- enzymatic oxidation of SOPC, SLPC and SAPC using 10 mM AAPH and incubation for 
24 hrs formed variety of oxidised species. The chromatographic separation using monolith 
column, and detection on Q-trap mass spectrometer using targeted approaches like PIS for 184 
Da for all oxidised and native species of phosphatidylcholine class, and NL 34 scan for 
detection of hydroperoxides in conjunction with IDA based MS/MS scans for structural 
information, enabled identification of more than 100 oxidised species. The figure 3.23 (A & 
B) and 3.24 illustrates the formation and up regulation of short chain oxidation products that 
eluted between 5-14 minutes, and long chain oxidation products eluting between 18-22 
minutes, in oxidised sample, compared to control sample. The figure 3.23 illustrates the 
unequivocal identification of hydroperoxide species that can be achieved by NL 34 scanning. 
Multiple peaks may represent isobaric compounds with different chemical composition or may 
correspond to multiple positional isomers of the same OxPC, which elutes as clusters of poorly 
separated peaks. As an example illustrated in figure 3.23 (C & D), the native di-unsaturated 
phosphatidylcholine: 1-plamitoyl, 2-linoleoyl-phosphatidylcholine (PLPC, m/z 758.5) after 
oxidation forms a di-hydroxide species, m/z 790.5 (by addition of 2(OH)), and a 
monohydroperoxide species, m/z 790.5 (by addition of OOH). The native phospahtidylcholine 
species (di-stearoyl-phosphatidylcholine, m/z 790.5) is also isobaric to the above mentioned 
oxidation species and these all species were observed in the PIS 184 scan. While the XIC for 
m/z 790.5 from PIS 184 scan showed 3 chromatographic peaks at 17.5 minutes, 19.5 minutes 
and 25.5 minutes, the XIC for m/z 790.5 in NL 34 scan showed a single peak at 19.5 minutes. 
Thus, NL 34 scans can be used to identify all hydroperoxide species. Without the 
chromatographic separation, the resolution requirement to separate these two isobaric peaks at 
m/z 790.5608 (PLPC-2(OH)) and 790.5563 (PLPC-OOH) would be 100,000, which would had 
been possible only on fourier transform- ion cyclotron instruments. 
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Figure 3.23: Overlaid Total ion chromatogram (TIC) of PIS 184 scan (A) and NL 34 scan (B) for control (black) 
and oxidised PC mix sample (grey). It illustrates formation and early elution of short chain and long chain oxidised 
PC species compared to native PC species. The figure (C &D) are overlaid XIC for m/z 790.5 from PIS 184 scan 
(C) and NL 34 scan (D) that illustrates the unequivocal identification of hydroperoxide species by NL 34 scan. 
This experiment was performed using monolith column for separation and Qtrap MS with targeted approaches 
for detection. 
 
86 
 
 
 
 
 
 
Figure 3.24: LC-MS analysis of 10 mM AAPH treated SOPC,SLPC and SAPC samples using monolith column 
for chromatographic separation and NL 34 Da, PIS 184 Da and IDA based product ion scanning for identification 
of species on Absciex Qtrap 5500 mass spectrometer (N=3). The individual peak areas were calculated by 
generating extracted ion chromatogram (XIC) for individual species, normalised using peak area of internal 
standard (13:0 /PC) added before extraction step and represented as heat map where light colour corresponds to 
low abundance level and dark colour corresponds to relative high abundance. 
As expected, due to oxidative fragmentation of oxidised fatty acid residue or addition of 
oxygen, the OxPC species eluted from the reverse-phased monolithic column significantly 
earlier as compared to the native phospholipids.  We were able to detect more than 100 different 
oxidised species using our method based on targeted approaches, which were up regulated in 
the oxidised sample, compared to control sample (figure 3.24). The XIC’s were generated for 
the nominal masses of all previously identified OxPC species and peak area was measured. The 
experiment was repeated three times, measured peak area was averaged and normalised to the 
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peak area of the internal standard and heat map was generated for mean peak area of all species 
in control and oxidised sample, representing colour coded abundance. The list consisted of 5 
different categories of oxidised PCs consisting of lyso-products, short chain oxidation products 
encompassing fragmented ω-terminal, fragmented α-β unsaturated aldehydes and dicarboxylic 
acids, non-fragmented prostane ring species, long chain oxidation products (hydroperoxides, 
hydroxides)  and native PCs. 
3.4.4.2 Confirmation of presence of hydroperoxides using FOX 2 assay 
The UV spectrophotometric assay based on the principle of detection of ferric ion-xylenol 
orange complex that is formed when the ferrous ions present in reagent is converted to ferric 
ion in presence of hydroperoxides. This method was utilized to validate the level of 
hydroperoxide species in in-vitro oxidised samples.The table 3.5 summarises the concentration 
of the total hydroperoxide in control and treated samples and the values represents the mean ± 
standard deviation mM equivalent to H2O2. The oxidised samples showed higher levels of 
hydroperoxides compared to the control samples. 
Table 3.5: Hydroperoxide quantification using FOX 2 assay. The values are mean± std. dev equivalent to mM eq. 
of H2O2 concentration  
 
3.4.4.3 High resolution LC-MS analysis on QTOF 5600 
Based on previously identified and functionally characterised types of oxidation products, we 
measured exact masses, molecular formula, and retention time using current chromatographic 
condition for monolith column and detection on high resolution Q-TOF mass spectrometer was 
performed to validate our identification. Automated data analysis using Progenesis QI software 
was used to confirm and validate the manual data analysis.The table 3.6 summarise the findings 
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of automated data analysis of high resolution data of SOPC, SLPC and SAPC samples treated 
with 10 mM of AAPH.  
Table 3.6: Automated data analysis using Progenesis QI of high resolution data of oxidised samples of SOPC (a) 
,SLPC (b)  and SAPC (c)  respectively generated on Absciex 5600 QTOF instrument. The table shows the retention 
time, statistical analysis p-value post ANOVA, accepted identification, mass error and the sample where high 
levels was found 
a) SOPC 
Experimental 
m/z 
Retention 
time (RT) 
ANOVA 
(p) 
Accepted 
compound ID 
Formula 
Mass 
Error 
(ppm) 
Highest 
Mean 
522.3550 6.18 0.494 PC(0:0/18:1(9Z)) C26H52NO7P -0.73 control 
524.3706 8.75 0.549 PC(18:0/0:0) C26H54NO7P -0.95 treated 
650.4390 12.05 0.001 S-7KPC C33H64NO9P -0.29 treated 
678.4686 16.24 0.000 SONPC C35H68NO9P -2.74 treated 
694.4633 16.16 0.000 SAzPC C36H69NO10P -2.74 treated 
788.6140 25.50 0.007 SOPC C44H86NO8P -3.05 treated 
804.6049 23.92 0.000 SOPC-OH C44H86NO9P -8.00 control 
804.6057 22.10 0.000 SOPC-OH C44H86NO9P -7.02 treated 
820.6006 22.42 0.002 SOPC-OOH C44H86NO10P -6.85 treated 
820.6011 19.17 0.002 SOPC-OOH C44H86NO8P -6.46 treated 
836.5963 19.41 0.000 SOPC-OOH-OH C44H86NO9P -6.02 treated 
b) SLPC 
520.3398 5.73 0.162 PC(18:2(9Z,12Z)/0:0) C26H50NO7P 0.12  
524.3712 8.26 0.071 PC(18:0/0:0) C26H54NO7P 0.31  
536.3345 4.67 0.000 PC(18:2(OH)/0:0) C26H50NO8P -0.30 treated 
552.3293 4.56 0.000 PC(18:2(OOH)/0:0) C26H50NO9P -0.50 treated 
650.4383 8.80 0.000 S-7KPC C33H64NO9P -1.27 treated 
650.4742 18.92 0.266 13-0PC-internal standard C34H68NO8P -2.04  
666.4684 13.94 0.000 Unknown    
678.4684 15.75 0.000 SONPC C35H68NO9P -3.00 treated 
692.4476 14.30 0.000 Unknown    
692.4818 18.54 0.000 Unknown    
694.4633 15.64 0.000 SAzPC C35H68NO10P -3.01 treated 
704.4840 18.65 0.000 Unknown    
706.4962 17.27 0.000 Unknown    
732.4768 17.32 0.000 KODA-PC-Stearoyl C38H70NO10P -5.75 treated 
734.4925 15.75 0.000 HODA-PC-Stearoyl C38H72NO10P -5.63 treated 
748.4727 16.28 0.000 KDdiA-PC-Stearoyl C38H70NO11P -4.27 treated 
750.4872 16.72 0.000 HDdiA-PC-Stearoyl C38H72NO11P -4.95 treated 
750.4879 18.84 0.000 HDdiA-PC-Stearoyl C38H72NO11P -4.90 treated 
786.5973 24.98 0.000 PC(18:2(9Z,12Z)/18:0) C44H84NO8P -4.37 control 
800.5761 23.12 0.000 SLPC=O C44H82NO9P -4.88 treated 
802.5905 23.59 0.000 SLPC-OH C44H84NO9P -6.38 treated 
802.5915 21.77 0.000 SLPC-OH C44H84NO9P -5.17 treated 
816.5703 19.67 0.000 SLPC,epoxy,keto C44H82NO10P -5.60 treated 
818.5861 20.50 0.000 SLPC-2(OH) C44H84NO10P -5.43 treated 
818.5862 22.29 0.000 SLPC-OOH C44H84NO10P -5.32 treated 
832.5662 20.34 0.000 SLPC-OOH,keto C44H82NO11P -4.40 treated 
834.5809 19.14 0.000 SLPC-OOH,OH C44H84NO11P -5.50 treated 
848.5624 20.14 0.000 Unknown    
848.6062 22.16 0.036 Unknown    
850.5787 19.72 0.000 SLPC diOOH C44H84NO12P -2.00 treated 
864.5781 20.53 0.000 SLPC-diOOH ,keto C44H82NO13P 21.30 treated 
870.5564 19.89 0.000 Unknown - -  
882.5954 19.64 0.000 SLPC-diOOH ,OH,OH C44H84NO14P 28.50 treated 
c) SAPC 
524.3710 8.78 0.0192 PC(18:0/0:0) C26H54NO7P -0.11 treated 
544.3392 5.55 0.0061 PC(0:0/20:4(5Z,8Z,11Z,14Z)) C28H50NO7P -1.00 treated 
608.3897 9.31 0.0000 Unknown    
622.4058 9.56 0.0000 SOVPC C31H60NO9P -3.27 treated 
638.4007 9.64 0.0001 SGPC C31H60NO10P -3.23 treated 
648.4205 14.77 0.0000 7-Keto,5-heptaenoyl-SPC C33H62NO9P -4.60 treated 
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650.4355 11.84 0.0005 7-OH,5-heptaenoyl-SPC C33H64NO9P -5.60 treated 
666.4293 9.67 0.0057 7-OOH,5-heptaenoyl-SPC C34H68NO9P -6.70 treated 
676.4146 10.90 0.0000 KOOA-PC-stearoyl C34H62NO10P -5.63 treated 
678.4300 9.72 0.0000 HOOA-SPC C34H64NO10P -6.00 treated 
682.4250 8.67 0.0001 Unknown    
692.4090 9.64 0.0010 KOdiA-PC-stearoyl C34H62NO11P -6.22 treated 
694.4248 10.17 0.0014 HOdiA-PC-Stearoyl C34H64NO11P -6.01 treated 
718.4588 15.08 0.0012 5-OH-6,8-undecedienoyl-
SPC 
C37H68NO10P -9.10 treated 
720.4400 10.67 0.0990 Unknown    
734.4533 9.78 0.0004 5-OH-6,8-undecediendioyl-
SPC 
C37H68NO11P -9.50 treated 
760.4700 15.71 0.0004 10-OH-5,8,11-tridecatrienoyl-
SPC 
C39H70NO11P -7.80 treated 
780.4679 9.14 0.0015 Unknown    
810.5937 25.36 0.0002 SAPC C46H84NO8P -8.70 control 
826.5875 22.48 0.0004 SAPC-OH C46H84NO9P -10.30 treated 
838.5515 21.64 0.0000 SECPC C46H80NO10P -9.30 treated 
840.5169 24.29 0.0107 SAPC-OH,keto C46H82NO10P -9.00 treated 
844.5475 18.51 0.0001 Unknown    
856.5613 20.17 0.0000 SEIPC C46H82NO11P -9.60 treated 
856.5616 21.15 0.0000 SEIPC C46H82NO11P -9.60 treated 
860.5926 22.07 0.3497 F2isoprostane-Stearoyl C46H86NO11P -9.88 treated 
870.5458 17.57 0.0000 SAPC-OOH,di-keto C46H80NO12P -3.80 treated 
872.5563 19.07 0.0000 SAPC-OOH,keto,hydroxy C46H82NO12P -9.70 treated 
874.5706 19.01 0.0000 SAPC-diOOH C46H84NO12P -10.30 treated 
876.5836 17.65 0.0000 Isofuran-SPC  C46H86NO12P -14.20 treated 
886.5383 19.01 0.0000 Unknown    
888.5524 17.32 0.0000 SAPC-diOOH,keto C46H82NO13P -8.20 treated 
890.5656 17.76 0.0000 SAPC-diOOH,OH C46H84NO13P -10.90 treated 
892.5354 21.78 0.0051 Unknown    
892.5380 20.98 0.7132 Unknown    
902.5663 20.39 0.0005 Unknown    
906.5611 17.15 0.0000 SAPC-triOOH C46H84NO14P -10.10  
922.5568 16.70 0.0000 SAPC-triOOH,OH C46H84NO15P -9.00  
934.5794 19.92 0.0001 Unknown    
936.5486 18.09 0.0000 SAPC-triOOH,OH,Keto C46H84NO16P 4.50  
938.5507 17.71 0.0005 SAPC-tetraOOH C46H84NO16P -10.00  
954.5468 15.22 0.0017 SAPC-tetraOOH,OH C46H84NO17P -8.60  
Similar result was obtained when PC mixture was used as a model to study phospholipid 
oxidation. The data is shown in the appendix II section. 
3.4.5 Optimisation of chromatographic separation of OxPL 
 
3.4.5.1 Altering the stationary phase and mobile phase to achieve better selectivity 
 
The chromatographic separation of OxPC species was evaluated using several columns like C-
8 Luna column (150 x 1mm), C- 18 Luna column (150 x 1mm), C-30 Luna column (150 x 
2.1mm) and Proswift –RP 4H polystyrene – divinyl benzene coated monolith column (1 x 
250mm); and mix mode Hichrom amino based HILIC column (150 X 3.1mm) using different 
solvent systems. The detailed description of chromatographic system is provided in the 
appendix section. Extracted ion chromatogram (XIC) of five representative species of short 
chain oxidation products, long chain oxidation products and native PCs separated on different 
columns and solvent system was obtained and the median time point  with inter-quartile range 
of the elution for each group was calculated and graphically represented to evaluate the 
separation (N=3) (figure 3.25). The data illustrates that the polystyrene-divinylbenzene coated 
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monolith column provided robust separation of short chain oxidation products from long chain 
oxidation products and unmodified PCs and PEs, compared to other tested columns and solvent 
systems. 
While the C-18 column with Hexane-methanol solvent system (Solvent system B) also 
provided better separation, reproducibility was an issue owing to volatile nature of the solvent 
system. Moreover, dispersibility of separation within each group represented by the inter-
quartile range, which is defined by the separation of different species belonging to the same 
group, was observed to be better with monolith column, compared to other conventional reverse 
phase columns.  While the HILIC column separated different phospholipid classes more 
effectively, different classes of oxidised species within phospholipid class were not separated 
effectively using a HILIC column. The overlaid extracted ion chromatogram (XIC) of 
representative species grouped into chain shortened products, long chain oxidation products 
and native PC’s showing elution profile for different chromatographic separation system is 
shown in section 2.6 of appendix II. 
 
Figure 3.25: Evaluation of chromatographic separation of OxPC species using several columns and solvent 
systems. Extracted ion chromatogram (XIC) was generated of five representative species for each group; chain 
shortened products (POVPC, m/z 594.5; PONPC, m/z 650.5; SONPC, m/z 678.5; SAzPC, m/z 694.5 and KODA-
PC, m/z 704.5), long chain oxidation product (PLPC-OH, m/z 774.5; PLPC-OOH, m/z 790.5; SEIPC, m/z 856.5; 
SLPC (2OOH), m/z 850.5 and SLPC-OOH, m/z 818.5) and Native PCs (DPPC, m/z 734.5; PLPC, m/z 758.5; 
SLPC, m/z 786.5; PAPC, m/z 782.5 and SDHPC, m/z 834.5) and the median elution time with inter-quartile range 
for each group was used to plot the data. Different solvent systems were also used to optimise the separation of 
different species. Solvent system B represents the ternary solvent system consisting of Methanol:Hexane:0.1M 
ammonium acetate (71:5:7) as eluent A and methanol: hexane (95:5) as eluent B. Solvent system D indicates 
solvent system for HILIC column: eluent A- 20% Isopropyl alcohol (IPA) in Acetonitrile (ACN) and eluent B- 20 
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% IPA in ammonium formate (20mM); Solvent system C indicates another solvent system consisting of eluent A 
as Tetrahydrofuran (THF):methanol:water (30:20:50) and eluent B as THF: methanol: water (70:20:10) with 
10mM ammonium acetate and Solvent system A consist of water with 0.1% formic acid and 5 mM formate as 
eluent A and methanol with formic acid and 5mM formate as eluent B. 
 
 
Further evaluation was performed by measuring the chromatographic peak width at half height 
(Full width at half maximum (FWHM) and  selectivity factor (α)  for each representative species 
of the short chain oxidation product, long chain oxidation product and native PC species.  The 
formula for calculating the selectivity factor is the ratio of retention time of the parent analyte 
to the retention time of the product analyte. 
The table 3.7 summarises the FWHM for all the representative analytes of each oxidised 
product category measured for the chromatographic system under evaluation. The measurement 
indicates that the chromatographic peaks for chromatographic system involving monolith 
column and solvent system A were broader compared to other silica based columns such as C8 
and C18 in combination with the solvent system B. This may affect the chromatographic 
resolution adversely. However, the chromatographic resolution is majorly influenced by the 
selectivity that is the elution profile of the analyte of interest relative to other analytes.  
To further evaluate the chromatographic performance the ratio of retention time of short chain 
oxidation product and long chain oxidation product to their precursor native species was 
calculated to investigate the relative retention difference between parent and product analytes. 
The table 3.8 lists the selectivity factor calculated for the representative short chain and long 
chain oxidation products. The calculation suggests that monolith column provided selectivity 
better than C8, C18 and C30 column when solvent system A or C was used but the opposite 
effect was observed when solvent system B was used in combination with silica based columns. 
Moreover, when the inter-day repeatability was investigated for the chromatographic system 
involving solvent system B and C18 column, substantial drift in retention time was observed 
and therefore, it was concluded that monolith column provided robust separation when 
compared to other chromatographic system. The figure 3.26 shows the overlaid total ion 
chromatogram (TIC) of precursor ion scan of the same sample acquired on day 1 and day 3 
using the C18 and solvent B chromatographic system. Significant difference in the elution time 
of peaks is observed suggesting the change in organic strength of the mobile phase over period 
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of time.  These can adversely affect the chromatographic alignment and peak picking & 
identification process during comparative analysis. 
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Table 3.7: Evaluation of the efficiency of several  chromatographic systems by calculating the peak width at half height (FWHM) for representative analytes of the oxidised products. 
 
chain shortened product Long chain oxidation product Native PC 
 
P
O
N
P
C
 
S
O
N
P
C
 
P
O
V
P
C
 
S
A
z
P
C
 
K
O
D
A
-P
C
 
A
v
e
ra
g
e 
P
L
P
C
-O
H
 
P
L
P
C
-O
O
H
 
S
E
IP
C
 
S
L
P
C
2
-
O
O
H
 
S
L
P
C
-O
O
H
 
A
v
e
ra
g
e 
P
L
P
C
 
S
L
P
C
 
P
A
P
C
 
P
P
P
C
 
S
D
H
P
C
 
A
v
e
ra
g
e 
Monolith column - Solvent System 
A 0.72 0.37 0.6 0.72 1.08 0.71 0.66 0.67 0.57 0.72 0.47 0.618 0.73 0.58 0.37 0.65 0.64 0.594 
C8 - Solvent System A 0.4 0.7 0.5 0.5 0.7 0.56 0.6 0.5 0.6 0.54 1.4 0.728 0.2 0.3 0.4 0.3 0.6 0.36 
C8 - Solvent system B 0.28 0.22 0.2 0.2 0.33 0.246 0.36 0.6 0.46 0.56 0.3 0.456 0.3 0.37 0.3 0.29 0.3 0.312 
C-18 0.23 0.23 0.2 0.22 0.2 0.216 0.32 0.34 0.27 0.45 0.32 0.34 0.36 0.4 0.3 0.28 0.32 0.332 
C-30 0.3 0.3 0.3 0.3 0.4 0.32 0.7 0.6 0.4 0.5 0.4 0.52 0.4 0.4 0.3 0.4 0.5 0.4 
HILIC Solvent System D 0.31 0.3 0.3 0.35 0.4 0.332 0.35 0.36 0.45 0.52 0.45 0.426 0.26 0.36 0.3 0.27 0.32 0.302 
C8 Solvent System C 0.6 0.7 0.4 0.7 0.4 0.56 0.8 1.1 0.6 0.9 0.9 0.86 0.5 0.4 0.5 0.4 0.5 0.46 
C-18 Solvent System B 0.3 0.56 0.25 0.3 0.53 0.388 0.67 0.32 0.3 0.57 0.46 0.464 0.35 0.47 0.31 0.36 0.3 0.358 
 
Table 3.8: Evaluation of the efficiency of several  chromatographic systems by calculating the selectivity factor (α) for representative analytes of the oxidised products. 
 
chain shortened product 
 
Long chain oxidation product 
 
 
PONPC SONPC POVPC SAzPC KODA-PC Average α PLPC-OH PLPC-OOH SEIPC SLPC(2OOH) SLPC-OOH Average α 
Monolith column - Solvent System A 3.28 2.05 4.35 2.02 3.03 2.94 1.11 1.17 1.29 1.30 1.15 1.20 
C8 - Solvent System A 1.31 1.23 1.43 1.21 1.36 1.31 1.09 1.09 1.15 1.12 1.09 1.11 
C8 - Solvent system B 4.40 4.52 4.60 4.42 3.93 4.37 2.57 2.57 3.49 2.93 2.50 2.81 
C-18 1.34 1.33 1.43 1.24 1.42 1.35 1.15 1.16 1.25 1.17 1.19 1.19 
C-30 1.37 1.35 1.51 1.25 1.29 1.35 1.13 1.14 1.26 1.16 1.24 1.19 
HILIC Solvent System D 0.96 0.92 0.95 0.93 0.96 0.94 0.99 1.00 0.99 0.98 0.98 0.99 
C8 Solvent System C 1.89 1.71 1.94 1.68 1.82 1.81 1.08 1.13 1.19 1.13 1.10 1.12 
C-18 Solvent System B 5.52 4.38 6.27 5.43 6.27 5.57 2.02 2.04 2.58 2.66 1.61 2.18 
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Figure 3.26: Overlaid chromatographic run of oxidised PC mixture acquired on day 1 and day 3 that were analysed 
using C18 column and solvent system B using precursor ion scan 184 Da.The bold line profile shows the day 1 
run and the light line shows the day 3 run of the same sample. 
 
 
3.4.5.2 Testing different solvent system with monolith column to achieve best separation 
 
Once the stationary phase that provided better separation was determined, other solvent systems 
were tested to further refine the separation. The figure 3.27 shows that the monolith column 
with solvent system-A provided better separation compared to other solvent systems. Three 
representative species for each group was selected and median elution time with inter quartile 
range was calculated to evaluate the separation. 
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Figure 3.27: Evaluation of chromatographic separation of OxPC species using monolith column and different 
solvent systems. Extracted ion chromatogram (XIC) was generated of three representative species for each group: 
chain shortened, long chain oxidation product and Native PCs and the median elution time with inter-quartile range 
for each group was used to plot the data. Different solvent systems were also used to optimise the separation of 
different species. Solvent system B represents the ternary solvent system consisting of Methanol:Hexane:0.1M 
ammonium acetate (71:5:7) as eluent A and methanol: hexane (95:5) as eluent B. Solvent system C indicates 
another solvent system consisting of eluent A as Tetrahydrofuran (THF):methanol:water (30:20:50) and eluent B 
as THF: methanol: water (70:20:10) with 10mM ammonium acetate and Solvent system A consist of water with 
0.1% formic acid and 5 mM formate as eluent A and methanol with formic acid and 5mM formate as eluent B. 
 
3.4.5.3 Optimisation of flow rate and gradient system 
 
The optimum separation of analytes is dependent on longitudinal diffusion, resistance to mass 
transfer and eddy diffusion, which again is associated with running samples at optimal linear 
velocity. Therefore, an oxidised PC sample was run at different flow rates on monolith column 
with solvent system A to determine optimal flow rate for better separation.  
The experiment was repeated three times and the median elution time of three representative 
species for each group of short chain oxidation products, long chain oxidation products and 
native PCs was calculated along with the normalised peak area that is associated with sensitivity 
to determine optima flow rate for separation. The figure 3.28 shows that the flow rate at 50 µl/ 
minute was optimal for best separation and sensitivity. The table in appendix II enlists all the 
species with calculated peak area that were used in the evaluation. 
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Figure 3.28: Evaluation of chromatographic separation of OxPC species using monolith column solvent system A 
at different flow rates. Extracted ion chromatogram (XIC) was generated of three representative species for each 
group: chain shortened, long chain oxidation product and Native PCs and the median elution time with inter-
quartile range for each group and normalised peak area was used to plot the data. 
 
Finally, the gradient was optimised for monolith column and solvent system A at 50 µl/ minute flow 
rate.  
Three different gradients: a short gradient running from 70 % B to 100 % B in 16 minutes; a long 
gradient running from 70 % B to 100 % B in 26 minutes and a program consisting of three step gradients 
from 70 % B to 100 % B in 16 minutes was evaluated for optimal separation. The details of the gradient 
program are provided in the appendix section. The figure 3.29 shows the evaluation of elution profile of 
representative species within each group of short chain oxidation product, long chain oxidation product 
and native PCs analysed at different chromatographic gradient program. 
  
Figure 3.29: Evaluation of chromatographic separation of OxPC species using monolith column, solvent system-
A, flow rate of 50 µl/minute using different gradient program. XIC was generated of three representative species 
for each group: chain shortened, long chain oxidation product and Native PCs and the median elution time with 
inter-quartile range for each group was plotted for evaluation. 
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The maximum efficiency of the  monolith column, which is longer than the conventional 
reverse phase columns used in several published research for analysis of OxPL is achieved by 
using a shallow gradient ( 26 minute gradient), compared to the steep gradient or the step 
gradient ( figure 3.28). 
3.4.6 Method Validation 
 
3.4.6.1 Assessment of reproducibility and repeatability 
 
Oxidised PC mixture samples were analysed at different times of a day and at different days to 
assess the repeatability and reproducibility of the method. The experiment was repeated 3 times 
and the relative standard deviation was calculated from the average peak area and standard 
deviation of sampled species across all groups of oxidised species.  The figure 3.30 shows the 
intra-day repeatability and inter- day reproducibility of the method. The RSD of most of the 
peaks were below 20 % although, some species showed greater deviation, which could be due 
to integration error that becomes more prominent for very low abundant species as well as 
isobaric nature of the species. 
 
Figure 3.30: Investigation of repeatability and reproducibility of the method by analysing quality control samples 
at different time points of the day and at different days (N=3). The evaluation was performed by calculating RSD 
for sampled species in all the replicates. The RSD for most of the species was less than 20 % that conformed to 
USFDA guidelines for LCMS methods. 
As per the US FDA guidelines, the variation should not be more than 20 % for LCMS based 
methods and the method conforms to the guidelines. 
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3.4.6.2 Assessment of normalisation approaches 
 
Different approaches were assessed and investigated to minimise technical variation and 
increase the robustness of the method. Normalisation approaches such as the internal standard 
method, Total ion intensity and global normalisation approach were compared. The table 3.9 
shows the snapshot of the effect and comparison of these 3 normalisation approaches on the 
relative standard deviation parameter that is calculated from the average normalised peak area 
and standard deviation of sampled species from 3 independent experiments. 
Table 3.9: Evaluation and comparison of the effect of different normalisation approaches on the calculated relative 
standard deviation for technical replicates (N=3). Five representative species for each group of short chain 
oxidation product, long chain oxidation product and native PCs were selected and the RSD was calculated post 
applying the transformation. 
m/z 
No 
normalisation 
TIC 
normalisation 
approach 
Global 
normalisation 
approach 
internal 
standard 
normalisation 
internal standard 
normalisation and 
log transformation 
RSD % 
594.3768 9.58 5.86 9.4 9.4 1.23 
610.3724 8.02 4.49 7.94 7.81 1.10 
650.4394 8.45 4.98 8.41 8.18 0.75 
666.4344 8.02 4.9 8.12 7.61 0.74 
678.4706 8.47 4.86 8.35 8.29 0.84 
760.5831 1.10 3.45 0.28 2.38 0.17 
782.5672 2.76 1.31 2.19 3.41 0.30 
786.5990 1.78 2.7 0.79 2.88 0.22 
806.5676 3.52 1.36 2.63 4.35 0.42 
834.5985 6.25 4.55 4.94 7.43 0.79 
790.5566 14.37 10.64 13.72 14.69 1.38 
774.5633 6.78 2.99 6.51 6.81 0.58 
828.5370 21.43 25.38 22.67 20.57 2.11 
842.5881 8.37 7.82 9.2 7.30 0.93 
906.5694 7.17 3.42 6.41 7.71 1.02 
While all the investigated approaches minimised the variance, the effect of post normalisation 
processing using log transformation was substantial in smoothening and homogenising the 
variance. 
The global normalisation approach and internal standard normalisation were softer and had 
milder effect compared to the total ion intensity approach as well as post processing approach 
using log transformation. This approaches will be investigated in more detail in other chapters 
involving profiling phospholipids in biological samples (Chapter 4 & 7). 
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3.4.6.3 Assessment of extraction variability 
 
The extraction variability was investigated by preparing a cocktail of phospholipid species of 
different classes along with commercially available oxidised species. One set was processed 
through the extraction procedure and another set was directly analysed by LCMS. This 
experiment was repeated three times and complemented by performing total phospholipid 
content assay of extracted and not-extracted samples. The figure 3.31 shows comparative 
analysis of extracted and not-extracted samples using normalised peak area of all the species 
that was added in equal amount in both the sets. 
 
Figure 3.31: Evaluation of extraction variability by LCMS analysis of extracted and not extracted set of cocktail 
of equimolar amount of phospholipid species from different classes. 
The data suggests that the extraction efficiency and recovery is nearly 100 % and there was no 
biasedness observed in preferential extraction of one species over another. This was further 
confirmed by measuring the total phospholipid content. The table 3.10 shows the phospholipid 
content in extracted and not extracted samples that was determined using malachite green assay. 
The data shows that the phospholipid content was similar in both the set of samples and this 
reinforces our observation about nearly 100 % extraction efficiency of the method used in this 
study. 
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Table 3.10: Malachite green assay to determine the total phospholipid content of extracted and not-extracted 
samples. 
Sample Average 
Absorbance at 660 nm 
Std. Deviation Amount of phospholipid 
( in µg ± std.dev) 
Cocktail  
(not extracted) 
0.5223 0.004 12.81±0.004 
Cocktail 
 (extracted) 
0.5225 0.036 12.82±0.036 
PC mixture control 0.411 0.011 8.30±0.011 
PE mixture control 0.3534 0.003 5.97±0.003 
PC mixture oxidised 0.3935 0.005 7.60±0.005 
PE mixture oxidised 0.3435 0.002 5.57±0.002 
 
3.4.6.4 Assessment of linear dynamic range 
 
The linear dynamic range of the method was investigated by analysing commercially available 
oxidised PC species like PAzPC, PONPC, POVPC and PGPC at concentration range spread 
over 6 orders of magnitude. Internal standard (13:0 PC) was added to each concentration, 
standard curve was prepared and weighted linear regression was used to relate the response and 
concentration. 
The figure 3.32 shows the standard curve of PAzPC that was analysed on Qtrap 5500 and QTOF 
5600 instrument. It illustrates that the limit of quantification  and linear range for method 
developed on Qtrap 5500 using targeted approaches and high resolution fast scanning method 
developed on QTOF 5600 is similar at concentration spread over three orders of magnitude.  
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Figure 3.32: Assessment of limit of quantification and linear dynamic range of the method developed using 
monolith column for chromatographic separation and detection using targeted approaches and validation on QTOF 
5600. PAzPC (m/z 666.5) was analysed at different concentrations over 6 orders of magnitude on Qtrap 5500 
instrument and QTOF 5600. The limit of quantification was found to be at 10 nM concentration. 
The table 3.11 summarises the equation and linearity range for PAzPC, PONPC, POVPC and 
PGPC that can be used for absolute concentration. The regression analysis for all but POVPC 
showed linear trend in response and concentration, and this could be due to discrepancy in the 
integration process of the peak or experimental handling of the standard.  
Table 3.11: Analytical parameters for quantification of OxPLs. Internal standard (13:0PC, 153.97pmoles) was 
applied on the column together with increasing concentration of calibrants.  Equation for calculation was 
obtained using 1/xweightedlinear regression.
 
3.4.7 Evaluation of 2D-LCMS analysis for separation of OxPL 
 
Serial coupling of the monolith column to HILIC column and running the gradient 
simultaneously was set up to investigate the improvement in separation of OXPL species. While 
reverse phase columns separates the polar oxidised species from their native species, it does not 
separate the oxidised species belonging to different phospholipid class. Moreover, HILIC 
column provides effective separation of different phospholipid classes but does not effectively 
separate oxidised species. Moreover, owing to differential ionisation variability, the analysis of 
different phospholipid classes in a single run is impractical; therefore, with the objective of 
further improving the separation that can improve the detection range and reduce the analysis 
time, the evaluation of 2D LC analysis was investigated. The figure 3.33 shows the separation 
profile of different groups of oxidised species of PC and PE class when monolith and HILIC 
column are used for separation alone or in combination by serially coupling the columns and 
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simultaneous gradient analysis. Median elution time of 5 representative species from each 
group was used to evaluate the separation.
 
Figure 3.33: Evaluation of chromatographic separation of OxPC species using monolith and HILIC column alone 
and in combination by serial coupling and simultaneous gradient analysis. Extracted ion chromatogram (XIC) was 
generated of five representative species for each group from PC class: short chain OxPC (POVPC, m/z 594.5; 
PONPC, m/z 650.5; SONPC, m/z 678.5; SAzPC, m/z 694.5 and KODA-PC, m/z 704.5), long chain OxPC (PLPC-
OH, m/z 774.5; PLPC-OOH, m/z 790.5; SEIPC, m/z 856.5; SLPC (2OOH), m/z 850.5 and SLPC-OOH, m/z 818.5) 
and Native PCs (DPPC, m/z 734.5; PLPC, m/z 758.5; SLPC, m/z 786.5; PAPC, m/z 782.5 and SDHPC, m/z 
834.5); PE class: short chain OxPE (POVPE, m/z 552.5; PONPE, m/z 608.5; SONPE, m/z 636.5; SAzPE, m/z 
652.5 and KODA-PE, m/z 662.5), long chain OxPE (PLPE-OH, m/z 732.5; PLPE-OOH, m/z 748.5; SEIPE, m/z 
814.5; SLPE (2OOH), m/z 808.5 and SLPE-OOH, m/z 776.5) and Native PEs (DPPE, m/z 692.5; PLPE, m/z 
716.5; SLPE, m/z 744.5; PAPE, m/z 740.5 and SDHPE, m/z 792.5 and the median elution time for each group 
was used to plot the data 
The serial coupling of monolith and HILIC column with modified program showed better 
separation of the OxPC and OxPE species. However, the native PCs and PE species co-eluted 
in this setting.  Altogether, this was a first step towards evaluation of two dimensional 
chromatography to improve the oxidised lipidome coverage and enhance high throughput 
analysis; and it requires further optimisation and experimentation to evaluate its efficiency. The 
details about the gradient is provided in the appendix I section. 
3.4.8 Discussion 
Oxidised phospholipids (OxPL’s), including chlorinated products, have been implicated in 
various inflammatory disorders; therefore, a need arises for sensitive methods for detection and 
quantification of these relatively scarce products in biological samples, in order to correlate 
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their concentration to the severity or stages of the disease. Earlier methods developed were for 
specific oxidation products and were limited to the instruments used and scanning methods used 
to support the identification. For instance, the LC-MS method developed by Gruber et.al (2012) 
for oxidised phosphatidylcholine compounds was by selective reaction monitoring scanning 
routine, monitoring the transition to a specific Phosphatidylcholine product ion (m/z 184) which 
may not be able to distinguish between isomeric and isobaric products of the PC class like a 
peak at m/z 790.5 would correspond to the mono-hydroperoxide of PLPC or the isotopic peak 
of the un-oxidised SOPC, owing to low resolution of the instrument used. Similarly, the LC-
MS method developed for analysis of chlorohydrins generated in-vitro by Jerlich et.al (2002) 
used a survey scan for identification of chlorohydrins, which may lack the sensitivity for 
identification of chlorohydrins in biological samples.  
Recently, hybrid mass spectrometers like Qtrap 5500 and QTOF 5600 were introduced, which 
were capable of performing (MS)n experiments with 10-fold increase in sensitivity and 
accuracy for detection of isobaric compounds. Other methods developed were based on 
improvements in understanding about analyte chemistry and fragmentation patterns on 
charging with collision energy using inert gases. For example, secondary oxidation products 
formed having aldehydes or hydroxyaldehydes as functional groups fragmented via following 
1-4 diene charge migration and hydrogen elimination mechanism and therefore, providing 
structural details pertaining to the position of functional groups  using tandem mass 
spectrometry. Similarly, hydroperoxides and chlorinated lipids on collision induced 
dissociation loses specific neutral compounds like H2O2 (34 Da) and HCl (36 or 38 Da) 
respectively that supports the identification. 
Recently, methods were developed through interfacing the separating power of HPLC systems 
to the sensitivity and resolution power offered by hybrid mass spectrometers like QTrap MS 
and QTOF instruments. However semi targeted methods using PIS and NL scans have been not 
utilised effectively in earlier methods. Moreover, earlier methods were limited to analysis of 
smaller section of the diverse range of oxidised phospholipids species and were not tested on 
detection of oxidised products in wide range of biological samples. The measurement of low 
molecular weight biomarkers of lipid peroxidation present in complex matrices such as brain 
tissue, plasma, urine or cerebrospinal fluid is a delicate and difficult task and there is a need for 
improved analytical methodology in this field of research. The major objective of this work was 
to develop methods using semi-targeted approaches to detect a range of oxidised PC species 
104 
 
within one analytical run and is sensitive enough to be translated to analyse OxPC species in 
different biological samples. 
An important aspect of our methodology was to evaluate the separation of several oxidised 
species using several reverse phase columns and we found that the better separation and robust 
method was achieved using monolith column as compared to other conventional reverse phase 
columns and mix mode HILIC column. Chromatographic separation of OxPLs, specifically 
short chain oxidation products that covered masses from m/z 450 – 750 was better with the 
system using monolith column and methanol-water solvent system, although similar results 
were obtained using C-8 column and hexane-methanol-water solvent system, the 
reproducibility of the retention time was the issue. While many LC-MS based method have 
been reported for analysis of OxPCs, limited work was done to evaluate the separation of 
oxidised phospholipid species and achieve chromatographic resolution (Hui et al., 2010). Most 
of the method reported have concentrated on faster analysis like the method reported for 
analysis of OxPCs by (Gruber et al., 2012) used a C-18 core shelled column and all the species 
reported eluted in the first 10 minutes. However, faster analysis can compromise the 
chromatographic resolution and sensitivity and therefore, can affect the relative quantification 
process. Moreover, faster analysis of complex samples can also lead to more false positive 
identification because overlapping of signals of co-eluting analytes and matrix effects. 
Therefore, better dispersion of separation is required for analysis of samples, when the objective 
is to identify and characterise several species including isobaric and isomeric species in a single 
run.  
Furthermore our work aimed to develop a method using targeted scanning approaches, which 
has been reported earlier but lesser exploited to characterise oxidised species in biological 
samples (Spickett et al., 2011) (Reis et al., 2013). With the fact, that a single poly-unsaturated 
phospholipid species can give rise to several oxidation products that can make the identification 
and quantification process of all species in a single run, a difficult task. Moreover, most of the 
earlier work done was reported and tested on in vitro oxidised samples and concentrated on 
analysis of pre-determined species. While the approach of multiple reaction monitoring (MRM) 
is the most used approach to quantify several pre-defined species, it has the limitations of only 
able to quantify certain number of species in a single run. Moreover, most of the mass 
spectrometry based methods developed so far have either used MRM based approaches in 
positive and negative mode or high resolution mass spectrometry based on accurate masses to 
characterise oxidised PC species (Hui et al., 2010, Gruber et al., 2012, Nakanishi et al., 2009, 
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Davis et al., 2008). Furthermore, the primary oxidation products that are hydroperoxide species, 
which are very unstable and they get oxidatively fragmented to short chain oxidation products 
or are reduced to hydroxides by several enzymes in-vivo. Therefore, their abundance level in 
biological samples can be very low and can be below the detection level of existing 
methodologies. In our method, we tested a series of targeted approaches to selectively identify 
several oxPC species in a single run. In this project, the neutral loss scan for 34 Da in 
combination with precursor ion scanning for head group ions (selective for phospholipid class 
specific identification) allowed identification of several oxidised phospholipid species in a 
single run as demonstrated in our results. The experiments with in-vitro generated OxPL 
mixture and using targeted mass spectrometry approach and monolith column for separation 
demonstrated the detection efficiency as more than 100 different OxPL species were identified 
in a single run, which is comparable to the MRM analysis method protocols developed by 
(Gruber, 2012). Moreover, the identification of mono-hydroperoxides, hydroxyl-
hydroperoxides, and poly hydroperoxides was facilitated by using the targeted approach and in 
absence of specific standards. 
Although, mass spectrometry technology provides wealth of information about your samples, 
it brings along the complexity of data analysis and intrinsic variability of instrumentation that 
can lead to misinterpretation of findings, unless the raw data is appropriately processed and 
normalised. Therefore, when the developed method is based on scanning approaches on a low 
resolution mass spectrometer, it is often required to validate the findings using a different 
chromatographic set-up or transferring the method to another high resolution mass spectrometry 
instrument. Therefore, we used an approach by transferring the methodology to a high 
resolution Q-TOF mass spectrometer to validate our findings. The method was also assessed 
for its qualitative and quantitative use by investigating the injection precision and inter-day 
variability. The relative standard deviation (CV %) was found to be less than 10 % for 
substantial number of species.  There were some outliers that can be accounted for due to 
integration errors, peak distortion because of co-eluting species and extraneous level of oxidised 
species formed during storage.  
The similar qualitative assessment was performed for the transferred method on the Q-TOF 
instrument to assess the technical variability and in-sequence variability. It showed comparable 
results to that observed on a low resolution Q-Trap instrument. Moreover, data analysis 
validation was performed by using Progenesis QI software capable of automated pre-processing 
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the raw mass spectrometry data, thereby facilitating rapid data analysis and further validate the 
findings. 
Finally, a pilot study to improve the chromatographic separation was performed by serially 
coupling two columns having orthogonal chemistry. This was a first attempt to-date in the field 
of oxidative lipidomics although, similar work had been carried out in the field of metabolomics 
(Haggarty, Oppermann et al. 2015). We found that the methodology using two dimensional 
chromatography has a potential to improve the oxidised lipidome coverage as demonstrated by 
our work and further work needs to be done to evaluate several columns of different chemistry 
and mobile phases to highlight this not so popular technology in the field of Lipidomics.  
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4 Deciphering the oxidised lipidome of ascites of lean and obese rats model 
of acute pancreatitis 
4.1 Background 
 
Acute pancreatitis is a disease caused by localised inflammation of the pancreatic gland that 
results in acinar tissue damage and interstitial edema; migration of neutrophils; and haemolysis 
leading to oxidative stress (Schoenberg, Birk et al. 1995, Perez, Pereda et al. 2015). To 
understand the pathogenesis and etiological factors most experimental studies use animal 
models like rats and mice induced with acute pancreatitis by treatment with varieties of stimuli. 
Examples of treatment are free fatty acid infusion to study alcohol induced hyperlipidemic 
pancreatitis (Anderson, Jeffrey et al. 1986, Morita, Yoshikawa et al. 1998) or  two hour period 
of ischemia to study ischemic induced pancreatitis (Schanaider, de Carvalho et al. 
2015)((Sanfey, 1984 #5516), which is termed as ex-vivo perfused canine pancreas preparation 
model. The other model termed hemorrhagic necrotising pancreatitis model is induced by 
infusion of sodium taurocholate (0.25 % to 5 %) into the pancreatic duct to study oxidative 
stress and hemodynamic effects that contributes to symptomatic processes in acute pancreatitis 
(Pereda, Perez et al. 2012). Although, the mortality rate from acute pancreatitis has decreased 
over the last decades owing to improvement in treatment and diagnosis, the prevalence in 
developed countries including United Kingdom still remains very high (Yadav and Lowenfels 
2013). 
Previous studies reported a link between oxidative stress and pathologies involved in acute 
pancreatitis using animal models described above (Kruse, Loft et al. 1997, Morita, Yoshikawa 
et al. 1998, Winterbourn, Bonham et al. 2003). These studies investigated triglyceride levels, 
reduced glutathione levels, free fatty acid levels, phospholipid levels, lipase activity, protein 
carbonyls and malondialdehyde levels. All of these provide an indication of the global measure 
of oxidative stress without providing information at the species level. A recent study reported 
a significant increase in level of peroxidised products in ascites fluid of rat with acute 
pancreatitis compared to control samples (Gutierrez, Folch-Puy et al. 2008, Kiziler, Aydemir 
et al. 2008, Grigor'eva, Romanova et al. 2011). Obesity is considered as a risk factor for acute 
pancreatitis and it is one of the factors that induce the pro-inflammatory state (Franco-Pons, 
Gea-Sorli et al. 2010, Robles 2013). High levels of fat necrosis and isoprostanoids were 
observed in obese rats compared to lean rats with acute pancreatitis and this excess fat was 
associated with severity of the disease (Pereda, Perez et al. 2012, Perez, Pereda et al. 2015). 
These results supported the hypothesis for possible role of obesity to the oxidative stress 
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conditions in acute pancreatitis and therefore, to confirm the translational relevance of the 
findings in obese and lean model of acute pancreatitis, a study to perform comparative analysis 
for levels of a range of oxidised phospholipid (OxPL) species is required.  
No study to date have been conducted that measures and relatively quantify oxidised 
phospholipid (oxPL) levels and give information at the species level using mass spectrometry 
technology in obese and lean model of acute pancreatitis. In addition, a rational approach 
combining pre-processing of raw data with validation of a statistics method was developed to 
improve differential profiling of OxPL in biological samples within inherent large biological 
variation. Such approach has been applied for metabolomics data but it remains yet to be applied 
in the OxPL field (Bijlsma, Bobeldijk et al. 2006, Want and Masson 2011). While issues in data 
analysis such as analytical variation, assumption of normality, homoscedasticity and correction 
for multiple testing with their influence on statistical analysis are known, they are often ignored 
while analysing LC-MS based datasets (Vinaixa, Samino et al. 2012).  Depending on the 
biological matrix and origin of samples, different approaches are required to minimize systemic 
variation. For example, samples from obese and lean rats in which the total lipid composition 
will be very different with obese rats having higher levels of triglyceride levels and therefore, 
normalisation using total ion intensity will skew the data. OxPL levels that are largely affected 
by the pathological conditions does not held a self-averaging property i.e. change in levels of a 
family or a specific class of analytes is not balanced by the level of another class of analytes 
(Sysi-Aho, Katajamaa et al. 2007).  
4.2 Aim and objectives 
 
The aim of this study was to measure and relatively quantify oxidised phospholipids in total 
lipid extract of ascites of obese and lean rats induced with acute pancreatitis using sodium 
taurocholate infusion in the pancreatic duct. The hypothesis for this study was that obese rat 
samples will have high levels of oxidised phospholipids as marker of oxidative stress relative 
to lean rat samples. To achieve this aim following objectives were outlined: 
1. Analysing of total lipid extract of ascites of obese and lean rats with acute pancreatitis 
on Qtrap 5500 instrument using targeted approaches and monolith column for 
chromatographic separation to measure and relatively quantify oxidised phospholipids. 
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2. Cross validation of manual data analysis of data generated on Qtrap 5500 instrument by 
reacquisition of total lipid extract of ascites of obese and lean rats with acute pancreatitis 
on Q-TOF 5600 instrument using high resolution general survey scan with data 
dependent MS/MS scans and monolith column for chromatographic separation followed 
by automated data analysis using Progenesis QI software. 
3. Development and evaluation of rational data analysis approach involving pre-
processing of raw data and different normalisation approaches to establish a data 
analytical flow that can improve the biological information of the data. 
4.3 Results 
 The ascites of lean and obese rats (7 each) was collected by the group of Prof Juan Sastre at 
University of Valencia; post induction of acute pancreatitis in animal models using sodium 
taurocholate and was couriered to us. The total lipid was extracted from ascites of seven obese 
and lean rats’ samples followed by analysis on Qtrap 5500 instrument using targeted approaches 
and QTOF 5600 instrument for validation of findings. The figure 4.1 shows the total ion 
chromatogram (TIC) of obese and lean rat sample with marked areas indicating the elution time 
for short chain oxidation products (a); long chain oxidation products (b) and unmodified 
phospholipid species (c) which were identified as discuss in chapter 3. As discussed in the 
method development chapter (chapter 3), the  monolith column provided better selectivity and 
separation compared to other reverse phase columns containing C-8, C-18 or C-30 stationary 
phase and the same method was utilised to profile the ascites of lean and obese rat with acute 
pancreatitis. 
The monolith column provided better separation compared to other reverse phase columns for 
short chain oxidation products that eluted early from 5 – 10 minutes compared to long chain 
oxidation products, eluting at 18 – 22 minutes preceding unmodified species that eluted in 22 – 
26 minutes. 
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Figure 4.1: Total ion chromatogram (TIC) of total lipid extract of obese and lean rat models of acute pancreatitis. 
The marked shapes shows the elution time for short chain oxidised species including lyso species, long chain 
oxidised species and native species. 
Subsequently, several oxidised species were identified by studying the fragmentation pattern, 
looking at signature fragment ions related to the head group as well as fragments related to the 
fatty acyl chains as illustrated in figure 4.2 with examples of XIC, fragmentation spectra and 
QTOF-MS spectra for m/z 594.3765 (POVPC) and m/z 774.5643 (PLPC-OH) respectively. 
The fragmentation spectra of POVPC shows more than two fragments linked to different groups 
within the structure, thereby providing more confidence in the identification whereas, that of 
PLPC-OH shows only the fragment of the headgroup at m/z 184.07 Da that corresponds to the 
phosphocholine group. The experimental masses for samples acquired on high resolution Q-
TOF instrument were compared to theoretical masses with tolerance set to 5 ppm and any 
difference greater than the tolerance level was highlighted and categorised in a putative 
identification category. All this information together was utilised to develop a holistic approach 
for categorising the identification process of species with different level of confidence as shown 
in table 4.1. 
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a) 
b) 
 
 
Figure 4.2: Representative strategy used in identification of oxidised species. The top panel a) shows the extracted 
ion chromatogram (XIC) (A) for m/z 594.3765 with the MS spectra (B) and MS-MS spectra (C) supporting the 
identification with the fragmentation pattern linked to the structure (D). The bottom panel shows XIC with MS 
and MS/MS profile for m/z 774.5643. 
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Table 4.1: Holistic approach for categorising the identification process based on interpretation of MS and MS/MS 
spectra acquired on low resolution Qtrap 5500 and high resolution QTOF 5600 instrument. 
Description Category 
Species identified on low resolution QTrap 5500 
as well as high resolution QTOF 5600 instrument 
a 
Species identified only on Qtrap 5500 or QTOF 5600 b 
Fragmentation spectra with three or more peaks on either of the instrument c 
Fragmentation spectra with less than 3 peaks for identification purpose d 
No fragmentation spectra (identification solely based on accurate mass) e 
Missing values for >=20 % of samples in a set f 
 
The identification process was categorised based on the observation of peaks on both of the 
instruments that is low resolution Qtrap 5500 using targeted approaches and the high resolution 
QTOF 5600 (see table 4.1) as well as the number of fragment ions that aided the identification. 
For example, the peak that corresponded to POVPC at m/z 594.3756 in TOF MS spectra 
showed 3 fragmented peaks in the MS/MS spectra and was also observed in the precursor ion 
scan spectra on Qtrap 5500 instrument therefore, the identification was categorised as “a, c”. 
The extracted ion chromatograms (XIC) were calculated for m/z 594.3761 (POVPC), 650.4391 
(PONPC) and 774.5649 (PLPC-OH) for all samples acquired on Qtrap 5500 and QTOF 5600 
and the distribution profile of   normalised peak area of each species was compared to check 
for any systemic errors as shown in figure 4.3. It displays the distribution of abundance of 
species under investigation on the two different instruments using scatter plot with 95 % 
confidence interval. The distribution of abundance for m/z 594.3761, 650.4391 and 774.5649 
on Qtrap 5500 matched the pattern observed for same masses on QTOF 5600 instrument. 
Moreover, noticeable variability was observed in the distribution pattern of these species in one 
or 2 samples that exceeded the 95 % confidence interval, thereby skewing the distribution, and 
significantly affecting the average abundance.  
Conversely, the distribution profile for m/z 842.5 acquired on Qtrap 5500 and QTOF 5600 
instrument showed a very different profile as shown in figure 4.4. Further investigation revealed 
that the profile observed for Qtrap 5500 instrument that used targeted approaches for species 
identification matched the profile of  only one of three co-eluting  isobaric species (m/z 
842.5905) identified on high resolution QTOF MS owing to narrow mass detection window 
whereas, the other two species with m/z 842.5112 and 842.5221 that are not observed on Qtrap 
instrument (low resolving power) did not affected the distribution of the matched profile 
because of lower abundance. 
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Figure 4.3: Differential profiling of oxidised phosphatidylcholine (OxPC) species in lean and obese rat model of 
acute pancreatitis. Total lipid extract of ascites of 7 lean and obese rats each were analysed on Qtrap 5500 using 
targeted approaches (left panel) and high resolution Q-TOF mass spectrometer (right panel) and extracted ion 
chromatogram (XIC) for m/z 594.5, 650.5 and 774.5 that corresponded to POVPC, PONPC and PLPC-OH 
respectively was calculated and scatter plot with mean and 95 % confidence interval was plotted to investigate the 
difference in profiling and response for lean and obese rats on two different instruments. 
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Figure 4.4: Differential profiling of oxidised phosphatidylcholine (OxPC) species in lean and obese rat model of 
acute pancreatitis. Total lipid extract of ascites of 7 lean and obese rats each were analysed on Qtrap 5500 using 
targeted approaches (top-left panel) and high resolution Q-TOF mass spectrometer (top-right panel & bottom 
panels) Only single peak at m/z 842.5 was observed on a low resolution QTrap 5500 instrument whereas, three 
peaks that corresponded to co-eluting isobaric species were observed on a high resolution QTOF instrument. 
Graphpad prism was used to plot scatter plot with mean and 95 % confidence interval to investigate the difference 
in profiling and response for lean and obese rats on two different instruments. 
 
Similarly, the peak areas of all identified species for all samples run on Qtrap 5500 and QTOF 
5600 respectively were calculated and the abundance distributions were compared to 
investigate the difference in instrument response and check overall distribution as shown in 
figure 4.5. While the abundance distribution for most of the species on two different instruments 
matched, differences in distribution were observed for low abundant long chain oxidation 
products, specifically the ones that were formed from species bearing polyunsaturated fatty 
acids. For example, the peak at m/z 798.5 and 814.5 that corresponds to the hydroxylated 
product (+ 16 Da) and di-hydroxylated (+ 32 Da) of PAPC (m/z 782.5) can have several co-
eluting positional isomers and can lead to chromatographic peak broadening, which affects 
accurate manual measurement of peak area. Therefore, manual peak area analysis performed 
on data generated on low resolution Qtrap 5500 for low abundant analytes can be erroneous, in 
contrast to automated data analysis using progenesis QI for high resolution data generated on 
the QTOF 5600 instrument. Moreover, the peak at m/z 830.5 was not observed on Qtrap 5500 
but was observed on QTOF 5600. However, no MS/MS profile was collected for this species 
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on QTOF instrument and it not being detected on Qtrap 5500 using targeted approaches (PIS 
184 Da) suggested the ion to be extraneous. 
 
 
 
Figure 4.5: Comparative profiling of oxidised phosphatidylcholine (OxPC) species in lean and obese rat model of 
acute pancreatitis. Total lipid extract of ascites of 7 lean and obese rats each were analysed on Qtrap 5500 using 
targeted approaches (left panel) and high resolution Q-TOF mass spectrometer (right panel) and extracted ion 
chromatogram (XIC) for m/z of native PC species, short chain oxidation products and long chain oxidation 
products was calculated and bar graphs were plotted to investigate the difference in profiling and response for lean 
and obese rats on two different instruments. 
A database was prepared in which all ions were annotated based on their experimental masses, 
observation of fragmentation spectra and comparison of retention time against standards. The 
categorisation based on the holistic approach described earlier in table 4.1 was also included. 
A summary of the database is shown in table 4.2 with information on compound identification 
and error listing the identification category according to the information generated on two 
instruments.  
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Table 4.2: List of all the species identified in total lipid extract of ascites of lean and obese rats with acute 
pancreatitis.  
m/z 
Retention 
Time 
Accepted compound 
Identification 
Identification 
category 
Mass error (in 
ppm) 
594.3761 5.29 POVPC a, c -0.68 
620.3921 5.71 (7-keto,5-heptenoic acid)-PPC a, e, f -0.19 
622.4116 6.60 (7-hydroxy,5-heptanoic acid)-PPC a, e 6.08 
650.4390 6.27 PONPC a, d -0.21 
666.4369 6.46 PAzPC a, e 4.28 
678.4734 7.21 SONPC a, d 4.29 
732.5541 21.74 PC(15:1(9Z)/17:0) a, d 0.41 
758.5697 22.36 PC(16:0/18:2(9Z,12Z)) a, d 0.32 
760.5847 22.94 PC(16:0/18:1(9Z)) a, c -0.52 
774.5649 20.36 PLPC-OH a, d 0.74 
782.5693 22.66 PC(16:0/20:4(5Z,8Z,11Z,14Z)) a, d -0.16 
786.6000 23.80 PC(18:0/18:2(9Z,12Z)) a, d -0.93 
788.6135 24.27 PC(18:0/18:1(9Z)) a, d -3.63 
798.5604 19.54 PAPC-OH a, d -4.95 
802.5946 21.91 SLPC-OH a, e, f -1.25 
806.5684 23.05 PC(16:0/22:6(4Z,7Z,10Z,13Z,16Z,19Z)) a, d -1.30 
810.6000 23.99 SAPC a, c -0.60 
812.5449 23.46 15-J2IsoP with Palmitoyl a, e, f 1.27 
814.5599 18.64 PAPC-OOH a, d 1.04 
822.5572 21.45 PLPC-2(OOH) a, e 9.87 
826.5935 21.27 SAPC-OH a, d -2.58 
830.5687 22.94 Not known a, d  
834.5998 24.38 PC(18:0/22:6(4Z,7Z,10Z,13Z,16Z,19Z)) a, d -1.18 
842.5221 22.42 J2IsoProstane with stearoyl a, d 4.74 
842.5112 21.80 Not known b, e  
842.5915 21.40 SAPC-OOH b, d 0.60 
(b) Phosphatidylethanolamine class (PE) 
454.2932 5.02 LysoPE(0:0/16:0) a, d 1.41 
482.3254 5.68 LysoPE(0:0/18:0) a, d 2.73 
580.3587 5.29 SOVPE a, e, f -3.49 
586.3103 5.02 LysoPE(0:0/24:6(6Z,9Z,12Z,15Z,18Z,21Z)) b, d -6.60 
690.5065 19.80 PE(16:1(9Z)/16:0) a, d -0.49 
716.5240 20.62 PE(18:1(9Z)/16:1(9Z)) a, d 2.18 
724.5276 23.24 PE(O-16:0/20:5(5Z,8Z,11Z,14Z,17Z)) b, e, f 0.00 
740.5243 22.72 PE(16:0/20:4(5Z,8Z,11Z,14Z)) a, e, f 2.52 
764.5225 23.38 PE(16:0/22:6) a, e, f 0.30 
768.5557 24.05 PE(18:0/20:4(5Z,8Z,11Z,14Z)) a, d 2.44 
Subsequent step was to develop a rational approach involving post-acquisition data processing 
and statistical analysis that can minimise the inherent biological variation of biological samples 
caused by genetic and environmental factors, thereby improving the information generated 
from the data. 
One of the data processing normalisation approaches that was developed and evaluated was the 
total phospholipid content approach. This was calculated by measuring the total phospholipid 
content of lean and obese rat samples and the average phospholipid level in each sample was 
used for normalisation (described later in the chapter), which is shown in figure 4.6 as bar plot 
with error bars representing the standard deviation calculated for three individual replicates. 
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Variable amount of total phospholipid was observed in each sample of lean and obese rat with 
overall total phospholipid higher in obese rats compared to lean rats. 
 
Figure 4.6: Investigation of total phospholipid content of total lipid extract of ascites of lean and obese rats with 
acute pancreatitis. Ammonium Ferrothiocynate (AFC) assay with detection using UV spectrophotometry was used 
to measure the total phospholipid content. The graph represents the average values of three individual replicates 
with standard deviation that was extrapolated from the calibration curve generated using commercially available 
phospholipid mixture. 
This information about total phospholipid content along with other normalisation approaches 
like internal standard normalisation, global normalisation, total ion intensity and scaling 
techniques such as log transformation was utilised to transform the calculated raw peak area 
with the objective of improving the biological information of the data as well as empowering 
the statistical analysis, which can be misleading otherwise.  Any analyte that was not detected 
in at least 80 % of the samples within the group was not included in the analysis. For example, 
a species at m/z 580.3587 ( table 4.2) identified as SOVPE , was present only in 2 out of total 
7 samples in each group and therefore was not considered for the analysis.  
The figure 4.7 illustrates the application of several post data acquisition approaches to 
calculated raw peak area of unmodified phosphatidylcholine species and comparison of 
distribution profile pattern. The six different approaches: internal standard normalisation with 
log transformation, internal standard (IS) normalisation, global normalisation, total ion intensity 
normalisation, total phospholipid normalisation and total phospholipid normalisation with IS 
normalisation were applied and statistical analysis was performed with correction for multiple 
comparison using false discovery rate approach using Graphpad prism software.  
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While the abundance and distribution pattern of all species matched for all approaches, total 
ion intensity and total phospholipid content normalisation showed a completely different 
pattern for some but not all species such as m/z 758.5697, which corresponded to PLPC 
(16:0/18:2 PC).  Moreover, an alternative and unconventional   statistical significance rule was 
proposed and implemented. The proposed rule was defined by the imperative with the pre-
requisite of calculated p-value to be same in 4 out of 6 total applied approaches in order to be 
truly significant.  Using this rule, relative abundance of no species was found to be statistically 
significant.  However, the relative abundance for peak at m/z 732.5541 that corresponded to 
16:0/16:1 PC showed statistically significant difference in abundance in obese rats compared 
to lean rats in three out of six approaches, it was deemed to be non-significant based on the 
defined rule. 
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Figure 4.7: Comparison of several post-acquisition data processing approaches on the profile of native PC species 
in lean and obese rats’ samples. Peak area of several species were calculated and processed (transformed) using 
one of the six  approaches as labelled  and statistical analysis with correction for  multiple comparisons using false 
discovery rate approach on Graphpad prism was performed. Statistical significance is shown by asterisk (*) mark 
set at 95 % confidence interval  
A similar approach was applied to short chain oxidation products and the same is represented 
in figure 4.8. The observed pattern suggested minimal difference and influence of post-
acquisition approaches on the distribution profile.  
Lean rats Obese rats 
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No statistical significance was reported in the abundance profile, although, the trend suggested 
higher abundance in lean rats samples compared to obese rats but the total variance was not 
possibly accounted by any approaches. 
 
 
Figure 4.8:  Comparison of several post-acquisition data processing approaches on the profile of short chain Ox 
PC species in lean and obese rats samples. Peak area of several species were calculated and processed 
(transformed) using one of the six  approaches as labelled  and statistical analysis with correction for  multiple 
comparisons using false discovery rate approach on Graphpad prism was performed. Statistical significance is 
shown by asterisk (*) mark with 95 % confidence interval. 
Lean rats Obese rats 
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The figure 4.9 shows the effect of different post-acquisition approaches on the abundance 
profile and distribution pattern of long chain oxidation products.  
 
 
Figure 4.9: Comparison of several post-acquisition data processing approaches on the profile of long chain OxPC 
species in lean and obese rats’ samples. Peak area of several species were calculated and processed (transformed) 
using one of the six  approaches as labelled  and statistical analysis with correction for  multiple comparisons using 
false discovery rate approach on Graphpad prism was performed. Statistical significance is shown by asterisk (*) 
mark. 
Lean rats Obese rats 
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The peak at m/z 842.5221, which is putatively an oxidised PC species based on the accurate 
mass and fragmentation pattern showed statistically high levels in lean rats in 4 out of 6 
approaches compared to obese rats. However, similar pattern was not observed for this ion for 
data generated on Qtrap 5500 owing to limitations with the resolution or there might be 
possibility of extraneous peaks from the matrix or contaminants that can influence the intensity 
of the analyte peak in high resolution instrument like QTOF MS using general MS survey scan 
for detection. 
All but the total ion intensity normalisation approach and the total phospholipid content 
approach showed similar distribution profiles, suggesting that these two approaches had greater 
influence on the distribution pattern, thereby reducing the effectiveness of statistical analysis. 
4.4 Discussion 
 
The underlying mechanisms involved in the pathogenesis of acute pancreatitis is ill understood 
and therefore, several animal models as investigative tools have been developed to understand 
the pathophysiology of the disease (Hue Su, Cuthbertson et al. 2006). Different non-invasive 
approaches such as induction with alcohol or hormone as well as invasive approaches such as 
pancreatic duct perfusion or vascular induced reperfusion have been used to develop animal 
models to study the disease. Moreover, obesity have shown to be the definitive risk factor of 
severity and mortality in acute pancreatitis (Martínez, Johnson et al. 2006) (Funnell, Bornman 
et al. 1993).  In this project, bilo-pancreatic duct injection model using sodium taurocholate 
injection was used for induction of acute pancreatitis in lean and obese rats and the ascites was 
collected from the peritoneal cavity post 6 hours of induction. 
   Alteration in lipid metabolism in acute pancreatitis has long been recognised and it has been 
reported that obesity further exacerbates the pathology (Pereda, Perez et al. 2012, Fujisawa, 
Kagawa et al. 2016). Higher levels of free fatty acid oxidation products (Gutierrez, Folch-Puy 
et al. 2008, Grigor'eva, Romanova et al. 2011) and isoprostanoids have been observed in ascites 
of rats with acute pancreatitis  using biological assays and several reports suggested high levels 
in obese rats with acute pancreatitis (Pereda, Perez et al. 2012). However, comprehensive 
investigation to decipher the oxidised lipidome using mass spectrometry has never been 
attempted.  
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Earlier reports using biochemical assays like TBARS assay showed higher levels of 
peroxidation products in blood samples of patients with acute pancreatitis suggesting the role 
of oxidative damage and lipid peroxidation (Verlaan, Roelofs et al. 2006, Milnerowicz, 
Bukowski et al. 2014). Another clinical study in New Zealand measured oxidative stress 
markers like protein carbonyls and lipid oxidation using TBARS assay in plasma samples of 90 
patients to assess the association and likelihood score of oxidative stress with the disease (Abu-
Zidan, 2000).  
The mass spectrometry method developed using targeted approaches and chromatographic 
separation with monolith column enabled identification of several oxidation products in total 
lipid extract of ascites of lean and obese rat samples with acute pancreatitis (table 4.2) that 
supported the earlier reports. Moreover, the identification and relative quantification was 
complemented by the analysis of same samples on high resolution QTOF analysis with 
automated data analysis using progenesis QI software that authorised and validated the 
identification and data analysis. Also, a holistic approach to minimise any inherent biological 
variability, thereby improving the quantitative information of the data was implemented along 
with robust statistical analysis to minimise misinterpretation of data. Intial data analysis using 
mean peak area of all identified species showed that short chain oxidation product species like 
POVPC (m/z 594.5) and PONPC (m/z 650.5) were abundant in lean rats compared to obese 
rats but after looking at the distribution in individual samples, it was found that two samples 
within the set of 7 samples for each set were showing diferent profile, thereby skewing the 
results. Therefore, a rational approach was developed that involved normalisation of datasets 
with five different methods and performing comparative statistical analysis.If 4 out of five data 
sets treated with different normalisation approach provided similar statistical inference, then 
only the difference was considered valid. 
Although, our investigation did not found any significant difference in the levels of oxidised 
phospholipid species in lean and obese rats, these findings are only static i.e. they represent the 
level at a single time point and does not account for the rate of consumption/turnover of these 
oxidised species. For instance, short chain oxidised phospholipid species bearing terminal 
aldehydes/ketones with conjugated double bonds are known to be very reactive and they can 
form Schiff bases and Michael adducts with proteins in the vicinity thereby modulating their 
functions. Moreover, high lipolytic activity like phospholipase A2 (PLA-2) activity as well as 
plasminogen activity factor- acetyl hydrolase (PAF-AH) was recently reported in obese model 
of acute pancreatitis (Patel, Trivedi et al. 2015) (McIntyre, Prescott et al. 2009, Evans, 
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Papachristou et al. 2010). Therefore, the possibility and the extent of oxidised species that got 
processed by this higher lipolytic activity cannot not be ruled out.  While, mass spectrometry 
technology is the method of choice for characterization of biological samples owing to the 
sensitivity and selectivity it offers together with the information rich data it generates, the 
process of relative quantitation using this technology can be a challenging task considering the 
fact that several factors and components involved such as ionisation, matrix effects can 
seriously hamper the quantitative nature (Wasinger, Zeng et al. 2013, Webb-Robertson, Wiberg 
et al. 2015). While, in this project we attempted to apply and compare several post data 
acquisition processing approaches along with proposing an all-inclusive unconventional 
statistical approach to improve the biological content of the data, there is a need of a more 
robust solution using computational tools to handle the multi factorial, multi dimensionality 
information that is generated by using this technology. 
As stated earlier, there are several approaches to produce animal models that closely mimics 
the disease condition, although, they differ in pathophysiological nature of the disease that can 
be studied using this model. For example, alcohol induced acute pancreatitis resembles or is 
more suitable to study the mild category of the disease with aetiological factors related to 
alcohol abuse whereas, invasive approach using bilo-duodenum injection of sodium 
taurocholate is associated with more severe form of the disease associated with development of  
haemorrhagic and necrotic changes in the acinar cells (Hue Su, Cuthbertson et al. 2006). 
Moreover, recent report attempted to assess the role of ascetic fluid in pathophysiology of the 
disease and raised the question about the peritoneal cavity fluid to be the location with higher 
enzymatic activity or the gateway for the toxicological substances to the systemic circulation 
(Mayer, Airey et al. 1985, Dugernier, Laterre et al. 2000).  Nevertheless, protocols need to be 
standardised to collect the peritoneal fluid along with quenching the proteolytic activity.  
Observation of the raw data suggested variability in the levels of species between replicates 
within treatment group that can add to the variability and obscure the true biological effect. 
Therefore, care should be taken to minimise any variability that can be caused while handling 
and induction of disease in the animals. Nevertheless, our study provides useful information 
about the level of oxidised phospholipid species that reinforces the relationship of oxidative 
stress with acute pancreatitis and provides a draft of a framework to attempt similar biological 
characterisation. 
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5 Oxidised lipidome profiling of isolated components of red blood cell 
infected with malarial parasite. 
5.1 Background 
 
Malaria is a parasitic disease affecting more than 100 countries, causing an estimated of 200 
million new infection every year (Percario, Moreira et al. 2012). While active research is being 
undertaken across the globe to unravel the mechanisms of drug resistance to the current 
treatment regime for malarial disease caused by Plasmodium.falciparum species, factors 
leading to this resistance are still not well known, owing to a lack of thorough understanding 
on the pathophysiological mechanism of the disease (Ihekwereme, Esimone et al. 2014). 
The malarial parasite resides inside erythrocytes (RBCs) of the infected host during the asexual 
blood stage of its life cycle. Malaria infection in the host begins with a bite from an infected 
female anopheline mosquito. As the mosquito feeds, sporozoites are inoculated into the skin. 
Some drain into the lymph nodes and those that enter the blood stream travel to the liver In 
humans, the parasites grow and multiply initially in the liver cells and then in the RBCs. In the 
RBCs, successive offspring of parasites grow inside and destroy them, releasing daughter 
parasites (merozoites) that continue the cycle by invading other red cells (Pandey, Babbarwal 
et al. 2003). The blood stage parasites are those that cause the symptoms of malaria. When 
certain forms of blood stage parasites (gametocytes) are picked up by a female anopheles 
mosquito during a blood meal, they start another, different cycle of growth and multiplication 
in the mosquito. After several days, the parasites are found as sporozoites in the mosquito's 
salivary glands. When the anopheles mosquito takes a blood meal on another human, the 
sporozoites are injected with the mosquito's saliva and start another human infection when they 
parasitize the liver cells. After this initial replication in the liver (exo-erythrocytic schizogony), 
the parasites undergo asexual multiplication in the RBC’s (erythrocytic schizogony). 
Merozoites infect red blood cells. Alternatively, at this stage (the ring stage trophozoites) 
mature into schizonts, which rupture releasing merozoites (Sullivan 2002).  Thus the mosquito 
carries the disease from one human to another (acting as a "vector").  
The pathophysiology of malaria results from the destruction of RBCs, liberation of the parasite 
and RBC material or toxins (hemozoin (HZ) or malaria pigment) and cellular debris into the 
circulation, as well as the host reaction to these events. The parasite digests up to 80% of the 
host erythrocyte haemoglobin, but the haem is toxic, is dimerized to form the insoluble 
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crystalline form hemozoin, and is stored in its digestive vacuole (Schwarzer, Kuhn et al. 2003, 
Sullivan 2005). The hemozoin-containing vacuole is expelled into circulation as a residual body 
(RB) during schizogony (Coronado, Nadovich et al. 2014). 
 The liberated hemozoin is bioactive as several reports have been published showing its 
potential role in modulating biological function such as crucial immune functions, especially 
targeting phagocytes (Sullivan 2005) (Simoes, Goncalves et al. 2015). Previously, hydroxy 
fatty acids were identified in saponified hemozoin and found to inhibit monocyte functions, 
though information about their phospholipid source is scarce (Schwarzer, Kuhn et al. 2003). In 
another study examining plasma and membrane phospholipids infected RBCs of 60 children 
with malaria showed a negative correlation between P.falciparum infection and phospholipid 
levels, suggesting modification or increased consumption of phospholipids (Abessolo, Nguele 
et al. 2009). Similarly, a different lipid profile was observed  in RBC infected with the five 
different sexual stages compared to uninfected RBC and asexual tropozite infected RBC (Tran, 
Brown et al. 2016). Total cellular lipidome alteration at different stages of liver infection was 
observed by shotgun mass spectrometry, which suggested a requirement for  host 
phosphatidylcholine for survival and growth of parasites (Itoe, Sampaio et al. 2014). Moreover, 
In HZ and parasitized RBCs (pRBCs) monohydroxy derivatives of arachidonic acid (HETEs- 
hydroxyeicosatetraenoic acid) and linoleic acid (HODEs-hydroxyoctadecanoic acid), and large 
amounts of the terminal aldehyde: 4-HNE (4-hydroxynonenal) have been determined by the 
group at University of Turin by demonstrating their role in inhibiting the differentiation of 
monocytes to macrophages as well as increased cytoadherence and chemotaxis (Schwarzer, 
Kuhn et al. 2003). 
Hemozoin is involved in several aspects of the pathology of the disease as well as in important 
processes such as the immunogenicity elicited. It is known that the once best antimalarial drug, 
chloroquine, exerted its effect through interference with the process of hemozoin formation 
(Martinez, Rajapakse et al. 2008, Coronado, Nadovich et al. 2014).  
Moreover, characterisation of isolated components of parasitized red blood cells (RBCs) 
including Hemozoin (HZ) is yet to be realised that can provide useful insight about the 
pathology of the disease and may offer novel therapeutic targets. This study was done in 
collaboration with a research group at University of Turin who provided us with the isolated 
components of parasitized RBC including the residual bodies (RB), Schizonts (SH), Hemozoin 
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(HZ) and uninfected RBC (RBC). Our work involved investigation of phospholipid and 
oxidised phospholipid composition of free HZ and RBs from synchronized cultures of P. 
falciparum parasitized erythrocytes either immediately or 24h after schizogony, with uninfected 
erythrocytes as controls.  
5.2 Aim and Objectives 
This study aimed to undertake comparative profiling of oxidised lipidome in isolated 
components of parasitized RBC like hemozoin (HZ), residual bodies (RB), Schizonts (SH) and 
uninfected erythrocytes (RBC). To achieve this aim, total lipid extract of the isolated 
components were analysed on Qtrap 5500 MS instrument using targeted approaches and 
manual data analysis involving identification of oxidised phospholipid species and peak area 
integration. This is compared with analysis on high resolution QTOF 5600 instrument and 
automated data anlaysis on Progensis QI software. 
5.3 Results 
 
Total lipid extract from isolated components of parasitized red blood cells (RBC’s)  were 
analysed on a Qtrap 5500 mass spectrometer using targeted approaches as described in chapter 
3. Figures 5.1 and 5.2 illustrate the total ion chromatograms (TIC) for all components under 
investigation with the corresponding mass spectra in the insets from mass range m/z 450 – 700 
in figure 5.1 and m/z 700 – 850 in figure 5.2 respectively. The TICs were obtained using a 
precursor ion scan of 184 Da, which is selective for the identification of phosphatidylcholine 
class of phopholipds. Comparison of the ion intensity of the major chromatographic peaks in 
the 22- 28 minutes region for all samples suggested a difference in the total phospholipid 
content. Moreover, the averaged spectra for the m/z range 490 – 700 showed high levels of 
short chain oxidation products in hemozoin samples compared to other samples. The number 
of oxidised species that were identified in hemozoin samples was higher than in the other 
isolated components. For example, the mass spectra of the hemozoin sample showed the peaks 
at m/z 524.5 (18:0 lyso phosphatidylcholine), 594.5 (palmitoyl-oxo-valeroyl 
phosphatidylcholine (POVPC)), 622.5 (stearoyl – oxo-valeroyl phosphatidylcholine 
(SOVPC)), 650.5 (palmitoyl- oxononanoyl phosphatidylcholine (PONPC)) and 666.5 
(palmitoyl- azealoyl phosphatidylcholine (PAzPC  respectively, whereas the spectra of other 
isolated components, viz. residual bodies, schizonts and uninfected RBCs did not show all of  
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these peaks. Additionally, the intensity of these peaks assessed by comparing the peak heights 
seemed to be higher in hemozoin sample compared to the other isolated components.  
The averaged spectra for the m/z range 700 – 850 in figure 5.2 showed high levels of long chain 
oxidation products in hemozoin samples compared to other samples. The number of oxidised 
species that were identified in hemozoin samples was higher than in the other isolated 
components. For example, the mass spectra of the hemozoin sample showed the peaks at m/z 
774.5 (hydroxide of palmitoyl,lineoyl phosphatidylcholine -PLPC-OH), 788.5 (keto, hydroxide 
of palmitoyl,lineoyl phosphatidylcholine –(PLPC-OH,Keto)), 800 (hydroxide of 
stearoyl,lineoyl phosphatidylcholine –(SLPC-OH)), 818.5 (hydroperoxide of stearoyl,lineoyl 
phosphatidylcholine –(SLPC-OOH)) and 830.5 (Keto,hydroperoxide of stearoyl,lineoyl 
phosphatidylcholine –(SLPC-OOH,Keto)) respectively, whereas the spectra of other isolated 
components, viz. residual bodies, schizonts and uninfected RBCs did not show all of  these 
peaks. Additionally, the intensity of these peaks assessed by comparing the peak heights seemed 
to be higher in hemozoin sample compared to the other isolated components 
To estimate the total phospholipid in samples for loading, a spectrophotometric assay using 
ammonium ferrothiocynate was performed and the results suggested that the lipid content 
varied in different components, as shown in figure 5.3. The residual bodies had lowest amount 
whereas the schizonts showed the highest amount.  
The values of total phospholipid content obtained using these assays were in accordance with 
the interpretation of the chromatograms in figure 5.1 and figure 5.2.  However, owing to limited 
amount of sample available, this assay was performed without any replicates or technical 
replicates and therefore, no statistical difference can be inferred using this data. Nevertheless, 
the information provided by the global analysis of the total phospholipid content suggested the 
value of an alternative approach for oxidised lipidome profiling, namely analysis of the fold-
change in levels of identified species relative to the uninfected RBC’s. 
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Figure 5.1: Total ion chromatogram with 
averaged MS spectra from 4-10 minutes in inset 
for isolated components of parasitized RBCs. 
(A-C, Hemozoin, Schizonts and Residual 
bodies) and uninfected RBC’s (D) showing 
different short chain oxidised 
phosphatidylcholine species profile as well as 
variable total phospholipid visible by different 
peak intensities in the region of 20-28 minutes 
of the chromatogram where the unmodified 
species elutes. The inset showed the averaged 
spectra for the 4-10 minutes region of m/z 
range 450 – 700, which pointed to a different 
distribution profile for short chain oxidised 
species. For example, the spectra for hemozoin 
sample showed peaks at m/z 524.5, 594.5, 
622.5, 650.5, 666.5 that corresponded to 18:0 
lysoPC, POVPC, SOVPC, PONPC and PAzPC 
respectively whereas several of these peaks 
were absent in other samples or were present 
with low intensity. 
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Figure5.2: Total ion chromatogram with averaged MS 
spectra from 18-22 minutes in inset for isolated 
components of parasitized RBCs. (A-C, Hemozoin, 
Schizonts and Residual bodies) and uninfected RBC’s 
(D) showing different long chain oxidised 
phosphatidylcholine species spectral profile as well as 
variable total ion chromatogram by different peak 
intensities in the region of 18-22 minutes of the 
chromatogram where the long chain oxidised species 
elutes. Moreover, the inset is showing the averaged 
spectral profile for the 18-22 minutes region of m/z range 
700 – 850 for all isolated components. For example, the 
spectra for hemozoin sample showed peaks at m/z 
774.5,788.5,  800.5, 816.5, and 830.5  that corresponded 
to PLPC-OH, PLPC-OH-keto, SLPC-OH SLPC-OH-
Keto and SLPC-OOH-Keto respectively whereas several 
of these peaks were absent in other samples or were of 
lower intensity. 
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Figure 5.3: Total phospholipid content of isolated components of parasitized RBC’s and uninfected RBC 
determined by Ammonium Ferrothiocynate assay (AFC). The assay was performed with single sample without 
any replicates for all components and therefore, no statistics was performed. 
The figure 5.4 shows the fold change analysis for all the unmodified phosphatidylcholine 
species in isolated components of parasitized RBCs relative to the uninfected RBC. The 
manual peak integration was performed for each species followed by normalisation with the 
peak area of the internal standard. Subsequently, calculation of the fold change was performed 
by taking the ratio of normalised peak area of species in each isolated components to 
corresponding peak area of the species in uninfected RBC that indicated increased or decreased 
abundance level relative to the uninfected RBC.  The error bar represents the standard deviation 
calculated for the pooled extracted sample. In agreement with the total phospholipids content 
and interpretation of the chromatogram, schizonts showed high levels of the unmodified 
species identified using targeted precursor ion scan for 184 Da as well as the MS/MS spectra 
and the residual bodies showed lowest levels. 
Similarly, fold change analysis was performed for short chain oxidation products and long 
chain oxidation products as represented in figure 5.5 and 5.6 respectively. Here the fold change 
difference observed was species specific and different to that observed with the unmodified 
species, where the levels of all the species were higher in schizonts and lower in residual 
bodies. For example, the relative fold change to uninfected RBC’s for (9-OH, 10-
dodecenedioic acid)-PPC, m/z 722.5 is negative for schizonts (high phospholipid content) and 
that of residual bodies (lowest phospholipid content) is equivalent to the uninfected RBC’s. 
Similarly, the relative fold change for (8-oxo-octanoic acid) PPC, at m/z 636.5 is nearly the 
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same for all isolated components. Overall, the levels of oxidised species were higher in 
hemozoin compared to other components. 
 
Figure 5.4:  Relative fold change analysis of abundance of unmodified PC species in isolated components of 
infected erythrocytes relative to uninfected RBC. The data were generated on a Qtrap 5500 MS using targeted 
approaches coupled with a monolith column for chromatographic separation.  10 µl of total lipid extracts were 
injected using auto sampler. The data were normalised using 13:0 PC (m/z 650.5) as internal standard and the 
normalised peak area for each identified species was divided by the peak area of the same species in uninfected 
RBC sample to calculate relative fold change. The error bars represent the pooled extract sample repeats. 
 
 
Figure 5.5: Relative fold change analysis of abundance of short chain oxidised PC species in isolated components 
of infected erythrocytes relative to uninfected RBC. The data were generated on a Qtrap 5500 MS using targeted 
approaches coupled with a monolith column for chromatographic separation.  10 µl of total lipid extracts were 
injected using auto sampler. . The data were normalised using 13:0 PC ( m/z 650.5) as internal standard and the 
normalised peak area for each identified species was divided by the peak area of the same species in uninfected 
RBC sample to calculate relative fold change. 
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The relative fold change for long chain oxidation products as illustrated in figure 5.6 showed 
that the levels of entire spectrum of identified species were lower in schizonts compared to 
other components.  
Also, some species such as F2 isoprostanes were found be more than 500 fold higher in 
hemozoin samples compared to the uninfected RBC samples. Some other species like POPC-
OH were equivalent in all components. Moreover, there was substantial number of missing 
values (species undetectable or below the level of detection) observed in replicates of schizonts 
samples that could obscure the biological effect or decrease the statistical power of the 
experiment and therefore, to overcome this, imputed values (mean of the values present) was 
used and therefore, the error bars in schizonts are skewed.  
Nevertheless, same samples were analysed on a high resolution QTOF mass spectrometer and 
data were analysed using Progensis QI software, which can handle missing values and unequal 
variance (assumption of normal distribution) more effectively using their co-detection 
algorithm and the data analysis is summarised in table 5.1. 
 
Figure 5.6: Relative fold change analysis of abundance of long chain oxidised PC species in isolated components 
of infected erythrocytes relative to uninfected RBC. The data were generated on a Qtrap 5500 MS using targeted 
approaches coupled with monolith column for chromatographic separation.  10 µl of total lipid extracts was 
injected using auto sampler. . The data were normalised using 13:0 PC, m/z 650.5) as internal standard and the 
normalised peak area for each identified species was divided with the peak area of the same species in uninfected 
RBC sample to calculate relative fold change. 
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The table presents the accurate masses, retention time, p-value of statistical analysis test 
performed post variance stabilisation and correction for multiple comparison using false 
discovery rate approach (ANOVA analysis), maximum fold change, information on the 
samples having highest and lowest levels and accepted identification based on accurate masses 
and MS/MS spectra with error in ppm for all the identified species in ascending order. It also 
includes the categorisation of the identification based on the information provided by the 
MS/MS spectra and mass error i.e. the number of fragments in the MS/MS spectra supporting 
the identification process and difference between theoretical and experimental masses. 
The results obtained with the high resolution mass spectrometry and automated analysis using 
Progenesis QI software using global normalisation approach were in agreement with the 
manual data analysis of the data obtained using targeted approaches on low resolution 
instrument. For instance, the hemozoin samples showed high levels of oxidised species, 
whereas the unmodified species were high in abundance in schizont samples. Also, mass error 
of most of the oxidised species was greater than 5 ppm that suggested the possibility of 
misidentification and they could be alternative isobaric species with similar masses, although, 
the putative identification cannot be ruled out as the retention time did match the elution profile 
of oxidised standards as reported in chapter 3. In addition, the MS/MS profile of all these 
species showed the fragmentation pattern with the most abundant fragment at m/z 184.07 Da 
suggestive of the phosphatidylcholine class. 
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Table 5.1: List of oxidised species of phosphatidylcholine class identified in isolated components of parasitized 
RBC. Samples were acquired on high resolution QTOF instrument and data mining and statistical analysis 
performed using Progenesis QI software. 
m/z Retention time 
(min) 
Max Fold Change  
Accepted 
Compound ID 
Identification 
category1 
 
Formula 
Mass Error (ppm) 
496.3401 5.21 2.845199 PC(16:0/0:0) a C24H50NO7P 0.64 
522.3547 5.56 2.794573 PC(18:1(9Z)/0:0) a C26H52NO7P -1.40 
524.3702 6.29 17.89929 PC(0:0/18:0) a C26H54NO7P -1.59 
544.3377 5.34 7.970868 PC(0:0/20:4) b 
  
594.3744 5.65 13.28413 (5-keto-pentanoic 
acid)-PPC 
b C29H56NO9P -3.58 
622.4058 6.31 20.08312 (5-keto-pentanoic 
acid)-SPC 
c C31H60NO9P -3.36 
636.4187 6.15 8.633886 2-(8-oxo-octanoic 
acid)PPC  
b, d C32H62NO9P -7.60 
650.4354 6.56 3.690696 PONPC a, d C33H64NO9P -5.70 
666.4365 7.01 2.105689 (nonadioic acid)-
PPC 
b C33H64NO10P 3.62 
678.4675 15.54 1.669812 Unkown d 
  
692.4451 7.56 83.37132 (8-OH,11-keto-9-
undecenoic 
acid)PPC 
b, d C35H66NO10P -6.62 
722.4579 7.03 26.47589 (9-OH,10-
dodecenedioic)-
PPC 
c C36H68NO11P -3.25 
732.5507 20.20 3.499473 PC(16:1(9Z)/16:0) a C40H78NO8P -4.27 
740.5212 20.66 17.49153 PC(18:3(9Z,12Z,1
5Z)/15:1(9Z)) 
a C41H74NO8P -1.76 
756.5476 23.44 7.467103 PC(20:2(11Z,14Z)/
14:1(9Z)) 
a, d C42H78NO8P -8.16 
758.5656 21.09 4.49116 PC(16:0/18:2(9Z,1
2Z)) 
a, d C42H80NO8P -5.04 
760.5780 24.13 5.876087 PC(16:0/18:1(9Z)) a, d C42H82NO8P -9.35 
762.5903 24.93 8.791366 PC(18:0/16:0) a, d C42H84NO8P -13.72 
770.5256 20.44 5.783693 Unknown d 
  
772.5410 21.14 37.71306 PLPC=O a, d C42H78NO9P -10.00 
774.5582 19.94 15.1768 PLPC-OH a, d C42H80NO9P -7.90 
776.5705 20.35 6.101742 POPC-OH a, d C42H82NO9P -12.28 
782.5614 24.02 3.504922 PC(20:4(5Z,8Z,11
Z,14Z)/16:0) 
a, d C44H80NO8P -10.28 
786.5922 24.98 5.532142 PC(18:0/18:2(9Z,1
2Z)) 
a, d C44H84NO8P -10.91 
788.5389 16.36 Infinity PLPC-OH,keto b, d C42H78NO10P -5.93 
788.6082 25.31 10.55653 PC(18:0/18:1(9Z)) a, d C44H86NO8P -10.41 
790.5518 17.86 25.76968 PLPC-2(OH) a, d C42H80NO10P -9.44 
798.5528 21.01 1.761227 PAPC-OH b, d C44H80NO9P -14.43 
804.5654 18.96 16.1373 
 
d 
  
806.5607 24.43 3.907098 PC(22:6(4Z,7Z,10
Z,13Z,16Z,19Z)/16
:0) 
a, d C46H80NO8P -10.85 
810.5920 25.29 6.998587 PC(20:4(5Z,8Z,11
Z,14Z)/18:0) 
a, d C46H84NO8P -10.77 
814.5513 21.09 24.8947 PAPC-OOH b, d C44H80NO8P -10.21 
816.5663 19.25 27.5427 SLPC-OH,keto b, d C44H82NO10P -10.58 
818.5810 20.20 7.123335 SLPC-2(OH) b, d C44H84NO10P -11.72 
822.5459 22.96 1.829299 PLPC-2(OOH) c C42H80NO12P -3.94 
830.5439 18.15 228.1374 D2isoprostane-
Palmitoyl 
b, d C44H80NO11P -12.43 
832.5585 17.35 Infinity F2isoprostane-
Palmitoyl 
b, d C44H82NO11P -13.67 
834.5751 17.92 31.84536 SLPC-OOH,OH b, d C44H84NO11P -12.42 
834.5916 25.23 11.99911 PC(18:0/22:6(4Z,7
Z,10Z,13Z,16Z,19
Z)) 
b, d C48H84NO8P -11.00 
842.5091 23.72 1.934857 PAPC-OOH,di-
keto 
b, d C44H76NO12P -10.37 
850.6099 13.04 19.95115 
 
d 
  
852.5358 18.54 Infinity 
 
d 
  
856.5607 17.92 1369.026 SEIPC b, d C46H82NO11P -10.62 
858.5734 19.02 463.8776 D2isoprostane-
Stearoyl 
b, d C46H84NO11P -14.09 
874.5689 18.93 187.9257 SAPC-diOOH b, d C46H84NO12P -13.18 
2Identification categories:   a, MS/MS spectra with more than 3  fragmentation ion peaks; b, MS/MS spectrum 
with only class specific fragmentation ion; c, No MS/MS spectrum; d, unknown compound or compound 
identified but with mass error of greater than 5 ppm  .
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5.4 Discussion 
Reactive  oxygen  species  (ROS)  have  been  increasingly  implicated  in  playing  a central 
role in the pathophysiology of malarial infections. The production of ROS is a steady-state 
event in aerobic respiration. In malaria infections, intra-erythrocytic stages of P. Falciparum are 
mainly responsible for all pathological effects in humans. Uncontrolled production of ROS is 
problematic for both the host and the parasite. It is generally accepted that oxidative stress is an 
important mechanism for the destruction of malaria and other intracellular parasites 
(Vennerstrom and Eaton 1988). ROS are continuously generated by the intra-erythrocytic and 
hepatic-stage malaria parasites, the RBC or the host immune cells (Golenser et al, 1991). It has 
been shown that malaria parasites are particularly prone to oxidative stress during the 
erythrocytic stages (Becker, Tilley et al. 2004). 
The malaria parasite haemoglobin digestion produces high concentration of the redox active 
by-products, free heme and H2O2, conferring oxidative stress as a result and formation of 
hemozoin that have peculiar biological activities (Muller 2004, Wrenger and Muller 2004). The 
schizont burst releases merozoites and residual bodies containing large amount of parasite 
products such as hemozoin and parasite membrane fragments, which is able to interact with the 
innate immune system. The toxic effects of these inflammatory mediators are evident from the 
characteristic periodicity of malaria paroxysms, including peak fever depending on cyclic 
schizogony events. During acute malaria infections monocytes and macrophages actively 
phagocytose HZ released during rupture of schizonts. The presence of  HZ-containing  
monocytes  in  peripheral  blood  smears  is  used  as  a  marker  of disease severity. The 
percentage of HZ-containing monocytes has been reported to be significantly higher in severe 
malaria cases among Gabonese, Nigerian, Malian and Ugandan children compared to 
uncomplicated malaria cases (Mujuzi, Magambo et al. 2006) (Metzger, Mordmuller et al. 
1995).Apart from inhibiting RBC production, monocyte functions such as the induction of 
oxidative burst and the ability to perform subsequent rounds of phagocytosis are also impaired 
upon uptake of HZ (Schwarzer, Turrini et al. 1994, Schwarzer, Kuhn et al. 2003, Skorokhod, 
Schwarzer et al. 2007, Deroost, Tyberghein et al. 2013, Tyberghein, Deroost et al. 2014, 
Schwarzer, Arese et al. 2015, Bujila, Schwarzer et al. 2016). 
Malaria-infected patients have always reported to show evidence of an increase in lipid 
peroxidation during infection, particularly in falciparum malaria. This increase is directly 
proportional to parasitaemia levels. The reduction of antioxidant potency with increased lipid 
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peroxidation has also been observed to be equally accountable to oxidative stress development 
in patients. In malaria infection ROS are not only generated as a result of hemoglobin 
degradation but they are also derived from an immune system activation response leading to 
the release of ROS as an antimicrobial action (Antoine, Fisher et al. 2014) (Skorokhod, Caione 
et al. 2010, Uyoga, Skorokhod et al. 2012). These conclusions suggest that oxidative stress is 
one of the major factors contributing to the development of malarial anemia. 
Lipid membrane peroxidation through its final product 4-HNE can be formed by radical-
dependent oxidative routes.  It has been demonstrated that it generates conjugates with specific 
aminoacid residues of RBC membranes proteins in Pf -in vitro cultures (Skorokhod, Caione et 
al. 2010, Tyberghein, Deroost et al. 2014). It  has  also  been  reported  that  the  hydroxyl-fatty 
acids  HETE  and  HODE  found present in HZ are final peroxidation products of the 
arachidonic and linoleic acid. This is due to the continuous generation of lipoperoxidation 
products in the parasite, during stage maturation in the RBC. (Uchida, 2003).  
While the pathological relationship between oxidative stress and malaria parasite have been 
long established, comprehensive profiling of phospholipid peroxidation products of isolated 
components of parasitized RBC was not attempted so far. Our study in collaboration with the 
Schwarzer group at University of Turin, Italy attempted to profile phospholipid oxidation 
products in isolated components of parasitized RBC using sophisticated mass spectrometry 
techniques. 
The findings showed that the hemozoin samples contained high levels of oxidised species 
compared to other components like schizonts and residual bodies. This could be one of the 
reasons for immunogenicity expressed by hemozoin crystals. Several published reports and 
reviews agreed on unique biological activities of hemozoin.  Specifically, isoprostanoids linked 
phosphatidylcholine species were shown to be higher in hemozoin samples compared to other 
oxidised species, which were found to be more than 400 fold higher. Also, several short chain 
oxidation products like POVPC, PONPC and PGPC, whose biological effects have been 
established in previous studies involving atherogenic models, were shown to be in high 
abundance in hemozoin samples compared to schizonts or residual bodies. These species have 
shown to have chemotactic properties as well as pro-inflammatory properties as reported in 
earlier studies. However, owing to semi quantitative nature of mass spectrometry technique due 
to several factors that affect the quantitation including missing values, inherent biological 
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variation and amount of sample loaded; manual data analysis using internal standard 
normalisation and automated data analysis using Progenesis QI software capable of  efficient 
handling  of the missing values and heterodasticity were compared. The results using both the 
approaches were comparable. Moreover, phospholipids content was estimated using 
spectrophtometric assay and it showed hemozoin and schizont samples contained phospholipid 
that is double the amount than found in residual bodies. Nevertheless, the data analysis 
interpretation does not change even after accounting for this loading variability.  
Looking from diagnostic perspectives, blood smear tests are currently the gold standard and the 
measurement of levels of isoprostanoid like compounds may provide the alternative approach, 
which can provide information on severity/ occurrence of the disease, although, it may require 
using sophisticated instruments like mass spectrometry. 
Current therapeutic regimens includes artemisinin (an endoperoxide) and querctin (flavonoids 
like compounds) that exert their effect by altering the oxidative stress of the parasitized RBC 
(Ferreira, Luthria et al. 2010). The levels of oxidised phospholipids including the level of 
isoprostanoids can be used to determine the therapeutic efficacy. Also, the number of different 
oxidised species identified can offer for alternative therapeutic targets or novel classes of 
compounds. Moreover, drug resistance being the major factor in malarial treatment, novel 
therapeutic targets can be developed that can target  lipid oxidation products, thereby providing 
symptomatic relief to patients. 
This study was performed using total extract of single replicates and pooled samples and 
therefore, similar profiling should be conducted on several replicates to validate the findings. 
Nevertheless, this study provided a comprehensive characterization of oxidised lipidome that 
can offer further insight about the composition of bioactive components of parasitized RBC and 
provide novel target to develop newer therapeutic agents. 
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6 Oxidised lipidome profiling of plasma samples of diabetic patients using 
mass spectrometry technology: A pilot study  
6.1 Background 
 
Type 2 diabetes is a complex polygenic disorder of intermediary metabolism with pathogenesis 
related to insulin resistance and dyslipidaemia (Krauss 2004). It has also been associated with 
several metabolic anomalies related to glucose metabolism, lipid metabolism as well as the 
oxidative stress especially at the mitochondrial site (Schrauwen and Hesselink 2004). It is one 
of the most prevalent disease of the 21st century and current statistics suggest that about 10 % 
of the world population aged 60 and above is likely to be suffering from this disease (Chang 
Wang and Xu 2005). While insulin resistance is the major etiological factor for type 2  and 
insulin deficiency for type 1 diabetes, several studies have demonstrated that dysregulation of 
lipid metabolism in the disease (Çakatay, Kayali et al. 2004, Merzouk, Hichami et al. 2004, 
Niedowicz and Daleke 2005, Kostolanská, Jakuš et al. 2009).   
 LDL (low density lipoprotein) and HDL (high density lipoprotein) are the lipids carrier present 
in extracellular fluids including plasma and their levels have long been associated with the 
development of cardiovascular diseases and metabolic diseases. Insulin resistance and 
dyslipidaemia have shown negative correlation with the levels of lipoproteins such as LDL and 
HDL and positive correlation with oxidised form of these lipoproteins (Krauss 2004, Merzouk, 
Hichami et al. 2004, Silva, Vinagre et al. 2014, Le, El Alaoui et al. 2015, Trpkovic, Resanovic 
et al. 2015). Moreover, it was reported that the oxLDL reduced preproinsulin mRNA expression 
and insulin secretion in pancreatic tumor derived islet β cell line (Okajima, Kurihara et al. 
2005). 
There are very few reports of the use of mass spectrometry to profile the lipidome and oxidised 
lipidome in biological fluids of patients suffering with type 2 diabetes.  Mass spectrometry has 
been used to measure phospholipids in diabetic plasma using LC coupled to mass spectrometry, 
and using a range of pre-processing approaches and multivariate analysis the investigators were 
able to identify biomarkers that could discriminate between control and disease groups (Chang 
Wang and Xu 2005). A recent study showed altered phosphatidylcholine : 
phosphatidylethanolamine (PE) ratio related to insulin sensitivity in skeletal muscle cells from 
type 2 diabetic patients using direct infusion mass spectrometry (Newsom, Brozinick et al. 
2016) . Other studies using mass spectrometry and non mass spectrometry based techniques 
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have  focussed on the levels of oxidised fatty acid derived from HDL or LDL in healthy and 
diabetic conditions (Morgantini, Meriwether et al. 2014) (Silva, Vinagre et al. 2014, Le, El 
Alaoui et al. 2015, Lokhov, Maslov et al. 2015, Trpkovic, Resanovic et al. 2015). Other types 
of oxidised lipid compounds such as F2-isoprostanes levels were found to be higher in urine of 
diabetic patients using gas chromatography mass spectrometry methodology compared to 
control samples (Devaraj, Hirany et al. 2001). 
All the earlier studies demonstrated the extend of lipid peroxidation in the pathogenesis of 
diabetes by either using colorimetric assays like thiobarbituric acid reactive substances 
(TBARS assay) or using HPLC-chemiluminescence based assay like FOX assay to measure 
level of peroxidation or hydroperoxides (Felber, Ferrannini et al. 1987, Nagashima, Oikawa et 
al. 2002) (Fujiwara, Nishihara et al. 1997).  Using these methods, plasma phosphatidylcholine 
hydroperoxides (PCOOH) concentration was shown to increase in hyperlipidemic and type 2 
diabetic patients (Kinoshita, Oikawa et al. 2000, Nagashima, Oikawa et al. 2002).  Glycation 
reaction between amino phospholipid such as PE and reactive aldehydes derived from oxidation 
of sugar leading to formation of advanced glycation products (AGE) are known to increase in 
diabetic patients and have shown to increase lipid peroxidation and formation of PCOOH 
(Miyazawa, Nakagawa et al. 2012) (Bucala, Makita et al. 1993, Kostolanská, Jakuš et al. 2009, 
Dias and Griffiths 2014).  
No attempt so far has been made to identify and quantify specific hydroperoxide bearing 
oxidised phospholipid species levels as well as other secondary oxidised phospholipid species 
using LCMS technology. In this chapter we describe a pilot study using plasma samples from 
diabetic patients (provided by Dr James Brown, Aston University), to develop an optimised 
method using neutral loss 34 m/z selective scanning approach on a hybrid mass spectrometer 
Qtrap 5500 that enables detection of all hydroperoxide species. Detection of other oxidised 
species using head group based scanning approaches was attempted.  
6.2 Aim and objectives 
 
The aim of the study was to demonstrate the effectiveness of the selective scanning of neutral 
loss 34 Da to detect hydroperoxide species in plasma samples of diabetic patients and healthy 
volunteers, and to use the identified mass to identify the specific oxidised phospholipid species. 
141 
 
To meet the objectives, a total lipid extract of plasma samples of diabetic patients and healthy 
volunteers were analysed on Qtrap 5500 using targeted approaches and monolithic 
polyvinyldibenzene column for chromatographic separation. Furthermore, to validate the 
identification, same samples were analysed on a Sciex tripleTOF 5600 instrument using a high 
resolution survey scan with data dependent generation of MS/MS scans. 
6.3 Results 
 
Chromatographic separation using a monolith column, and detection using targeted approaches 
such as NL 34 scan for detection of hydroperoxides in conjunction with IDA based MS/MS 
scans for structural information enabled identification of a number of hydroperoxide species in 
plasma samples of healthy and diabetic patients. Figure 6.1 (a & b) show representative total 
ion chromatograms (TIC)  for a NL 34 scan of total lipid extract of plasma samples from a 
diabetic patient and a  healthy volunteer.  The corresponding summed mass spectra (c & d) 
illustrates the up regulation of hydroperoxide species in diabetic patient sample relative to 
healthy plasma sample that eluted between 18-22 minutes. Several peaks corresponding to 
PLPC-OOH, PAPC-OOH and SAPC-OOH at m/z 790.5, 814.5 and 842.5 were observed in the 
MS spectra of diabetic sample that were seemingly absent in healthy sample. 
Figure 6.2 (a &b)  shows the  total ion chromatograms (TIC) for PIS 184 Da scan of diabetic 
plasma and  healthy plasma with representative averaged spectra for short chain oxidation 
products that elute between 4-14 minutes, long chain oxidation products eluting between 18-22 
minutes and unmodified phospholipid species eluting between 22 – 26 minutes. Multitude 
peaks representing oxidised phospholipid species in each category of short chain and long chain 
oxidation products were observed containing varied functional groups such as: the terminal 
aldehyde group in POVPC at m/z 594.5, the terminal carboxylic acid in PONPC at m/z 650.5, 
the epoxy-prostanoid in PEIPC and PECPC at m/z 810.5 and 828.5, as well as hydroxide species 
like PLPC-OH and PAPC-OH at m/z 774.5 and 798.5. Moreover, unmodified 
phosphatidylcholine species at m/z 758.5, 786.5 and 810.5 that correspond to PLPC, SLPC and 
SAPC respectively were observed with similar intensity in the average spectra of healthy and 
diabetic plasma samples. 
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Figure 6.1: Total ion chromatogram (TIC) of neutral loss (NL) scan for 34 Da of total lipid extract of  plasma of diabetic and healthy volunteers (a&b) and corresponding 
spectra (c &d). The TIC along with MS spectra illustrates the unequivocal identification and estimation of abundance of hydroperoxides in diabetic samples relative to healthy 
plasma. The peaks observed at m/z 790.5, 814.5 and 842.5 corresponded to PLPC-OOH, PAPC-OOH and SAPC-OOH respectively. This experiment was performed using 
monolith column for separation and Qtrap MS with targeted approaches for detection. 
 
 
(a) TIC of NL 34 Da: Diabetic 
(b) TIC of NL 34 Da: Healthy 
(c)Mass        
spectra: 
Diabetic 
(d)Mass        
spectra: 
Healthy 
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Figure 6.2: Total ion chromatogram (TIC) of precursor ion scan (PIS scan for 184 Da of total lipid extract of plasma of diabetic and healthy volunteers (a&b) and corresponding 
spectra representing the elution of short chain oxidation products ( 4- 14 minutes), long chain oxidation products (18-22 minutes) & native phosphatidylcholine species (22 -26 
minutes) respectively .. This experiment was performed using monolith column for separation and Qtrap MS with targeted approaches for detection. 
 
TIC of PIS 184 Da 
Diabetic plasma 
Healthy plasma 
Diabetic 
plasma 
Healthy 
plasma 
Diabetic 
plasma 
Healthy 
plasma 
22 – 26 minutes (Native PC) 4 – 14 minutes (short chain 
oxidation products) 
18 – 22 minutes (long chain 
oxidation products) 
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This was followed by identifying of all the oxidised phospholipid species by comparing the 
elution profile and MS-MS spectra of all of identified m/z with that of the standard mixture 
generated in-vitro, and calculating the peak area of all the observed oxidised species and 
unmodified species in total 7 biological replicates each of diabetic and healthy plasma samples 
and normalised using the internal standard approach. Figure 6.3 displays the average 
abundance of each identified species in diabetic and healthy samples categorised into (a) lyso-
PC, (b) hydroperoxide, (c) short chain oxidation products and (d) hydroxide species  with the 
variance being represented by the calculated standard error of the mean.  Overall, lysoPCs were 
more abundant in healthy plasma samples and long chain oxidation products specifically 
hydroperoxide species in diabetic plasma samples whereas, the level of short chain oxidation 
products and hydroxide species were similar in diabetic and plasma samples.  However, 
substantial variability was observed in between biological replicates and therefore, no 
statistical significant difference were found by performing ANOVA analysis. There was a trend 
for increased level of hydroperoxides in diabetic samples; however, the differences were not 
statistically significant. 
 
 
 
 
 
 
 
 
 
 
 
Figure 6.3: Comparative analysis of abundance of  several  unmodified and OxPC species a) lyso PCs b) 
Hydroperoxides c) short chain oxidation products d) hydroxides in lipid extracts of diabetic plasma samples (Red) 
and healthy volunteers (Blue) (N=14). The error bar indicates the standard error of the mean of biological 
replicates. The data was generated on Q-Trap mass spectrometer using targeted approaches for identification and 
chromatographic separation was achieved using monolith column.  
To further confirm and validate the findings, the same samples were analysed on high 
resolution QTOF mass spectrometer with IDA based MS/MS scanning.  The data was analysed 
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using the global normalisation approach on Progenesis QI software. Table 6.1 is a list of the 
experimental masses of the identified species, mass error ( ppm) representing the difference in 
theoretical and experimental mass, verified identification based on accurate mass and MS/MS 
spectra, and the  p-value representing the statistical significance of the difference between 
control and diabetic samples  calculated by performing ANOVA analysis. The results 
confirmed the manual data analysis performed on data generated using targeted scanning 
approaches such as NL 34 scan on the Qtrap 5500 instrument. For example, the average 
abundance difference for POVPC (m/z 594.3776) between healthy and diabetic plasma 
samples was 1.01 fold found on high resolution QTOF instrument that was in agreement with 
the levels found by Qtrap instrument.  Moreover, statistical analysis using ANOVA analysis 
showed non-significant difference in levels of all the species identified in diabetic and healthy 
samples. 
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Table 6.1: List of oxidised species identified in plasma samples of healthy and diabetic patients using high 
resolution Q-TOF mass spectrometer. The table also summarises the comparative statistics performed using 2-
way ANOVA represented by p-value as well as categorisation of verified identification represented by ranking 
with letter ‘a’ and ‘b’ that is related to confidence in identification > 90 % and < 90% respectively based on 
MS/MS fragmentation score. The mass error in ppm representing the accuracy in identification based on elemental 
composition is also listed. 
 
 
 
6.4 Discussion 
 
While the association of oxidative stress with the pathology of type 2 diabetes has long been 
established, the relationship between phospholipid oxidation and type 2 diabetes is poorly 
defined as limited studies have been published measuring oxidised phospholipids at the 
molecular level. We hypothesized that the levels of oxidised species will be abundant in 
m/z 
Retention 
time 
(min) 
Anova 
(p) 
Max 
Fold 
Change 
Verified 
identification 
category 
Verified Compound ID Formula 
Mass 
Error 
(ppm) 
496.3408 5.29 0.62 1.12 b PC(16:0/0:0) C24H50NO7P 2.03 
520.3403 5.15 0.80 1.04 b PC(18:2(9Z,12Z)/0:0) C26H50NO7P 1.02 
524.3721 7.08 0.27 1.25 b PC(18:0/0:0) C26H54NO7P 1.92 
544.3401 5.34 0.39 1.17 b PC(0:0/20:4(5Z,8Z,11Z,14Z)) C28H50NO7P 0.58 
594.3776 5.86 0.96 1.01 a (5-keto-pentanoic acid)-PPC C29H56NO9P 1.76 
650.4418 7.54 0.42 1.29 b PONPC C33H64NO9P 4.08 
732.5521 22.50 0.49 2.38 b PC(16:1(9Z)/16:0) C40H78NO8P -2.32 
758.5700 22.32 0.90 1.01 b PC(16:0/18:2(9Z,12Z)) C42H80NO8P 0.76 
774.5655 18.72 0.74 1.10 b PLPC-OH C42H80NO9P 1.48 
782.5696 22.64 0.91 1.03 b PC(16:0/20:4(5Z,8Z,11Z,14Z)) C44H80NO8P 0.18 
786.5996 23.76 0.98 1.01 b PC(18:0/18:2(9Z,12Z)) C44H84NO8P -1.40 
790.5600 18.11 0.51 1.78 a PLPC-2(OH) C42H80NO10P 0.93 
790.5608 19.04 0.51 6.71 a PLPC-OOH C42H80NO10P 1.97 
798.5645 19.60 0.44 1.11 b PAPC-OH C44H80NO9P 0.25 
802.5970 20.55 0.91 1.04 b SLPC-OH C44H84NO9P 1.64 
806.5567 17.35 0.92 2.84 b PLPC-OH C42H80NO9P 3.21 
806.5691 23.13 0.70 1.10 b PC(16:0/22:6(4Z,7Z,10Z,13Z,16Z,19Z)) C46H80NO8P -0.39 
810.5989 24.16 0.64 1.16 a PC(18:0/20:4(8Z,11Z,14Z,17Z)) C46H84NO8P -2.25 
814.5598 16.62 0.49 1.26 a PAPC-OOH C44H80NO8P 0.74 
818.5903 20.89 0.86 1.99 a SLPC-2(OH) C44H84NO10P -0.32 
826.5953 21.27 0.41 1.12 b SAPC-OH C46H84NO9P -0.37 
830.5552 16.74 0.59 1.05 b D2isoprostane-Palmitoyl C44H80NO11P 1.22 
834.5860 19.53 0.90 2.99 b SLPC-(OOH)OH C44H84NO9P 0.64 
834.5999 24.56 0.51 1.20 b PC(18:0/22:6(9Z,11Z,13Z,15Z,17Z,19)) C48H84NO8P -0.99 
838.5603 19.39 0.93 4.05 b SECPC C46H80NO10P 1.23 
842.5912 18.92 0.20 1.45 b SAPC-OOH C46H84NO10P 0.78 
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diabetic patients compared to healthy volunteers and this oxidised lipidome analysis of plasma 
lipids might improve the understanding of this relationship. Moreover, carbohydrates and lipid 
metabolism share intimate relationship that suggested a need for further exploration of the 
association between type 2 diabetes and wide range of oxidised phospholipid species that may 
provide useful insight into the pathophysiology of the disease. While the recent studies reported 
the change in plasma lipidome associated with type 2 diabetes (Han, Xia et al. 2011, Zhu, Liang 
et al. 2011, Meikle, Wong et al. 2013), no study to date has profiled the oxidised lipidome at 
molecular level in diabetes. 
Initially, total lipid extract of seven plasma samples of each healthy and diabetic patients was 
analysed on Qtrap 5500 using targeted approaches. While, the initial analysis suggested high 
levels of hydroperoxide species in diabetic patients compared to healthy plasma samples, 
which was in agreement with other studies conducted using non-mass spectrometry based 
techniques (Kinoshita, 2000;Fujiwara, 1997; Kostolanská, 2009 ; Nagashima, 2002 ), the high 
variance between biological replicates resulted in the differences not being statistically 
significant. This variance could be due to several biological factors that are associated with the 
disease such as the difference in glycated haemoglobin (a measure of hyperglycemia), 
therapeutic drugs that are currently administered and level of HDL, LDL levels etc. A study 
reported a statistically significant relationship between glycated haemoglobin and the levels of 
malondialdehyde (MDA) in a case control study involving 30 diabetic patients and healthy 
volunteers (Goodarzi, Varmaziar et al. 2008). Moreover, a direct cause and effect relationship 
between oxidative stress and hyperglycemia has been established. Also, a correlation between 
the levels of HDL, LDL and the levels of F2-isoprostane, which is a kind of oxidised 
phospholipid species, was examined in a clinical study investigating the role of oxidative stress 
in rheumatoid arthritis (Rho, Chung et al. 2010). The extent of variability for these biological 
factors in plasma samples may account for the variance observed in our data analysis. 
Moreover, hydroperoxide species are relatively unstable species and generally get decomposed 
to hydroxide species by increased lipolytic enzymatic action, or follows oxidative 
fragmentation to more stable short chain oxidised species, which can add to the biological 
variation. Furthermore, the abundance levels observed with the current method provides static 
abundance levels and does not give any information on the flux magnitude of these identified 
species.  
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Similarly, there was no statistically significant difference in short chain oxidation products 
observed in healthy and diabetic patients although, one of the possible reason could be the 
marked reactivity of short chain oxidation products.  Short chain oxidation products 
specifically having terminal aldehyde groups are very reactive and they can form Michael 
adducts and Schiff bases with other biomolecules in the vicinity thereby generating newer 
species that are not detectable with the current method.  
The findings were further validated by re- running the samples on a high resolution mass 
spectrometer with data dependent MSMS.  Similar results were observed with the data 
generated on high resolution instrument that reinforces the confidence on the detection 
capability of targeted scanning approaches like neutral loss and precursor ion scan and points 
us to the direction of designing better experiments that involves further stratification of the 
subjects in the study.  
Further studies need to be carried out integrating several analytical approaches encompassing 
varied groups of analytes such as proteomics to study lipid protein interaction, glycated 
metabolomics studies and oxidative lipidomics studies to get a clearer picture about the 
pathology of the disease. Moreover, sample preparation can be modified by isolating HDL, 
LDL and chylomicrons from plasma of healthy and diabetic patients and extracting lipids from 
each component followed by mass spectrometric analysis to get a more comprehensive view 
of the disease.  Multivariate analysis (MVA) such as principal component analysis (PCA) and 
partial least square discriminant analysis (PLS-DA) can facilitate isolating and sharpening the 
difference between control and diseased samples by accounting for overlapping in signals 
because of covariance of multiple analytes, thereby aiding in biomarker identification.  
Although, our study was not able to reveal the biological difference and association of 
phospholipid oxidation with type 2 diabetes, it laid a step ahead in the direction that can help 
design experiments to better understand the pathophysiology of the type 2 diabetes and 
oxidative stress. 
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7 Biological effects of antifoaming agents in recombinant protein 
production 
7.1 Background 
 
A life of research scientist working with recombinant protein production can be quite 
challenging as their work requires  handling multi-dimensional data that is produced as well as 
optimisation of several cultivation strategies that includes but are not limited to design of 
expression vectors, optimisation of gene copy number or engineering of post-translational 
processing (Routledge and Clare 2012, Bill and von der Haar 2015, Looser, Bruhlmann et al. 
2015). The production of recombinant production on large scale is essential for development 
and manufacturing of biopharmaceuticals, enzymes and antibodies; to study functional 
proteomics and to understand cellular mechanisms (Routledge 2012). While transferring or 
upscaling the process of recombinant production that require aerobic respiration, different 
mechanical steps are followed like sparging of air from the bottom of reactor flasks and/or use 
of mechanical stirrers to homogenise and maintain the levels of dissolved oxygen in bioreactors 
(Garrett 2001, Garrett 2015, Routledge, Mikaliunaite et al. 2015). However, this can lead to the 
foaming process that affects the quality of recombinant protein produced, sterility environment 
and may block the exit filters of the bioreactors thereby damaging the equipment (Karakashev 
and Grozdanova 2012, Routledge 2014). Therefore, one such process and variable optimisation 
required during protein production is the addition of anti-foaming agents, which are defined as 
surface active chemical substances, usually derivatives of fatty acids or oils, that, when 
dispersed in the foaming media, will destroy the foam by bubble coalescence (Schulte 2003, 
Denkov 2004, Kougias, Boe et al. 2015). 
Various studies have been performed to investigate the physico-chemical effects of addition of 
antifoaming agents such as foam height with time and volumetric oxygen mass transfer 
coefficient (kLa) (Routledge, Hewitt et al. 2011); process of foam destruction explained by 
bridge stretching mechanisms  (Etoc, Delvigne et al. 2006, Gao, Yan et al. 2014); 
hydrophobicity (Ruzickova, Remesova et al. 2005); and growth, metabolic rates and release of 
lactate dehydrogenase (Hesse, Ebel et al. 2003). Little attention has been given to the biological 
effects of antifoaming agents on the host cells and recombinant proteins (Routledge 2012).  
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Previous studies to study the biological effects of the antifoaming agents has been limited to 
other host organisms like E-Coli K-12 culture producing β galactosidase (Koch, Ruffer et al. 
1995), Geobacillus thermoleovorans secreting α amylase (Uma Maheswar Rao and 
Satyanarayana 2003), Schizosaccharomyces pombe producing transferrin (Mukaiyama, Giga-
Hama et al. 2009), and Saccharomyces cerevisiae expressing FC fusion protein (Holmes, Smith 
et al. 2006, Routledge, Hewitt et al. 2011) and mainly investigated the effect on cell viability, 
specific growth rate and recombinant protein yield. Moreover, a study using P. Pastoris as host 
strain was published investigating the effect of five different antifoaming agents on several 
physical properties, growth and viability of the host strain as well as the effect on quality and 
functionality of recombinant secreted GFP (Routledge, Hewitt et al. 2011). All of these studies 
highlighted the range of effects different antifoaming agents a various concentrations can have 
on the host cell as well as the functionality of the protein produced. Single study till date has 
looked at the effect of antifoaming agents on the functionality and yield of membrane proteins. 
For instance, the study involving expression of A2aR membrane protein using P.Pastoris as 
host strain investigated the effect of J673A, an alkoxylated fatty acid ester and P2000, a 
polypropylene glycol on protein yield and cell density (Routledge 2012, Bawa, Routledge et al. 
2014).  
While a study using Bacillus species producing α amylase and investigating the effect of 
different composition of polyethylene glycol (PEG polymers) pointed out the change in 
membrane composition, no definitive conclusion was drawn (Andersson, Ramgren et al. 1987). 
Similar work pointed out the change in lipid composition when PEG8000 was added to the 
culture of Schizosaccharomyces Pombe producing human transferrin (Mukaiyama, Giga-Hama 
et al. 2009). Moreover, the membrane phospholipid composition and the functionality of the 
recombinant protein produced, in this case, Vitamin K epoxide reductase, an integral membrane 
protein was established in a study involving E.Coli strain as host with targeted production in 
the form of inclusion bodies (Jaenecke, Friedrich-Epler et al. 2015). Furthermore, functionality 
of the membrane protein and the importance of phospholipid environment was extensively 
reviewed  (Phillips, Ursell et al. 2009). However, no study so far investigated the effect of 
antifoaming agent on total phospholipid composition of the host cell. In this study, the 
assessment of comparative lipidomic profiling was performed for total lipid extract of P.pastoris 
yeast strain expressing GFP or A2aR protein that were treated with different concentrations of 
J673-A or P-2000 antifoaming agent. 
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7.2 Study goals 
This study in collaboration with Prof Roslyn Bill and Dr. Sarah Routledge at Aston University 
was designed to answer the following question: 
1. Does the phospholipid profile of total lipid extract of P.Pastoris secreting GFP protein 
differs from that of expressing A2aR membrane protein? 
2. Does the phospholipid profile of total lipid extract of P.Pastoris expressing GFP and 
A2aR membrane protein changes in response to treatment with different concentrations 
of J673-A antifoaming agent? 
3. Does the phospholipid profile of total lipid extract of P.Pastoris expressing GFP and 
A2aR membrane protein changes in response to treatment with different concentrations 
of P-2000 antifoaming agent? 
7.3 Results 
7.3.1 Comparative Lipidomic profiling for P.Pastoris strain expressing GFP or A2aR 
protein 
7.3.1.1 Evaluation and comparison of several exploratory data analysis strategies for lipidomic 
analysis 
This work was done in collaboration with Prof Rosalyn Bill and Dr Sarah Routledge based at 
Aston University. Handling of P.pastoris yeast strain and setting up of experiments for 
production of GFP or A2aR protein with treatment of 0.5 % and 1 % J673-A or P-2000 was 
done by Prof Rosalyn Bill lab and LC-MS analysis to study and compare lipidome for samples 
expressing different protein and treated with different antifoaming agents was performed by 
me. 
The samples were analysed on high resolution Q-TOF Absciex 5600 instrument with 
chromatographic separation achieved using HILIC column (Ace silica, 150x 2.1 mm, Hichrom, 
UK) fitted on Dionex 3000 HPLC system that was interfaced with the mass spectrometer. 
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7.3.1.1.1 Comparison of lipid profile calculated using automated and manual data analysis approach 
 
To check whether the automated data analysis performed on Progenesis QI complements the 
manual data analysis that includes generating extracted ion chromatogram (XIC) for individual 
species. The figure 7.1 summarises the comparison of peak area calculated for representative 
species manually or co-detection peak peaking algorithm on Progenesis QI. The XIC for m/z 
756.5538, 760.5851, 770.564 and 786.6007 that corresponded to 34:3 PC, 34:1 PC, 35:3 PC 
and 36:2 PC respectively was calculated manually for the lipid extract of P.Pastoris strain 
expressing GFP and A2aR protein respectively and compared with the peak area calculated for 
the same species using Progenesis QI software co-detection algorithm.   Both approaches 
showed similar profile for the representative species identified in P.pastoris strain expressing 
different proteins. 
 
Figure 7.1: Comparison of lipid profile of total lipid extract of P.Pastoris strain expressing GFP and A2aR 
membrane protein calculated using automated approach on Progenesis QI and manual XIC approach. Peak area 
for four representative phospholipid species was calculated using both approaches for comparison of profiles. 
Subsequently, all the species belonging to the phosphatidylcholine (Melo, Santos et al.), 
phosphatidylethanolamine (PE) and phosphatidylserine (PS) class were detected on Progenesis 
QI software by studying the MS and MS/MS spectra and matching the accurate masses and 
MS-MS fragmentation pattern using Lipidblast database with mass tolerance set to 5 ppm. The 
table 7.1 lists all the species with retention time, chemical composition and mass error.  
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Table 7.1: List of all species belonging to PC, PE and PS class identified in total lipid extract of P.Pastoris  
Strain expressing GFP or A2aR membrane protein. The identification was based on accurate mass and 
 Fragmentation matching against Lipidblast database embedded in Progenesis QI software. 
Phosphatidylcholine species 
Experimental 
Mass 
Retention 
Time 
Accepted 
Compound ID 
Chemical 
Formula 
Mass error 
In ppm 
482.3246 21.14 PC(15:0/0:0) C23H48NO7P 1.00 
494.3242 21.10 PC(16:1/0:0) C24H48NO7P 0.10 
508.3395 20.99 PC(17:1/0:0) C25H50NO7P -0.51 
520.3397 20.96 PC(18:2/0:0) C26H50NO7P -0.06 
522.3554 20.95 PC(18:1/0:0) C26H52NO7P -0.12 
538.3862 20.80 PC(19:0/0:0) C27H56NO7P -1.02 
550.3864 20.76 PC(20:1/0:0) C28H56NO7P -0.49 
636.4955 20.27 PC(26:0/0:0) C34H70NO7P -1.16 
704.5221 19.26 GPCho(15:1/15:0) C38H74NO8P -0.52 
718.5382 19.23 GPCho(16:1/15:0) C39H76NO8P 0.07 
726.5040 19.26 GPCho(14:0/18:4) C40H72NO8P -3.92 
728.5220 19.12 GPCho(17:2/15:1) C40H74NO8P -0.64 
732.5529 19.18 GPCho(16:1/16:0) C40H78NO8P -1.22 
744.5534 19.12 GPCho(16:1/17:1) C41H78NO8P -0.54 
746.5682 19.15 GPCho(15:0/18:1) C41H80NO8P -1.61 
754.5375 19.07 GPCho(18:3/16:1) C42H76NO8P -0.87 
756.5532 19.07 GPCho(18:2/16:1) C42H78NO8P -0.75 
758.5704 18.17 GPCho(16:0/18:2) C42H80NO8P 1.28 
760.5834 19.10 GPCho(18:1/16:0) C42H82NO8P -2.20 
768.5530 19.04 GPCho(18:3/17:1) C43H78NO8P -0.98 
770.5689 19.01 GPCho(18:2/17:1) C43H80NO8P -0.72 
772.5846 19.01 GPCho(17:1/18:1) C43H82NO8P -0.59 
782.5692 18.99 GPCho(16:0/20:4) C44H80NO8P 2.93 
784.5807 17.41 GPCho(16:0/20:3) C44H82NO8P 10.6 
786.5998 18.99 GPCho(18:0/18:2) C44H84NO8P -1.14 
796.5251 19.15 GPCho(17:2/18:4) C43H74NO8P -1.98 
798.5950 18.98 GPCho(18:3/19:0) C45H84NO8P -7.15 
804.5513 18.99 GPCho(20:5/18:2) C46H78NO8P -3.09 
812.6132 18.95 GPCho(20:1/18:2) C46H86NO8P -3.87 
814.6311 18.95 GPCho(20:2/18:0) C46H88NO8P -1.17 
844.6783 18.84 GPCho(20:0/20:1) C48H94NO8P -0.79 
872.7094 18.84 GPCho(18:1/24:0) C50H98NO8P -1.06 
884.7082 19.26 GPCho(22:2/21:0) C51H98NO8P -2.31 
884.7095 18.75 GPCho(18:2/25:0) C51H98NO8P -0.84 
896.7091 18.72 GPCho(18:3/26:0) C52H98NO8P -1.35 
898.7253 18.72 GPCho(18:2/26:0) C52H100NO8P -0.69 
Phosphatidylethanolamine (PE) species 
452.2771 14.82 PE(16:1/0:0) C21H42NO7P -0.05 
468.3085 14.68 PE(17:0/0:0) C22H46NO7P -0.09 
476.2757 14.77 PE(18:3/0:0) C23H42NO7P -3.06 
480.3086 14.64 PE(18:1/0:0) C23H46NO7P 0.25 
496.3390 14.57 PE(19:0/0:0) C24H50NO7P -1.53 
502.2903 14.63 PE(20:4/0:0) C25H44NO7P -5.02 
702.5072 12.71 GPEtn(16:1/17:1) C38H72NO8P 0.48 
704.5221 12.77 GPEtn(18:1/15:0) C38H74NO8P -0.49 
714.5066 12.66 GPEtn(16:1/18:2) C39H72NO8P -0.26 
716.5224 12.66 GPEtn(16:0/18:2) C39H74NO8P -0.13 
718.5374 12.66 GPEtn(16:0/18:1) C39H76NO8P -0.95 
726.5065 12.61 GPEtn(18:2/17:2) C40H72NO8P -0.42 
728.5222 12.61 GPEtn(18:3/17:0) C40H74NO8P 0.16 
738.5062 12.59 GPEtn(18:2/18:3) C41H72NO8P -0.84 
742.5375 12.58 GPEtn(18:2/18:1) C41H76NO8P -0.81 
744.5533 12.58 GPEtn(18:0/18:2) C41H78NO8P -0.68 
752.5200 12.59 GPEtn(20:4/17:1) C42H74NO8P -3.36 
764.5201 12.59 GPEtn(18:2/20:4) C43H74NO8P -3.15 
766.5349 12.58 GPEtn(18:1/20:4) C43H76NO8P -4.22 
772.5818 12.58 GPEtn(20:0/18:2) C43H82NO8P -4.19 
Phosphatidylserine (PS) species 
734.4966 14.28 GPSer(16:1/16:0) C38H72NO10P -0.07 
760.5121 14.28 GPSer(17:1/17:1) C40H74NO10P -0.31 
762.5275 14.28 GPSer(17:0/17:1) C40H76NO10P -0.57 
790.5571 14.28 GPSer(18:1/18:0) C42H80NO10P -2.76 
798.5247 14.31 GPSer(19:0/18:4) C43H76NO10P -4.12 
810.5245 14.14 GPSer(20:5/18:0) C44H76NO10P -4.33 
3GPcho, GPEtn and GPSer correspond to PC, PE and PS class phospholipid. The numerical 
annotation of species corresponds to carbon chain length and level of unsaturation of fatty acyl 
chain linked at sn-1 and sn-2 position. 
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Furthermore, the variability between biological replicates was investigated and several 
approaches were applied to minimise this uninduced variation (technical and inherent biological 
variation) that obscured the subtle variation due to the treatment. 
7.3.1.1.2 Exploratory analysis to investigate the effect of pre-treatment methods post-acquisition on 
distribution profile 
The figure 7.2 shows the total ion chromatogram (TIC) of three biological replicates of total 
lipid extract samples of P.pastoris strain expressing GFP protein and A2ar membrane protein. 
The TIC shows the elution time range of PE class species (12-13 minute) and PC class species 
(18-20 minutes) as well as the contribution of these species of specific class to the total ion 
intensity (broken boxes). The peak area corresponding to PC class and PE class shows RSD of 
52 % and 48 % respectively between replicates. This was further confirmed by comparing the 
spectra of samples expressing different protein for specific time window that showed the pattern 
and peak height variability between individual species as shown in figure 7.3. 
 
Figure 7.2: Total ion chromatogram (TIC) of biological replicates of total lipid extract of P.pastoris strain 
expressing GFP protein (left panel) and A2aR membrane protein (right panel).  The rectangular shape with broken 
PE class PE class 
PC class PC class 
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line represents the elution window of PE and PC class species. The peak area for total PC and PE class shows CV 
% of 52 % and 48 % respectively between biological replicates. 
 
The figure 7.3 showed the spectral profile of PC and PE class for samples expressing GFP 
protein (left panel) and A2aR membrane protein. The difference in the pattern of individual 
species abundance relative to each other within different clusters corresponding to total fatty 
acyl chain is observed. For example, the sample expressing GFP protein showed high 
abundance of di-unsaturated species relative to the mono-unsaturated species compared to the 
A2aR expressing samples. The relative abundance of peak at m/z 758.5 (di-unsaturated species 
with 34:2 carbon chain and number of double bonds) to m/z 760.5 (mono-unsaturated species 
with 34:1 carbon chain and number of double bond) is different between samples expressing 
different protein. 
 
Figure 7.3: LC-MS mass spectra in the positive ion mode of PC class  and PE class from Pichia Pastoris lipid 
extracts with GFP secreted membrane (left panel) and A2AR secreted membrane (right panel). The mass spectra 
of PC class in GFP secreted membrane show the predominance of di-unsaturated and polyunsaturated species, 
while the mass spectra of PC class in A2AR secreted membrane show the predominance of mono-unsaturated 
species. The mass spectra of PE class in GFP secreted membrane show the predominance of stearoyl based species 
(C36 cluster) while the A2aR expressing membrane showed predominance of palmitoyl (C34 cluster) based 
species. 
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Furthermore, this uninduced variability can be exemplified by overlaid XICs of individual 
species for GFP expressing samples and A2aR membrane protein respectively (figure 7.4). The 
different colour peaks corresponds to biological replicates to demonstrate variability between 
replicates.  The overlaid XIC for m/z 760.5851 of three biological replicates each for the A2aR 
expressing membrane extract and GFP expressing extract displays one sample differing 
significant from the rest two replicates suggesting error in sampling or sample preparation. 
Similar profile is observed in overlaid XIC for m/z 786.6007. These outliers can have profound 
effect on the average abundance calculation. 
 
Figure 7.4: The extracted ion current (XIC) obtained for ion at m/z 760.5851 (PC 34:1) of choline class (top panel) 
and m/z 786.6007 (PC 36:2) (bottom panel) shows variability between biological replicates thereby obscuring the 
subtle change in abundance due to treatment. 
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 Therefore, to minimise the effect of these outliers we tested several post-acquisition treatments 
that can account for the skewed variability. Different normalisation approaches like total protein 
content, pellet weight and global normalisation was used to account for this uninduced 
variability, thereby minimising its effect on induced variation.  
The specific protein concentration was determined by Prof. Roslyn Bill lab and the values were 
shared with us. Similarly, the weight of the pellet before total lipid extraction was performed 
using modified Folch method was calculated by Prof. Bill group and the values were shared 
with us. The raw peak area calculated for all peaks were normalised to the values of specific 
protein content or pellet weight and its effect on distribution was observed.  
The figure 7.5 shows the application of these approaches to calculated peak area of seven 
species to minimise the variance. However, none of these approaches were able to extract out 
the subtle biological response or difference. While the distribution and differential analysis for 
these peaks treated with pellet weight content or global normalisation approach showed similar 
profile, the treatment with specific protein content completely reversed the distribution profile. 
Morever, statistical analysis on graphpad prism with multiple t-test and false discovery rate set 
to 1% showed no statistical significance in the distribution profile. 
Subsequently, the total phospholipid content assay was performed to investigate if the total 
phospholipid varies between samples as these can affect the distribution profile and alter the 
abundance level more significantly, if not accounted for in comparative analysis. The figure 7.6 
shows the average total phospholipid content in all samples that corresponded to total lipid 
extract of P.pastoris strain expressing different GFP or A2aR membrane protein and treated 
with  either 0.5 % or 1% P-2000 or J673-A antifoaming agent respectively. The distribution 
shows substantial variability in total phospholipid profile between samples. For instance, the 
total phospholipid content in extract expressing A2aR protein treated with 0.5 % J673-A is 6 
times higher compared to the control extract expressing A2aR protein. Similar profile was 
observed in extract expressing A2aR membrane protein treated with P-2000 antifoaming agent, 
although to the lesser extent. However, the total phospholipid content profile for samples 
expressing GFP with or without treatment did not changed significantly. 
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Figure 7.5: Comparison of different normalisation approaches and its effect on the profile of the representative PC 
and PE species and relative abundance between GFP and A2aR expressing membrane extract. The data plotted is 
the average of three biological replicates with error bars representing the standard deviation. Statistical analysis 
was performed on graphpad prism using multiple t-test with false discovery rate correction set to 1 %. No statistical 
difference was observed. 
 
Figure 7.6: The effect of antifoams on total phospholipid content of P. pastoris. Cells were grown in shake flasks 
in the presence of 0%, 0.5% or 1% J673A or P2000 antifoams, and phospholipids were extracted from dry cell 
pellets by a modified Folch method.  Total phospholipid concentration was determined using the ammonium 
ferrothiocyanate assay. Error bars correspond to 1 S.E.M. (n=3). 
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Therefore, we applied these values of total phospholipid content to normalise the raw peak area 
and investigated its effect on the distribution profile. The figure 7.7 shows the effect of 
normalisation using total phospholipid content on the distribution profile of phospholipid 
species for extract samples expressing GFP or A2aR membrane protein without any 
antifoaming treatment. The distribution profile was similar to that observed with normalisation 
using pellet weight and global weight and this pre-treatment approach also did not significantly 
minimised the variance to improve the relevant biological information of the data. 
 
Figure 7.7:Effect of total phospholipid content normalisation on the distribution profile of the representative PC 
and PE species and relative abundance between GFP and A2aR expressing membrane extract. The data plotted is 
the average of three biological replicates with error bars representing the standard deviation. Statistical analysis 
was performed on graphpad prism using multiple t-tests with false discovery rate correction set to 1 %. No 
statistical difference was observed. 
 
7.3.1.1.3 Ratiometric analysis approach to study the distribution pattern for comparative analysis 
 
However, closer observing the spectra for all the three replicates, we found that the GFP 
secreting extract showed higher abundance of di-unsaturated and poly unsaturated fatty acyl 
linked phospholipid species in GFP expressing membrane extract compared to the A2aR 
expressing membrane extract. However, this biological information was obscured due to 
variability between replicates and therefore, the ratiometric analysis approach was performed 
by calculating ratio of peak area of monounsaturated liked phospholipid species to di-
unsaturated linked species as well as ratio of monounsaturated to polyunsaturated linked species 
for all the replicates and the average proportion was calculated, plotted on the graph and 
statistical analysis performed using multiple t-test comparison with false discovery rate set to 
1% using graph pad prism as shown in figure 7.8. For example, ratio of di-unsaturated PC 
160 
 
species (m/z 758.5, 16:0/18:2 PC) to monounsaturated PC species (m/z 760.5, 16:0/18:1 PC) 
and ratio of polyunsaturated PC species (m/z 782.5, 16:0/20:4 PC) to monounsaturated PC 
species showed significant higher proportion in GFP expressing species than A2aR expressing 
species, which was confirmed by the statistical test on graph pad prism using multiple t-test 
comparison and correction with false discovery rate (FDR) set to 1 %. Interestingly, species 
with odd carbon chain i.e. 17:0/18:2 PC and 17:0/18:2 PE at m/z 772.5 and 730.5 showed higher 
abundance in A2aR membrane expressing samples compared to GFP secreting membrane 
extract. This is illustrated in figure 1-8  by calculating ratio of m/z 758.5 to 772.5 for PC species 
and m/z 718.5 (16:0/18:1 PE) to 730.5 for PE species and comparing the ratios for both the 
groups showing statistically significant proportion in A2aR membrane extract. 
 
Figure 7.8: Ratiometric analysis approach to study the distribution of lipids in P.Pastoris membrane extract 
expressing different proteins: GFP and A2aR. Different combination of ratios were calculated where species 
belonging to same cluster having same number of carbon chain were proportionated as well as species with 
increasing level of unsaturation from same cluster series. Statistical analysis was performed on graphpad prism 
using multiple test with FDR set to 1 %. * represents significance set to 95 % confidence interval. 
 
7.3.1.2 Ratiometric analysis approach to study the effect of J673-A antifoaming agent on 
distribution pattern 
 
7.3.1.2.1 Effect of J673-A antifoaming agent on phospholipid profile of total extract of P.Pastoris 
expressing GFP protein 
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The ratiometric analysis approach was applied to study the effect of J673-A antifoaming agent 
on phospholipid distribution. It was performed by calculating ratio of peak area of 
monounsaturated liked phospholipid species to di-unsaturated linked species as well as ratio of 
monounsaturated to polyunsaturated linked species for all the replicates and the average 
proportion was calculated, plotted on the graph and statistical analysis performed using 2-way 
ANOVA with multiple comparison and correction using Tukey method and significant level 
set to 95 % interval as shown in figure 7.9.  The investigation suggests concentration dependent 
increase in abundance level of poly unsaturated fatty acyl chain linked phosphatidylcholine 
species like 16:0/20:4 PC and diunsaturated fatty acyl chain linked species like 18:/20:4 PC  
and both species  belongs to the C36 cluster whereas there was minimal influence observed on 
C34 cluster species like peak at m/z 756.5, 758.5 and 760.5. 
 
Figure 7.9: Ratiometric analysis approach to study the effect of J673-A on distribution of lipids in P.Pastoris 
membrane extract expressing GFP proteins. Different combination of ratios were calculated where species 
belonging to same cluster having same number of carbon chain were proportionated as well as species with 
increasing level of unsaturation from same cluster series. Statistical analysis was performed on graphpad prism 
using 2-way ANOVA with tukey method for correction for multiple corrections. * represents significance set to 
95 % confidence interval. 
7.3.1.2.2 Effect of J673-A antifoaming agent on phospholipid profile of total extract of P.Pastoris 
expressing A2aR membrane protein 
 
The effect of J673-A on phospholipid profile of total extract of P.Pastoris expressing A2aR 
membrane protein showed the similar effect as GFP expressing strain, which is illustrated in 
figure 7.10. 
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The abundance level of species with higher levels of unsaturation increased relative to saturated 
or monounsaturated containing species. On the other hand, the ratio of abundance levels of 
higher masses PE species (m/z 730.5, 17:0/18:2 PE) decreased relative to mono unsaturated 
lower mass species (m/z 718.5, 16:0/18:1 PE).  
 
Figure 7.10: Ratiometric analysis approach to study the effect of J673-A on distribution of lipids in P.Pastoris 
membrane extract expressing A2aR protein. Different combination of ratios were calculated where species 
belonging to same cluster having same number of carbon chain were proportionated as well as species with 
increasing level of unsaturation from same cluster series. Statistical analysis was performed on graphpad prism 
using 2-way ANOVA with tukey method for correction for multiple corrections. * represents significance set to 
95 % confidence interval. 
 
7.3.1.3 Ratiometric analysis approach to study the effect of P-2000 antifoaming agent on 
distribution pattern 
 
7.3.1.3.1 Effect of P-2000 antifoaming agent on phospholipid profile of total extract of P.Pastoris 
expressing GFP protein 
 
The ratiometric approach was further used to investigate the effect of P-2000 antifoaming agent 
on the phospholipid profile of total extract of P.Pastoris strain expressing GFP protein. The 
figure 7.11 with graphs plotted using the average calculated ratios for each group suggested 
that there was no significant effect on the distribution profile of species belonging to PC class. 
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Although, the abundance level of a single species of PE class with higher carbon number (m/z 
718.5, 16:0/18:1 PE) increased with treatment of 0.5 % P-2000 antifoaming agent. 
 
 
Figure 7.11: Ratiometric analysis approach to study the effect of P-2000 on distribution of lipids in P.Pastoris 
membrane extract expressing GFP proteins. Different combination of ratios were calculated where species 
belonging to same cluster having same number of carbon chain were proportionated as well as species with 
increasing level of unsaturation from same cluster series. Statistical analysis was performed on graphpad prism 
using 2-way ANOVA with tukey method for correction for multiple corrections. * represents significance set to 
95 % confidence interval 
 
7.3.1.3.2 Effect of P-2000 antifoaming agent on phospholipid profile of total extract of P.Pastoris 
expressing A2aR membrane protein 
The average ratios were calculated to study the relative distribution level of diunsaturated 
containing species and polyunsaturated containing species to saturated or monounsaturated 
species. The distribution profile for A2aR membrane expression extract did not changed on 
addition of P-2000 antifoaming agent as shown in figure 7.12. This effect was similar to that 
we observed with GFP expressing strain. 
164 
 
 
Figure 7.12: Ratiometric analysis approach to study the effect of P-2000 on distribution of lipids in P.Pastoris 
membrane extract expressing A2aR membrane proteins. Different combination of ratios were calculated where 
species belonging to same cluster having same number of carbon chain were proportionated with species with 
increasing level of unsaturation from same cluster series. Statistical analysis was performed on graphpad prism 
using 2-way ANOVA with tukey method for correction for multiple corrections. * represents significance set to 
95 % confidence interval 
 
Subsequently, we used the percentage composition analysis approach to investigate the effect 
on the distribution profile of PC class species and validate the ratiometric analysis. The figure 
7.13 shows the % total composition in the total lipis extract of P.Pastoris expressing GFP and 
A2aR membrane protein. The observed distribution profile is similar to that observed with the 
ratiometric analysis approach in figure 7.8 indicating the GFP expressing strain having higher 
proportion of di-unsaturated linked phospholipid species compared to A2aR expressing strain 
such as the (18:0/18:2) PC (m/z 786.6007) and (18:0/18:2) PE (m/z 744.5538). 
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Figure 7.13: Percentage composition analysis approach to study the distribution profile of lipids in P.Pastoris 
membrane extract expressing A2aR membrane proteins and GFP protein. Statistical analysis was performed on 
graphpad prism using 2-way ANOVA with tukey method for correction for multiple corrections. * represents 
significance set to 95 % confidence interval. 
Similarly, to investigate the effect of antifoaming agents, the percentage composition analysis 
was applied. The figure 7.14 shows the effect of antifoaming agents: J673-A (A&B) and 
P2000(C&D) on the distribution profile of phospholipid species in GFP and A2aR expressing 
strain of P.Pastoris. The result suggests J673A having concentration dependent effect on 
distribution profile of unsaturated linked species which is in agreement with the findings using 
the ratiometric analysis. Also, there was no significant effect observed for the P2000 
antifoaming agent on the distribution profile as shown before with the ratiometric analysis. 
The % composition of polyunsaturated containing species such as the (16:0/20:4) PC (m/z 
782.5694) and diunsaturated containing species such as at m/z 758.5694, 744.5538 and 
786.6007 that corresponds to 16:0/18:2 PC, 18:0/18:2 PE and 18:0/18:2 PC respectively are 
different in non-treated and J-673A treated strains expressing GFP and A2aR membrane 
protein.  
* 
* 
* 
166 
 
 
Figure 7.14: Percentage composition analysis approach to study the effect of J673-A (A&B) and P-2000 (C&D) 
on distribution of lipids in P.Pastoris membrane extract expressing GFP and A2aR membrane proteins. Statistical 
analysis was performed on graphpad prism using 2-way ANOVA with tukey method for correction for multiple 
corrections. * represents significance set to 95 % confidence interval 
 
7.4 Discussion 
 
The bioreactors for large scale protein production facilitates tighter control of pH, temperature 
and dissolved oxygen (DO) coupled with more effective feeding strategies which may promote 
higher product yields (Routledge, Mikaliunaite et al. 2015). However, foaming is an integral 
problem that can affect the quality and quantity of the protein produced. Foam may accumulate 
as a result of the gases sparged into the vessel or stirring to sustain the DO conditions required 
for growth of the organism (Routledge 2014). Moreover, the culture medium and the proteins 
produced may contribute to foam formation (Doran 2012). In many bioprocesses, foam 
formation is unwanted; unchecked accumulation leads to blocking of the filter exit and this may 
damage the bioreactors and also affects the sterility. This problem is commonly managed by 
the addition of chemical antifoaming agents (Vardar-Sukan 1998, Garrett 2001, Etoc, Delvigne 
et al. 2006, Junker 2007, Karakashev and Grozdanova 2012). Although, they are commonly 
used as additives, their effects upon the biological aspects of bioprocesses are not well studied. 
As demonstrated by the GFP bioreactor experiments, low concentrations of antifoam produced 
a better yield, whereas the opposite was true in shake flasks where high concentrations produced 
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more GFP (Bawa, Routledge et al. 2014). Although antifoams are not usually required to 
alleviate foams formation in these formats, it was observed that the yield of GFP was doubled 
in the presence of antifoams at higher concentrations than would normally be used. As changes 
to protein expression could not be explained by the effects of antifoams upon oxygen 
availability, their effects upon the lipid composition of P. pastoris membranes was next 
investigated in shake flasks to allow a range of conditions to be evaluated. The lipids were 
extracted from cultures expressing the soluble GFP and membrane protein A2aR grown in the 
absence of antifoam or treated with 0.5% v/v and 1% v/v of antifoams J673A and P2000.  
Yeast plasma membranes is rich in glycerophospholipds and sphingolipids. Ergosterol 
constitutes the major component of yeast plasma membranes providing structural integrity 
(Klug and Daum 2014). Membrane fluidity is important for nutrient uptake and exchange of 
substrates, and glycerophospholipid affects the movement and activity of membrane proteins 
and insertion sites. The major phospholipids present in P. pastoris membranes are 
phosphotidylcholine (Melo, Santos et al.) accounting for approximately 45% of total 
phospholipids, phosphatidylethanolamine (PE), (approximately 25%), and the rest proportion 
constituting phosphotidylserine (PS) and phosphotidylinositol (PI) (Koch, Schmidt et al. 2014).  
The method developed on a high resolution QTOF MS instrument along with chromatographic 
separation achieved using HILIC column enabled detection of 100’s of species belonging to the 
PC, PE and PS class (table 7.1). Molecular level information based on the number of carbon 
present and the level of unsaturation as well as the head group information was made available 
by this method. However, owing to inherent limitation in chromatographic separation using 
HILIC column due to co-elution of all species belonging to same phospholipid class, 
information on fatty acyl linked at different positions to the glycerol body was not possible. 
Therefore, it was not possible to tell whether a species belonging to PC class having total 34 
carbon and 2 double bond is a 16:0/18:2 PC, 17:1/17:1 PC or 15:1/19:1 PC.  
As exemplified in figure 7.1 – 7.3, peak area calculation for different species in replicates 
showed unaccounted variability. This could be because of several factors including instrument 
related factors relating to the ion detector and limitations in the dynamic range of QTOF 
analysers (Chernushevich, Loboda et al. 2001, Thakur 2008, Periat, Kohler et al. 2015, Khoury, 
El Banna et al. 2016). Although, the possibility of the error in experimental handling cannot be 
rule out and therefore, we tried different approaches to correct for this variability using several 
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approaches like protein content including the total phospholipid content (figure 7.5 -7.7) but 
the distribution profile variability between replicates was not totally accounted.  
Subsequently, a novel approach using ratiometric analysis of abundance levels of 
monounsaturated and unsaturated fatty acyl bearing species to polyunsaturated fatty acyl 
bearing species within the same cluster was performed and the mean ratio was used for 
comparative statistical analysis. Our data show that overexpression of different types of protein, 
either soluble or membrane, can affect the abundance of certain species of phospholipids in 
addition to affecting the chain length. Recombinant protein production dependent and anti-
foaming agent specific response was observed. J673-A treated samples showed higher levels 
of species bearing polyunsaturated fatty acyl chains compared to the species with 
monounsaturated fatty acyl chains whereas, P-2000 treated samples did not showed any effect 
on the abundance level. Recombinant protein production is associated with endoplasmic 
reticulum stress due to focussing of metabolic machinery for production of target protein and 
saturated fatty acid has been previously shown to degrade ER (Leamy, Egnatchik et al. 2014). 
Therefore, this increase production of polyunsaturated fatty acyl containing phospholipid 
species may be linked to alleviation of the ER stress and thereby improving the production and 
quality of target protein as it has been reported previously about the beneficial effect of 
docosahexaenoic acid (a poly unsaturated fatty acid) in resolving oxidative stress in diabetes 
(Vericel, Colas et al. 2015). 
Moreover, several reports suggested the requirement and composition of specific phospholipids 
for the functionality of recombinant protein production (Seddon, Curnow et al. 2004, Bill and 
von der Haar 2015, Grison, Brocard et al. 2015, Jaenecke, Friedrich-Epler et al. 2015). This 
study provides evidence based agreement to the theory.  Nevertheless, this study provided 
useful insight into change in lipid composition in response to different types of antifoaming 
agents and similar studies with different membrane proteins need to be designed and conducted 
to reinforce our findings. Moreover, multi-dimensional studies involving multivariate analysis 
with lipidomics are required to correlate the change in lipid composition with other physical 
parameters and protein production.  
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8 Discussion 
The major focus of this thesis and the underlying work was the development of an improved 
mass spectrometry based protocol for measurement of lipid peroxidation and oxidation products 
and factors that need to be considered when measuring them such as the variability in ionisation 
efficiency of different classes of phospholipids, consideration of isobaric species during data 
analysis as well as difference in linear dynamic range of the response for each oxidised species 
on a mass spectrometrometer. It is evident from several published articles in the literature that 
a plethora of oxidised phospholipid species are formed via non enzymatic oxidation and that 
these may have non- identical biological activities (van Meer 2005, Blanksby and Mitchell 
2010, Spickett and Fauzi 2011, Gruber, Bicker et al. 2012). Several other published reports 
have indicated that oxPL may contribute to development of disease pathologies (Niki 2009, 
Griffiths, Ogundare et al. 2011, Spickett and Fauzi 2011, Greig, Kennedy et al. 2012, Reis and 
Spickett 2012). Unsurprisingly, this has led to development of various improved methodologies 
for measurement of these markers of oxidative damage. However, most of the methodologies 
developed so far remained driven by technological advancement in the instrumentation aspects 
of mass spectrometry and separation science or they were focussed on measurement of a 
predefined list of species (Stutts, Menger et al. 2013) (Gruber, Bicker et al. 2012, Milic, 
Fedorova et al. 2012, Milic, Hoffmann et al. 2013). Therefore, several oxidised species whose 
levels may be close to the detection limit remained undetected leading to only partial 
information from the measurements. Also, semi targeted approaches like precursor ion scanning 
and neutral loss scanning that can add selectivity and sensitivity to the detection together with 
broader coverage of the oxidised species have been underutilised in previous studies, although, 
their potential and advantages have been known and reported extensively (Spickett, Wiswedel 
et al. 2010, Sandra and Sandra 2013). This suggests the need for development of more focussed 
& sensitive methodologies that can provide a better coverage of the oxidised lipidome in disease 
models.  
While methods using LCMS technology have been developed over decades for measurement 
of oxidised lipids, relatively speaking the power of chromatographic separation to improve the 
sensitivity and dynamic range of detection has been overlooked and limited attempt so far to 
the best of authors’knowledge has been made for optimisation and evaluation of 
chromatographic separation. This thesis begins to offer solution to aforementioned issues by 
initiating the optimisation and evaluation of chromatographic separation of oxidised 
phospholipid species by testing several reverse phase and mix mode columns and a range of 
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solvent systems together with application of semi targeted approaches for analysis of in-vitro 
generated oxidised phospholipid mixture belonging to PC and PE class. We evaluated the 
selectivity parameter achieved on several reverse phased columns with common stationary 
phases like C8, C18 and C30, a monolithic column with divinylstyrene benzene chemistry, as 
well as a mix mode silica based HILIC column together with testing several solvent system and 
gradient system. Our work suggested that monolithic column with methanol –water solvent 
system provided a robust method with better selectivity for short chain oxidation products, 
which eluted in the early part of the chromatographic run compared to other columns.  
Furthermore, emphasis was also placed on method validation by testing of repeatability and 
reproducibility along with recovery post extraction of samples. The intra-day and inter-day 
variability was calculated as less than 20 % for most of the oxidised species.  In Parallel, for 
comparison purpose the method was translated to a high resolution QTOF mass spectrometer 
and data analysis using Progenesis QI software to reinforce the identification and manual data 
analysis. A further attempt to evaluate the efficiency of separation using two-dimensional 
chromatography was also done and presented. This all led to presentation of an improved 
LCMS method that can be a starting point for research labs interested in oxidative lipidomics 
work. 
As a result of this work, a first attempt was made to perform comparative profiling of oxidised 
phospholipids in ascites of lean and obese rats induced with acute pancreatitis with the objective 
of investigation of association of obesity with oxidative stress. In addition, a post data 
acquisition approach by comparing several normalisation approaches was set up and 
investigated to improve the biological content of the data by minimising any inherent variation 
due to sample composition and variation occurred during handling. This analysis proved to be 
highly sensitive and capable of detecting a range of oxidised species in the total lipid extract of 
ascites of lean and obese rats. Despite the sensitive analysis and setting up of a post-acquisition 
data handling approach, it was not possible to ascertain any discriminating levels of oxidised 
phospholipid species between lean and obese rats model of acute pancreatitis although, the trend 
suggested high levels of short chain odation products in ascites of lean rats compared to obese 
rats. The difference in the level of several oxisised species like POVPC, PONPC between 
replicates of the same group were more than 2 standard deviation that obscured any significant 
difference in the level. However, a likely cause of this is that a single time point to collect the 
ascite fluid post induction of acute pancreatitis was investigated, thereby only providing a static 
snapshot of the levels of oxidised species at a single time point and it does not provide any 
information on the dynamics of oxidative stress. This may contribute to the confounding factors 
171 
 
that may obscure subtle differences in the levels and extent of oxidative stress and further 
studies are required to investigate it further.  
A second study used the methodology to profile the oxidised lipidome in isolated components 
of RBC infected with the malarial parasite P. falciparum was conducted. Statistically 
significant differnce of oxidised species such as POVPC (m/z 594.5), PONPC (m/z 650.5), 
PLPC-OH (m/z 774.5), SLPC-OH (m/z 800.5), PAPC-OH (m/z 798.5)   and isoprostanoids 
(m/z 832.5) were observed in hemozoin samples compared to other components such as the 
residual bodies, schizonts and uninfected RBCs. This was in agreement to the high levels of 
hydroxylated fatty acids detected in hemozoin samples in previous studies. It was also shown 
the association of these oxidation products and modulation of immune cell functions in 
monocytes and dendritic cells. While this study was conducted on a single set of pooled samples 
that was sent to use by our collaborators, it opens up further avenues for investigation of 
therapeutic efficacy of novel antimalarials that have been developed recently as well as improve 
our understanding about the pathological process involved in malaria and may contribute in 
development of novel intervention strategy targeting lipid oxidation. 
In the third study, an attempt was made to reproduce the result that was obtained using non-
mass spectrometry based methods in plasma samples of diabetic patients in earlier studies. 
While the trend suggested higher levels of oxidised species like PLPC-OOH (m/z 790.5), 
SLPC-OOH (m/z 818.5) in diabetic plasma compared to healthy plasma samples, the variability 
within group obscured the differences. This could be due to the multi-faceted nature of the 
disease often; it becomes difficult to account and control for all inherent biological variation. 
Moreover, no information was available on the drugs administered to the diabetic patients that 
can add to the variability and further stratification of samples based on BMI, drugs taken as 
well as other biochemical tests may improve the data analysis. Also, the effect of oxidative 
stress on lipidome may be too subtle to be detected in the plasma owing to its multi component 
nature and that an analysis of different components of plasma such as low density lipoprotein 
(LDL), chylomicrons and high density lipoprotein (HDL) may be better suited for studies 
involving such multi-faceted disease such as diabetes.  
During our method development and evaluation of chromatographic separation, it was observed 
that HILIC column separated different phospholipid classes that enabled profiling all lipid 
classes in a single chromatographic run. While all the previous chapters measured the oxidised 
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lipidome, this individual project was conducted to look at the levels of unmodified 
phospholipids todemonstrate the wider value of lipidomics, and to understand the biological 
effect of antifoaming agents used in recombinant protein production in bioreactors was carried 
out using yeast expression system. Same method was tested to assess any statistical difference 
in the levels of unmodified species of PC, PE and PS class.  Concentration and antifoaming 
specific effect on lipid composition was observed but biological implication of this altered lipid 
composition is yet to be investigated. 
Despite, the advances presented in this thesis, significant challenges in oxidised lipidome 
studies still exists and the potential solutions are explained below: 
a) Sample preparation: While new processes in sample preparation such as high throughput 
solid phase micro extraction (SPME) with dual reverse phase and cation/anion exchange 
cartridges have been introduced, their use in routine laboratory preparations is rather limited 
owing to preference for simple liquid-liquid extraction methodologies that have long been 
established in the field (Griffiths, Ogundare et al. 2011, Gross and Han 2011, Sandra and Sandra 
2013, Emwas 2015) . Furthermore, online SPME/ column trapping processes are evolving that 
may further improve the high throughput and minimise user intervention as well as reducing 
solvent use and sample preparation time.  
b) Chromatographic separation: While this study attempted to optimise and evaluate 
chromatographic separation, the potential to further improve separation still exist using recently 
developed convergence chromatography, which uses super critical fluids such as liquid carbon 
dioxide as the mobile phases. Furthermore, ultra high performance liquid chromatography 
(UHPLC) using narrowbore columns may improve chromatographic resolution in analysis of 
oxidised lipids and therefore, minimise co-elution as well as ion suppression (Yamada, 
Uchikata et al. 2013, Cajka and Fiehn 2014, Gika, Theodoridis et al. 2014). Furthermore, more 
robust investigation of two-dimensional liquid chromatography (2D-LCMS) is still required, 
although; we had attempted to evaluate the orthogonal 2D-LCMS for separation of oxidised PC 
and PE. 
c) Mass spectrometry: New developments in the mass spectrometry field happen at the pace 
with which the field of oxidative lipidomics is not able to cope. Therefore, most studies in the 
past have used similar platforms and potential new applications and evaluation of newer 
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developed technologies is rather limited or confined to more sophisticated laboratories that have 
the revenue to incorporate these advancements in their day to day analysis platform. One such 
technology that has the potential to improve the detection is the ion mobility mass spectrometry, 
which can offer a third dimension in LCMS separation by incorporation of drift cell between 
ionisation step and the entry to the mass analyser (Baker, Armando et al. 2014). Ions are 
separated based upon their collisional cross sectional area (CSS) where ions are passed into the 
drift chamber filled with collision gas usually helium or nitrogen and weak uniform electric 
field is applied to drag the ions through the drift chamber and the time taken for an ion to pass 
through the drift chamber is directly proportional to the number of collisions with the inert gas, 
which in turn is the direct result of the surface area of the molecule. 
d) Data analysis: One of the most rate-limiting yet overlooked processes in the study of 
oxidative lipidomics is the development of pragmatic approaches to handle and process mass 
spectrometric data. While commercial software and freeware exist to extract information from 
the mass spectrometric raw data, there is fundamental difference in how each software 
processes the data based on the mathematical model and algorithms it utilises from the step of 
chromatographic alignment to peak picking (Bro and Smilde 2003, van den Berg, Hoefsloot et 
al. 2006, Hartler, Tharakan et al. 2013, Chawade, Alexandersson et al. 2014, Mizuno, Ueda et 
al. 2016). Moreover, manual intervention is usually required and recommended as the 
information can be distorted by the process of data handling by this software. One of the most 
important process is the normalisation method that these softwares allow and usually limited 
number of approaches are incorporated by these softwares with the view of one size fits all 
approach, often overlooking the type of biological samples. This can add to the discrepancy of 
reporting and publication of the data that can hamper scientific development. Therefore, a more 
rational approach needs to be established. Also, no universal database exists for oxidative 
lipidomics platform and there is utmost need for development of database with harmonising the 
name of the species that can help speed up the development in this field. In this project,  
database that covered a wide range of oxidation products for PC, PE and PS class was developed 
in an excel file that included the chemical formula, exact mass, retention time, list of fragment 
ions and and structures of all species in sdf format, which was uploaded onto the progenesis 
software to aid in the identification process. 
e) Future oxidative lipidomics studies: There are still several areas where oxidative lipidomics 
is underutilised and could provide valuable insight. One such area includes mitochondrial 
diseases as mitochondrial membrane consists of specific type of lipid: cardiolipin and the 
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alteration in the composition of cardiolipin lipids may be associated with the pathology 
involving mitochondrial function (Bird, Marur et al. 2011). Furthermore, other disease 
pathologies involving oxidative stress may have association with altered lipid composition and 
this field of oxidative lipidomics needs to be integrated to further understand disease 
biochemistry. 
Concluding remarks: The work presented in this thesis offers a potential solution throug 
development of several mass spectrometry protocols with semi-targeted approaches and 
chromatographic separation using monolith column; to increase sensitivity and detection of low 
abundant oxidised species in several disease models. It also provides a starting point to conduct 
oxidative lipidomics studies that has the potential to uncover more subtle changes in the 
lipidome thereby further increasing our understanding of biochemistry underlying disease and 
exposure and provide discovery based solutions. 
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1 Appendix 1 
1.1 Graphical representation  of chromatographic program and solvent system 
used  for optimisation of chromatographic separation as detailed in chapter 
2: section 2.3.1.9. 
 
Solvent System A       
Eluent A: Water with 0.1 % formic acid and 5 mM Ammonium Formate  
Eluent B: Methanol with 0.1 % formic acid and 5 mM Ammonium Formate 
        
      
      % B        
0 70       
4 70       
8 80       
15 90       
20 100       
36 100       
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50 70       
 
 
 
Solvent System B      
Eluent A: Methanol: Hexane: 0.1M Ammonium Acetate (71:5:7) 
Eluent B:  (95:5:0) Methanol: Hexane    
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Solvent System C        
Eluent A: THF:MeOH:Water (30:20:50) with 10mM Ammonium Acetate   
Eluent B: THF:MeOH:Water (70:20:10) with 10mM Ammonium Acetate   
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0 20        
4 20        
20 100        
36 100        
38 20        
50 20        
 
 
 
Solvent System D      
Eluent A:20 % Isopropyl alcohol (IPA) in Acetonitrile (ACN)  
Eluent B: 20 % Isopropyl alcohol (IPA) in 20 mM Ammonium Formate 
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1.2 Graphical representation of chromatographic program for evaluation of 
chromatographic separation using monolith column with different gradients 
(Chapter 2 section 2.3.1.9) 
16 minute steep gradient      
Eluent A: Water with 0.1 % formic acid and 5 mM Ammonium Formate  
Eluent B: Methanol with 0.1 % formic acid and 5 mM Ammonium Formate 
        
      
% B        
0 70       
4 70       
20 100       
36 100       
38 70       
50 70       
 
 
Step gradient      
Eluent A: Water with 0.1 % formic acid and 5 mM Ammonium Formate 
Eluent B: Methanol with 0.1 % formic acid and 5 mM Ammonium Formate 
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Eluent A: Water with 0.1 % formic acid and 5 mM Ammonium Formate 
Eluent B: Methanol with 0.1 % formic acid and 5 mM Ammonium Formate 
       
      
% B       
0 70      
4 70      
30 100      
36 100      
38 70      
50 70      
 
 
 
1.3 Graphical representation of chromatographic program for evaluation of 
chromatographic separation using 2D-LCMS technology using monolith 
column and HILIC column with solvent system A and D (Chapter 2 section 
2.3.1.9) 
 
Solvent System        
Eluent A: Water with 0.1 % formic acid and 5 mM Ammonium Formate  
Eluent B: Methanol with 0.1 % formic acid and 5 mM Ammonium Formate  
Eluent A': 20 % Isopropyl alcohol (IPA) in Acetonitrile (ACN)   
Eluent B': 20 % Isopropyl alcohol (IPA) in 20 mM Ammonium Formate  
       
     % B       % B'      
0 70 8      
2 70 8      
5 74.5 9      
10 82 20      
16 91 25      
22 100 33.5      
23 100 35      
30 100 35      
32 70 8      
45 70 8      
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Eluent B: Methanol with 0.1 % formic acid and 5 mM Ammonium Formate  
Eluent A': 20 % Isopropyl alcohol (IPA) in Acetonitrile (ACN)   
Eluent B': 20 % Isopropyl alcohol (IPA) in 20 mM Ammonium Formate  
       
% B  % B'      
0 70 5      
1 70 5      
5 70 8      
10 80 15      
15 90 17.5      
20 100 20      
30 100 30      
35 70 35      
40 70 35      
41 70 5      
50 70 5      
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2 Appendix II 
 
2.1 Full spectra of precursor ion scan for 184 Da of control, UV treated as well as 
AAPH oxidised phosphatidylcholine mixture (PC mix) 
 
 
Figure 2.1: Direct infusion mass spectrometry of UV treated and AAPH treated PC mixture. The panel shows the 
different profile of oxidised phophatidylcholine (OxPC) that are formed through UV exposure and AAPH 
treatment. 
2.2 Tuning parameters optimisation  
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Figure 2.2: Direct infusion mass spectrometry (DIMS) analysis of 10 mM AAPH treated phosphatidylcholine 
mixture using NL 34 scan for optimisation of compound parameters. Hydroperoxides peaks at increment of 32 Da 
are observed at m/z 790.5 (758.5 + 32 Da) and 818.5 (786.5 + 32 Da) in 10 mM AAPH treated samples. The panel 
shows that the scan with step size of 0.1 and low Q1 resolution maximised ion intensity. 
 
 
Figure 2.3: Direct infusion mass spectrometry (DIMS) analysis of 10 mM AAPH treated 
phosphatidylethanolamine (PE) mixture using NL 34 scan for optimisation of compound parameters. 
Hydroperoxides peaks at increment of 32 Da are observed at m/z 748.5 (716.5 + 32Da) and 776.5 (744.5 + 32Da) 
in 10 mM AAPH treated samples. The 4 panel shows that the scan with CE set between 23 -25 eV provided better 
sensitivity 
 
Figure 2.4: Direct infusion mass spectrometry (DIMS) analysis of 10 mM AAPH treated 
phosphatidylserine (PS) mixture using NL 34 scan for optimisation of compound parameters. 
Hydroperoxides peaks at increment of 32 Da are observed at m/z 822.5 (790.5 + 32 Da) in 10 mM 
AAPH treated samples. The 3 panel shows that the scan with CE set between 20 -25 eV provided better 
sensitivity. 
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Figure 2.5:Direct infusion mass spectrometry (DIMS) analysis of 10 mM AAPH treated phosphatidylethanolamine 
(PE) mixture using NL 141 scan for optimisation of compound parameters. The 3 panel shows that the scan with 
CE set between 30 -35 eV provided better sensitivity. 
 
 
Figure 2.6: Direct infusion mass spectrometry (DIMS) analysis of 10 mM AAPH treated phosphatidylserine (PS) 
mixture using NL 185 Da scan for optimisation of compound parameters. The 3 panel shows that the scan with 
CE set between 30 -35 eV provided better sensitivity 
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2.3 Permission for re-printing the figure showing proton NMR analysis of SOPC, 
SLPC and SAPC chlorohydrin species 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
199 
 
2.4 Liquid-chromatography mass spectrometry (LC-MS) analysis of 
chlorohydrin species from PC mixture on Qtrap 5500 mass spectrometer 
using targeted approaches and cross validation on QTOF MS. 
 
 
Figure 2.7: LC-MS analysis of HOCl treated PC mixture using monolith column for chromatographic separation 
and NL 36, NL 38 and IDA based product ion scanning for identification of species on Absciex Qtrap 5500 mass 
spectrometer (N=3). The individual peak areas were calculated by generating extracted ion chromatogram (XIC) 
for individual species, normalised using peak area of internal standard (13:0 /PC) added before extraction step and 
represented as heat map where light colour corresponds to low abundance level and dark colour corresponds to 
relative high abundance 
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Table 2.1: Automated data analysis using Progenesis QI of high resolution data of chlorohydrin samples PC 
mixture generated on Absciex 5600 QTOF instrument. The table shows the retention time, statistical analysis p-
value post ANOVA, accepted identification, mass error and the sample where high levels was found. 
m/z Retention 
time 
(min) 
Anova 
(p) 
Accepted Compound ID Formula Mass 
Error 
(ppm) 
496.3397 6.02 5.82E-05 PC(16:0/0:0) C24H50NO7P -0.09 
524.3708 8.84 0.000203 PC(18:0/0:0) C26H54NO7P -0.60 
524.3708 7.83 0.00091 PC(18:0/0:0) C26H54NO7P -0.42 
572.3093 5.49 0.001028 Lyso-18-1-ClOH PC C26H51ClNO8P -3.68 
610.3699 6.73 2.90E-06 (pentanedioic)-PPC C29H56NO10P -2.61 
638.4009 10.93 0.000164 SGPC C31H60NO10P -2.91 
650.4001 7.74 0.000214 (5-OH,8-keto,6-octenoic acid)-
PPC 
C32H60NO10P -4.04 
650.4363 9.27 0.002842 PONPC C33H64NO9P -4.32 
664.4169 8.47 0.000405 (5-heptenedioic)-SPC C33H62NO10P -2.22 
666.4322 9.54 3.05E-06 PAzPC C33H64NO10P -2.85 
694.4625 16.11 1.47E-05 SAzPC C35H68NO10P -4.15 
704.4469 11.83 3.64E-06 KODA-PC C36H66NO10P -4.05 
758.5667 24.04 5.02E-08 PC(16:0/18:2(9E,11Z)) C42H80NO8P -3.66 
760.5805 24.45 3.70E-08 PC(16:0/18:1(9Z)) C42H82NO8P -6.01 
782.5652 24.56 1.12E-05 PC(16:0/20:4(5Z,8Z,11Z,14Z)) C44H80NO8P -5.44 
784.5631 24.62 0.000419 
   
786.6008 26.48 0.000206 PC(18:0/18:2(9Z,12Z)) C44H84NO8P 0.09 
810.5355 23.33 5.64E-06 PLPC-ClOH C42H81ClNO9P -6.77 
812.5515 21.65 9.65E-06 POPC-ClOH C42H83ClNO9P -6.38 
840.5829 23.13 2.89E-06 SOPC-ClOH C44H87ClNO9P -6.07 
862.5070 19.09 2.96E-07 PLPC-2(ClOH) C42H82Cl2NO10P -6.56 
890.5368 20.89 3.87E-06 SLPC-2(ClOH) C44H86Cl2NO10P -8.03 
890.5379 19.40 5.45E-06 SLPC-2(ClOH) C44H86Cl2NO10P -6.76 
914.4313 22.37 1.09E-07 
   
938.4882 18.34 0.000163 PAPC-3(ClOH) C44H83Cl3NO11P 4.26 
966.3846 20.66 2.90E-06 
   
990.4605 16.65 9.81E-05 PAPC-4(ClOH) C44H84Cl4NO12P 4.77 
1018.4744 19.88 0.001422 SAPC-4(ClOH) C46H88Cl4NO12P -2.32 
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2.5 Liquid-chromatography mass spectrometry (LC-MS) analysis of 
peroxidation species from PC mixture on Qtrap 5500 mass spectrometer 
using targeted approaches and cross validation on QTOF MS. 
 
Figure 2.8: Qualitative analysis of all OxPC species identified in control and oxidised PC mixture samples by 
generating heat map representing colour coded abundance levels of OxPCs. Over 50 different OxPC species were 
identified and shows upregulation in oxidised sample, compared to control sample. 
Table 2.2: List of oxidised phosphatidylcholine (OxPC) species with accurate masses, experimental masses, 
measured retention time and molecular formula. 
Compound Theoretical 
mass 
Experimental 
mass 
Error 
in ppm 
Retention 
time 
16:0 lysoPC 496.3402 496.3406 -0.81 5.6 
18:0lysoPC 524.371 524.3718 -1.53 7.93 
18:2 lysoPC 520.3407 520.3404 0.58 5.51 
18:1 lyso PC 522.3561 522.3563 -0.38 6.21 
20:4 lysoPC-OH 560.33468 560.3383 -6.46 4.51 
20:4 lysoPC 544.3403 544.34 0.55 5.71 
18:2lysoPC-OH 536.3356 536.3347 1.68 4.61 
18:2lysoPC-OOH 552.3317 552.33 3.08 4.33 
18:2lysoPC=O 534.3203 534.323 -5.05 4.56 
13:0PC (internal standard) 650.4755 650.4765 -1.54 18.12 
PLPC 758.5694 758.569 0.53 22.87 
POPC 760.585 760.5848 0.26 23.38 
PAPC 782.5694 782.568 1.79 23.11 
OLPC 784.5851 784.5836 1.91 23.47 
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SLPC 786.6007 786.6001 0.76 24.23 
SOPC 788.6163 788.6154 1.14 24.68 
PDHPC 806.5698 806.5687 1.36 23.63 
SAPC 810.6007 810.5998 1.11 24.53 
SDHPC 834.6012 834.5993 2.28 24.87 
P-7KPC(1palmitoyl-2-(7-oxoheptanoic acid) 622.40785 622.4082 -0.56 6.93 
P-8KPC(1palmitoyl-2-(8-oxo-octanoic acid) 636.4235 636.4237 -0.31 7.55 
P-7K5EPC (1palmitoyl-2-(7-oxo-5-heptenoic 
acid) 
620.3922 620.3931 -1.45 7.52 
P-11K9EPC(1-palmitoyl-2-(11-oxo-9-undecenoic 
acid)PC 
676.4548 676.4556 -1.18 10.17 
POVPC 594.3763 594.3775 -2.02 6.2 
PONPC 650.4391 650.4395 -0.61 8.43 
S-7KPC 650.43915 650.4388 0.54 11.51 
S-8KPC 664.4548 664.456 -1.81 13.28 
S-7K5EPC 648.4235 648.4236 -0.15 13.47 
S-11K9EPC 704.4861 704.4857 0.57 17.79 
SOVPC 622.40785 622.4084 -0.88 9.71 
SONPC 678.47045 678.471 -0.81 14.91 
PGPC 610.3714 610.3724 -1.64 6.27 
PAzPC 666.434 666.4347 -1.05 8.41 
HOOA-PC 650.40276 650.4035 -1.14 6.25 
KOOA-PC 648.38711 648.3866 0.79 6.21 
HDOA-PC 706.46536 706.4649 0.65 8.39 
KDOA-PC 704.44971 704.4483 2.00 8.44 
1-palmitoyl -2-(5-hydroxy-6,8-undecedienoic 
acid)PC 
690.43406 690.435 -1.36 13.95 
1-palmitoyl-2-(8-hydroxy-11-oxo-9-undecenoic 
acid)PC  
692.44971 692.4502 -0.71 10.42 
SGPC 638.40276 638.4035 -1.16 9.68 
SAzPC 694.4653 694.4659 -0.86 14.85 
HOOA-PC with 1 stearoyl 678.43406 678.4342 -0.21 9.72 
KOOA-PC wth 1 stearoyl 676.41841 676.4197 -1.91 8.33 
HDOA-PC with 1 stearoyl 734.49666 734.4953 1.85 14.88 
KDOA-PC with 1 stearoyl 732.48101 732.4792 2.47 14.85 
1-stearoyl -2-(5-hydroxy-6,8-undecedienoic 
acid)PC 
718.46536 718.4662 -1.17 13.92 
1-stearoyl-2-(8-hydroxy-11-oxo-9-undecenoic 
acid)PC  
720.48101 720.4794 2.23 13.67 
HOdiA-PC 666.39768 666.3984 -1.08 6.39 
HDdiA-PC 722.46028 722.4651 -6.67 7.25 
KDdiA-PC 720.44463 720.4425 2.96 8.26 
1-palmitoyl-2-(10-hydroxy-5,8,11-
tridecatrienedioicacid)PC 
732.44463 732.4456 -1.32 8.36 
HDdiA-PC with 1 stearoyl 750.49158 750.4921 -0.69 16.07 
KDdiA-PC with 1 stearoyl 748.47593 748.4761 -0.23 15.54 
1-stearoyl-2-(10-hydroxy-5,8,11-
tridecatrienedioicacid)PC 
760.47593 760.4765 -0.75 14.75 
PLPC-OOH 790.55926 790.5595 -0.30 17.7 
POPC-OOH 792.5749 792.5745 0.50 20.04 
SLPC-OOH 818.5911 818.5906 0.61 19.77 
SOPC-OOH 820.60621 820.6037 3.06 21.55 
PAPC-OOH 814.55926 814.5585 0.93 20.36 
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SAPC-OOH 842.5899 842.5898 0.12 20.95 
PDHPC-OOH 838.55926 838.5596 -0.41 20.92 
SDHPC-OOH 866.59056 866.5891 1.68 21.27 
PECPC 810.5279 810.5257 2.71 19.66 
SECPC 838.55926 838.5597 -0.52 19.5 
SEIPC 856.56983 856.5707 -1.02 19.55 
PEIPC 828.5381 828.5396 -1.81 17.16 
PLPC(OH)-OOH 806.5541 806.5554 -1.61 18.29 
SLPC(OH)-OOH 834.58548 834.5855 -0.02 17.74 
SAPC(OH)-OOH 858.58548 858.5843 1.37 19.46 
PAPC(OH)-OOH 830.55418 830.5563 -2.55 18.49 
PDHPC(OH)-OOH 854.55418 854.5563 -2.48 19.04 
SAPC-2(OOH) 874.58039 874.5805 -0.13 18.4 
PLPC-2(OOH) 822.54909 822.5502 -1.35 15 
SLPC-2(OOH) 850.58039 850.5992 -22.11 18.13 
POPC-OH 776.58 776.5801 -0.13 21.58 
PLPC-OH 774.5643 774.5641 0.26 21.02 
SOPC-OH 804.6113 804.6089 2.98 22.72 
SLPC=O 800.58 800.5796 0.50 22.09 
SLPC-OH 802.5959 802.5953 0.75 21.13 
SAPC-OH 826.5956 826.5956 0.00 21.78 
PDHPC-OH 822.56435 822.5636 0.91 20.58 
SDHPC-OH 850.59565 850.595 0.76 22.16 
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2.6 Evaluation of chromatographic separation of oxidised phosphatidylcholines 
(OxPC) using different chromatographic system 
 
 
 
 
 
 
2.1 Evaluation of flow rates on chromatographic separation of OxPC and signal 
to noise ratio 
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A) Monolith column        
(Proswift-4H, 1x 250mm) 
B) C-8 Luna column 
(1x150mm) 
C) C-18 Luna column 
(1x150mm) 
D) C-30 Acclaim column 
(2.1x150mm) 
     E) HILIC column** 
(3x150mm) 
F) C-8 Luna column* 
(2.1x150mm) 
1 - m/z 594.5, POVPC (short chain oxidation product);  2 -  m/z 650.5, PONPC (short chain oxidation 
product); 3 - m/z 774.5, PLPC-OH (long chain oxidation product); 4 - m/z 790.5 ,PLPC-OOH (long chain 
oxidation product); 5 -   m/z 758.5, PLPC (native PC); 6 -  m/z 786.5, SLPC (native PC)  
 
 Figure 2.9: Extracted ion chromatogram (XIC) were generated of two representative species for each group; chain 
shortened products (POVPC,m/z 594.5; PONPC, m/z 650.5), long chain oxidation product (PLPC-OH, m/z 774.5; PLPC-
OOH, m/z 790.5) and Native PCs (PLPC, m/z 758.5; SLPC, m/z 786.5) and overlaid to evaluate the elution profile of 
OxPCs using different column. Different solvent systems were also used to optimise the separation of different species. 
** indicates solvent system for HILIC column: eluent A- 20% Isopropyl alcohol (IPA) in Acetonitrile (ACN) and eluent 
B- 20 % IPA in ammonium formate (20mM); * indicates another solvent system consisting of eluent A as 
Tetrahydrofuran (THF):methanol:water (30:20:50) and eluent B as THF: methanol: water (70:20:10) with 10mM 
ammonium acetate 
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Table 2.3: Effect of flow rates on retention, sensitivity and resolution of representative oxidised species calculated by generating extracted ion chromatogram (XIC) and measuring peak area. The OxPC 
mixture was separated using monolith column at different flow rates and detection was performed on Q-trap mass spectrometer 
. 
Flow rate     50 μl/minute 100 μl/minute 200 μl/minute    
compound Monoisotopic 
mass (M+H)+ 
Molecular Formula 
(neutral compound) 
16:0 lysoPC 496.3402 C24H50O7NP 4.71 3.15E+06 2.25 2.82E+06 1.18 3.36E+05 
18:0lysoPC 524.3710 C26H54O7NP 5.53 2.35E+08 2.66 1.29E+08 1.38 3.62E+07 
18:2 lysoPC 520.3407 C26H50O7NP 4.8 2.45E+05 2.34 3.53E+05 0 0.00E+00 
18:1 lyso PC 522.3561 C26H52O7NP 5.05 3.29E+07 2.44 2.13E+07 1.22 4.71E+06 
20:4 lysoPC 544.3403 C28H50NO7P 5.11 5.33E+05 0 0.00E+00 
 
0.00E+00 
13:0PC (internal standard) 650.4755 C34H68O8NP 17.79 1.69E+07 10.94 1.07E+07 7 2.24E+06 
PLPC 758.5694 C42H80NO8P 22.99 7.10E+08 15.83 6.72E+08 11.85 2.31E+08 
POPC 760.5850 C42H82NO8P 23.52 1.61E+09 16.33 1.81E+09 12.32 6.73E+08 
SLPC 786.6007 C44H84O8NP 24.45 5.49E+08 17.22 6.42E+08 13.21 1.44E+08 
SAPC 810.6007 C46H84NO8P 24.77 5.86E+07 17.56 8.19E+07 13.54 2.18E+07 
P-7KPC(1palmitoyl-2-(7-oxoheptanoic acid) 622.4079 C31H60O9NP 6.02 1.68E+07 2.89 1.12E+07 1.54 2.23E+06 
P-8KPC(1palmitoyl-2-(8-oxo-octanoic acid) 636.4235 C32H62O9NP 6.4 4.01E+07 3.14 3.41E+07 1.6 7.26E+06 
P-7K5EPC (1palmitoyl-2-(7-oxo-5-heptenoic acid) 620.3922 C31H58O9NP 6.28 4.48E+06 3.08 3.30E+06 1.53 6.08E+05 
P-11K9EPC(1-palmitoyl-2-(11-oxo-9-undecenoic 
acid)PC 
676.4548 C35H66O9NP 8.11 
1.51E+07 
4.08 1.02E+07 2.29 4.29E+06 
POVPC 594.3763 C29H56O9NP 5.55 3.48E+06 2.66 2.55E+06 1.32 3.95E+05 
PONPC 650.4391 C33H64NPO9 6.96 1.48E+08 3.42 1.21E+08 1.79 2.33E+07 
S-7KPC 650.4392 C33H64O9NP 9.69 2.91E+06 0 0.00E+00 0 
 
SOVPC 622.4079 C31H60O9NP 7.55 2.22E+07 3.76 1.53E+07 2.02 3.10E+06 
SONPC 678.4705 C35H68NPO9 10.77 4.51E+07 5.57 2.99E+07 3.23 7.76E+06 
PAzPC 666.4340 C33H64O10NP 6.86 5.37E+07 3.39 5.23E+07 2.38 5.12E+06 
SGPC 638.4028 C31H60O10NP 7.48 1.47E+07 3.06 3.33E+07 1.56 6.43E+06 
SAzPC 694.4653 C35H68O10NP 10.44 2.24E+07 5.45 1.53E+07 3.18 3.24E+06 
PLPC-OOH 790.5593 C42H80O10NP 19.71 8.53E+07 12.99 7.02E+07 9.42 1.61E+07 
SLPC-OOH 818.5911 C44H84NO10P 21.42 2.96E+07 14.54 3.87E+07 10.79 9.74E+06 
PEIPC 828.5381 C44H78O11NP 18.55 2.88E+06 11.74 1.41E+06 5.17 1.58E+06 
PLPC(OH)-OOH 806.5541 C42H80NPO11 17.93 2.05E+07 11.21 1.31E+07 7.4 2.67E+06 
SLPC(OH)-OOH 834.5855 C44H84NO11P 19.97 5.05E+06 13.24 4.60E+06 9.62 1.40E+06 
POPC-OH 776.5800 C42H82NO9P 21.47 8.79E+07 14.5 8.90E+07 10.72 2.90E+07 
PLPC-OH 774.5643 C42H80O9NP 20.86 1.29E+08 13.96 1.35E+08 10.25 4.19E+07 
SAPC-OH 826.5956 C46H84NO9P 21.76 3.78E+06 12.42 2.53E+06 8.75 8.73E+05 
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